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Abstract 
Potential health benefits of antioxidant effects of wine on lipids 
D M Blackhurst 
The consumption of wine dates back to the Stone Age, but its potential health benefits 
only really began to make an impact after the French Paradox was postulated by Renaud 
and de Lorgeril in the 1990s. Their observations indicated that moderate consumption of 
red wine may have health benefits. Research since then has shown that wine, in particular 
red wine, is a source of a large number of different polyphenolic compounds that have 
antioxidant activity. 
The finding that the consumption of red wine might have a beneficial health effect was 
very appealing, resulting in a large number of epidemiological and experimental studies. 
To date, controversy still surrounds wine and its health effects. Several pertinent 
questions are still to be answered: What in vitro methods can be used to determine the 
antioxidant effects of wine? What are some of the in vivo effects of wine? Can wine be 
used directly as an antioxidant in cooking of the food that would ordinarily be exposed to 
conditions that may induce peroxidation of lipids? What effects does wine have at the 
cellular level? 
Four areas of research were undertaken in response to these questions. The first study 
examined the antioxidant effects of red wine on thermally-stressed polyunsaturated oil. 
The lipid peroxidation products present in various monounsaturated and polyunsaturated 
oils were examined: total and free thiobarbituric acid reactive substances being the most 
varied, while lipid hydroperoxides and conjugated dienes showed less variation. 
Thermally-stressed polyunsaturated fatty acid oil showed an increase above baseline of 
approximately 450% for conjugated dienes and lipid hydroperoxides, while there was a 
34% and a 10S001o increase of total thiobarbituric acid reactive substances and free 
thiobarbituric acid reactive substances respectively, over 75 hours. Macro and micro oil 
boiling assays were set up to determine the antioxidant capability of 9 different red wines, 
revealing similar results for all. The wines had a powerful antioxidant capability relative 
to copper, a pro--oxidant, diminishing by SO-I 00% the peroxidation products tested. 
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There was a trend for red wine to protect the unsaturated lipids in red meat against 
conjugated dienes during moderate cooking. Marinating changed the conjugated dienes in 
meat after cooking from the raw state by -23.3%, the lipid hydroperoxides by -21.6%, 
and the thiobarbituric acid reactive substances by 37.1%. Loss of fatty acids from the 
meat into the red wine marinade was minimal as established by gas chromatography, 
which also determined that the fatty acid profile was not significantly altered during the 
cooking. 
The possible antioxidant effect of the consumption of red wine on postprandial 
lipoproteins (chylomicrons) was investigated. There was no significant difference 
between the peroxidation products in isolated chylomicrons generated with and without 
wine, nor did they differ in their resistance to copper-induced lipid peroxidation. 
There was a significant increase in the diameter of the brachial artery, relative to the 
baseline, over 2 hours after moderate consumption of red wine, although flow-mediated 
dilatation of the artery did not increase significantly. Wine consumption also significantly 
impaired the vasoconstriction with ice immersion after 60 minutes, but did not alter the 
vasodilatation after trinitroglycerine. 
Wine is a complex beverage which may have beneficial health effects. These studies 
show that wine has strong antioxidant effects that can be simply described with 
nutritionally relevant polyunsaturated fatty acids in a boiling experiment, that there is a 
potential for wine to limit lipid peroxidation during food preparation and that its 
immediate effects on flow-mediated dilatation need further investigation. Ultimately, 
only a prospective, controlled interventional study evaluating cardiovascular outcomes 
can conclusively prove the health benefits of wine consumption. 
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CHAPTER 1. WINE, ITS mSTORY AND CULTURE, AND THE CHEMISTRY 
OF ITS EFFECTS ON LIPIDS AND HUMAN HEALTH 
1.1. The history and culture of winemaking 
1.1.1. History and culture 
The origins of wine can be traced back as far as the Stone Age due to the discovery in 
Northern Iran in 1996 of a pot of fennented grape juice, probably the earliest fonn of 
wine. The pot was dated back to 5400--5000 BC (1). Literature includes a number of gods 
and goddesses of wine: Liber the Roman god, Siduri the Sumerian goddess, Sekhmet the 
Egyptian goddess, Sura the Indian goddess, Tepoztecatl the Aztec god and Ssu-ma 
Hsiang-ju the Chinese god. 
Ancient Egyptian pottery shows that wine played an important role in their civilisation. 
Passages from the Bible refer to wine as ''the blood of grapes". In the Koran, Paradise is 
described as a place where there are ''rivers of wine, an exquisite delight for drinkers" (2). 
Ancient Chinese medicine refers to the medicinal use of fennented drinks and medical 
writing from the 6th century B.C. from India describes the health benefits of alcoholic 
drinks. 
The growing of vines and winemaking spread through Egypt to the west and south and 
also became entrenched in the Greek civilisation. The ancient Greeks travelled ·and traded 
overseas and took with them vines and the knowledge of wine production. Their trading 
with the Romans at about the first century A.D. marks the beginning of vine cultivation in 
Europe. Grape vines that are grown now are related to these vines. They belong to the 
family Vitaceae, genus Vilis. Vilis is divided into two subgenera: Euvilis, the true grapes, 
and the Muscadinia. The wine industry of the world is built upon one of the 60 Vilis 
species, called Vilis vinifera, which is often called the European grape (3). 
By the end of the 5th century A.D. the Romans had established some of the world's 
best-known vineyard areas for example Burgundy, Bordeaux and the Rhine valley of 
Gennany. During the collapse of the Roman Empire and the ensuing Dark Ages, the 
Church became the focus of winemaking. By the 12th century the powerful Benedictine 
and Cistercian monasteries owned most of the French and Gennan vineyards. Wars, the 
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power of the Church and royal marriages between the English, French and Gennan 
nobility were some of the factors that controlled the wine markets well into the Middle 
Ages. 
Initially the wine served and sold was very young and acidic. At first it was stored in 
flasks called amphorae, until the Romans developed glass blowing (4). This was followed 
shortly afterwards by the practice of sealing the bottles with stoppers. It was then possible 
to store wine for longer periods of time. The Bordeaux and Burgundy regions started 
producing wines specifically for ageing, called "reserve" wines. 
Different types of wine were introduced, for example Champagne, a "sparkling" wine 
with bubbles of carbon dioxide generated by a second fennentation. It became very 
popular in the Cafe societies of the 1720s. Fortified wines were introduced, at first by 
adding grape brandy to wine to enable the wine to be transported by ship without the 
wine becoming vinegar. In 1730 the sweet fortified red wine, Port, was introduced in 
England. 
During the French Revolution of 1780 the vineyards were taken from the Church and 
nobility and auctioned back to the citizens. By the 19th century the wine market was 
doing very well. The vine spread to other continents. In South Africa, Jan van Riebeeck 
planted the first vines in the Cape in the 1650s from French stock. In 1685 the Constantia 
estate was established. The first vines introduced into southeastern Australia were via the 
Cape. The gold rush of the mid-1800s resulted in the introduction of vines to California. 
A very popular sweet wine at that time was Constantia from South Africa. 
In the 1860s, the French vines were decimated by an aphid-like insect known as 
phylloxera that attacked the roots of the vines (5). The disease spread across Europe and 
further down to the Cape, destroying most of the vines there by the 1880s (6). The 
disease was a disaster at that stage but the outcome was that only the most resistant vines 
survived and fonned the basis of modem viticulture. 
1.1.2. Winemaking, with special reference to South Africa 
There have been huge advances in modem viticulture and winemaking science and 
technology during the last 35 years. Results from many studies have suggested that 
certain wine polyphenols play a positive role in human health, and for this reason 
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problems in winemal..mg are due 10 inaJequ"lc 'Ott 
I 1 incomplete )u" ferTllC'nt.,lIon. which i~ due to iU'lJfficient m1ro¥tn In the lIOiI and 
2, ",inc with tOO high 3 pi I. which is due [0 uu.<,s pot3'-"um III the ""'il /lhe Ilsual 
p ~1 for .... hue ",inc IS 3.G-3.3 and (Of red table "'ltIC I~ 31-' 4. (3)1. 
tll:U rf 1.1. S tl'f"nbel"l .. in<,)·uds in CalX' Town. 
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1. 1.1.2. 119rn~stlng 1m, i:rI' r-
Picking me grapes by IlaOO I~ Mill earried OUI fDirly e\ten~.vdy in Soulh A frica. but 
harvesting by mach l~ i~ .. Iso u-ed. Thi~ method 1$ k$.\ cOMly IlIId ks.s tllne-consuming. 
bul \lie grapes are oflCIi IIlOIl: dJllldgcd. White gr'.iJl'L':' are used In the making of "hite 
..... /lC. Their skins rJngc I.t colour from green to yellow 10 PilI:. bul their juke is "white", 
The: juice of mI grapes b also p;t.1e lind the s~in~. helng dark In coIoor. are used 10 colour 
the red ... il!c:~ 
Fif:UI'l.' 1.4. 1\ lechanical sampli ng or Ihe graJX' load. 
~""i gurc 1.5. Cunlaincr "ith n~h:lIlical scrt'w for collecliun of 
grapes al ofT- loadinf:. 
1.1.2J. Wincmaking in gCfll' r.1I 
D,fferenl wincmaking Icch-.iqucs. including using different ageing temper.uure~ and 
tim~,. and oxygen exposure. are found to innucnce Lhe cl"" composition and 
concentrations of phenols in win.:. For exantple dunng agcmg. conccntr~tion;; of 
anthocyunins (pigmenh thaI significantly contribute to red wine colour) (Figure 1.24) 
" 
( 10) 
1.1.2.3.1. Whl l ~ .. IT>\' m:lklnl: 
After am~!ng Ul the .. (nery. lh~ grope~ arr eilher rre_lo<.-« immedlalely 10 SCparJle Ihe 
Ju,ce fn,m the S~ IRS and '>('ed~. or cru~h~d lighll>' and le ft rur ap" roxnn;,lely a day before 
pn:~"ng. "lIo .. ,,,!! the \kin, und Juice to re:X:1 together for this ~hort lime re,uhs in II 
more Oavourful "UII; as .. ell a. incrc!l.l ing the con~'(ntnltlon of pol)·phcnol ... ",hlch has 
been foond 10 ,mpro,-e the 3ntiO." dUnt calXlC,ly of \lillie ",hlle .... inc. (11)_ TIll: juice I. 
then 1I1ln)fcrn'tl InIO ti:rm~ntullon ,·nh. ",tll,h may be old-(u;.hioncd concre te (Figure 
1.61. oak or stoinle" 'I~"CI (Fisun: 1.9). 
Figun! 1.6. CORCn' le val~ alit.. Vln:l Cousida Macul .. i"",r} in 
Sanllaga . OIik. Soulh An",rica . 
1. 1.2.3.2. R~ .. -ilIt' making 
In L'OntruSI III .. h,le ,,·inc ... lhe JUIce ,1> wdl a. the: skins and liCOOS are PUI IniO stuIIllcss 
,Ieel \at~ or oak b;l1TCb for the fellTlCnlal10n proccs>. During fermentation. anth{1Cyanins 
an:: able 10 CondCII'IC .. nh t.lnnin>, from clt'Kr the: ~ or oak, in the: pte-.e1lCC of 
accl.lldchydc. ICa1:ltng 10 the: prodUClion of ptpot'nt>. .. hieh in \Olullon are ITIoOr"" rrsistant 
to pH chang<- lind bkachlng by ~tphur dIOxide and an" gcnerJlly more stable than 
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>oOluuons of umI!OCY"IT In., alone. Thl~ I' imflOnan! fot .he mention of mI "inc colour 
(12.13), 111(': presence of acelUklehyde IS due to Ille slow upta~c of small amounts or 
o~y~n Im irro-o.~}gcn:llion) Ihrough oa~ b:uttl~ or by ~ITIJ.II mr:buml addllions .0 I~ 
slainiess 51eel valS. and in Ihe prtscnce of a Iran!'lIIon melul (,ron. COppeT or m3ng~nesel 
the ()~}'gen ~omcs activaled. Thi~ acti\'~led oxygen. rtrn'sellied by hydrogen pcro ~ lde. 
IS ab le 10 oxidl)e alcohol 10 a.,.'elaldehyde. and this ~Ulblli!loCs lhe anLlIocpnill-.aITmn 
real:lion ( p"',.on~1 <'ommuniClilmn ""I! Michael BlUXhol/ •• he "'ITCmal.er :lL Oi.,ell 
Wi nery). 
Tho: majori.y of South African red "iJ'lC!. act fClml'lltcd in ~t."nlc'~ steel ~ Jts. some 
"ilh oal. SI;L\CS or oak chips :tdded 10 the "al dunng lhe pnxcss. Concrete Wb art ~tillln 
use in Soolh Africa. Fertllem~lIOn tCIllpl'rJIUre. all' conlroUed \II arp<Oximalely 25-28 C 
ror many Soolh Arnc:m red ""1eS 
Hgu .... 1.7. Red gnl'" juice. Sl",ds Mnd ~ ~ln are Irll nsrerred Inlu II "al. 
lJ 
Fi l!u~ 1.8. \(~d win~ r~rml.: nllltion in a sl"inlcss stt..,1 va t. 
OIlring rcrmcnl~uon tile colour from the anthoc)'anin~ as weli a~ tann In, from tile ~ llll' 
Ic~cll<:' 1I1t0 the Ju ice (mu~t). Th,s process is called matl'r"uon. Dark red WIflC"\ (for 
C~ ample Merl ot :md Shinu.) requi re Ihat the , ki ns and Ju ice" react together for longer (for 
example IWn wech) than the lighter--colnured reJ wines. which may hal'e onl} a few 
d"),, w re,I.:!, before thc juice i, tr"n ,f<'rred 10 V:IIS III conlinII<' wilh lhe fermentaunn 
(lfoc'C,;, E~amples of red wine, afl: CabemCi Sauvignon. Shlr~7 an" !'inOluge (from 
South .Mrlca·~ 0\\0 grape: hybrid of PinO! Noir and Hermit"ge). A rccem comp;lri,oo of 
dI fferent euh,, ;m; of red WlOC<; from different regions '>\orldwide ,ho\lcd wide ranges III 
ca techin and cpicatlXhin concemnll ion\ ( 14) ti'lO'iC from South Afrie''' WCll: Hmong~t the 
lowcst ~tudied Table 12 sho'>\s compositional d.lla of red and \lhite wines. Among the 
potential reaSons gilen for Ihes.- d lffL""'1n"" ,,'el1' diffell:llt climal"~. ,oil, and ,n 
p;uilcular dIfferent winemaling techniques. 
1.1.2.4. Fermentation 
1.1.2 .... 1. Fermentation in general 
Ferment",ion i, the biochemk':ll proces> ... ·hen:by <;ugar (prcdomin~ntly gluCO\e ~nd 
fru(."(ose) in the juice of the grape,; is convened imo ethanol and earbon dl0\;dc hy the 
metabolism of yea,t: 
GIIICOSC' and fructose are mc1aboliscd b} yeast to p)'n"-~te ,;~ glyrol)~i). PYrlIv:lle ;) 
dcC'3fbo~}latcd to atttaldc:hydc:. "hlch is then Itduccd to cthanol by ycaM alcohol 
dehydrogenase (ADII ). 
GJ)cerol .s the major fcrmc:Rl3Ilon product afler ethanOl and c:trbon dio,ilk (15). 
AplClllalc and oXlo.lalj,·c ye:t>ts for example C:lIIdlda. aft the predominant yeasts on the 
grJpl'. bllt 5<""'''III1"n,..". urn'ma~ I~ the specie. rTIOStl) K_pon,<ble for alcoholic 
f.:rment:lllon a.- II i. tolerml 10 elhanol (16). The opumal growth ICffipl'f1IIUn:' for S 
~'n',s;a" is 25 C (17). It ;, II comple, JlI'OCC'is th.:at lila)" be ~ffeC1C<l by J nllml>l:r of 
f;K1Qf') Ih:ll ulllnl:m:l) affcct the quahty of the ""'oc. ~uch J) roonJXhllion of the gT:lJX' 
JUice. the IcmperJtun> of reml("m~lion. conct'mrJlion of wlphur dto~id<:' and WlI11l1 of 
yca.1 (18.19) O",ng to Insufficienl )"-,:,,t ('ells of the surf:w:t' of the grape •. natural or 
rultiv:ltcd ~·Ca._IS arc added afH"r Ihe ~ h:I.\e been crowd. During fcrmc:n1!lllon. thc 
heat gencf1l .... d by lhe prt.>C'eS$ rna) be )upprt'So<;cd by conlrolhng the Icmper.lture. fOI 
c~amp1c in Ihe Slainl."s sie-el q.h 
Figuh' 1.11. Stai ,Ms,; steel " Dis for ferme ntat ion. 
Rrmellt31ion cea-;e, when all the ,ug!lr has been convcrted (0 ethanol or "hen alcohol 
Inhibit, the process. Fcmlcntation SlOps at an alcohol content of 8- 10% (20). The 
s..>diment that is formed from dead yeast eells at the bollom of a vnl is kIlO"''' as "lees". 
Then: are many volatik compounds produced as a resull of ferm~ntation, illCluding 
isobutanol, ethyl hexanoale. acelic add and valerie add. and Ihese are responsible for 
wine aroma (2 1). 
Till' presence of sulphur dioxide in wine is dut' to del i bcrat~ addition 10 eit~r must or 
wme. or also the production by )'east dunng fermentation. ThiS results In gTO"'lh 
inhibition or death of undesirable bac":rin and yeast and pn:vention of bro"" pigmem 
dcvelopmem. These bacteria il1C lude acetic acid bacteria (genera Gfucoltohacft'r and 
Act'fo/Jacf('r), "'hich are present on the surface of grapes and ha\e been found to be 
present during alcoholic fermentation and subsequ~nt ageing of the wine. despile 
requiring aerobic condilions. They produce acetic acid from ethanol and so may 
contribute towards bacterial spoilage of the willC. Sulphur dioxide may prevenl this (22). 
Sulphites in winc have been found to have antioxidant propenics (23). Winc that conla-ins 
sulphur dioxide must have this declared by labelling (in South Africa. Australia and the 
United Slates of America) because individuals lacking lhe su lphite oxidase enzyme are 
highly sensitive to the compound. 
1. \.2 . ~ .2. MalolaNic frrmrntal ion 
This secondary fermemalion is an option tor white wine bUI is one that most red wines 
undergo. It is a natural process that takes place after the main fennentation and hcfore 
ageing and bollling. It involves the conversion of " an" malic acid (which. with tanane 
acid. are lhe dominant organic ocids in "ine: (24» 10 lactic acid and carbon dioxide 
(Figun: I . I 0) by lactic acid baCIl.'ria, which renders a ..... hile wine "creamy" and a red wine 
"soft and buuery". 
COOH 
I 
CHOH 
I 
CH2COOH 
COOH 
I 
CHOH + 
I 
CH, 
co, 
Flgur~ 1.10. ConHrslo n elf malic acid 10 laClk add. 
1.1.2.5. Ageing 
Most white wines an: made for drinking young, for example Sauvignon Blane and 
Chl-nin Blanc. whereas a few are best aged in oak. for example Chardonnay. Most white 
wirll:S undergo minimal. ifany. del iber .. t. bouIe-ageing. 
Most red wines are aged. lirst in oak (for 6-24 months) and then in boules (for up to 20 
years). In red wines the length of ageing is dependent upon the quality of the grape. the 
culti~ar and the "inemaking process itself. After ageing. mature red ,,;ncs have II red-
brown colour and are less astringenltha1 their younger eoonterpans. which are red- blue 
in coloUl' with a fairly astringent taste. This is dUl: to the reaction of anthocyanins in 
malun: ",;nes with the flavanol s (10). 
As ageing progresses. the aroma and flavour of the ",;nes change. leading to the 
development of softer. richer wines. Maturation of red wine in oak n:sults in complex 
interactions belwecn compounds in ,,-000 and ",inc. involving oxidation. hydrolysis and 
polymcrisation. This chemistry is 001 wtll-undcrstood. The antioxidam activity of wine 
during the fermentation stage has been lOund to be significantly lower than that of aged 
wine. although their total phenol conc~ntralions were similar. This suggests Ihat the 
larger polyphenol polymers that appear during ageing play an imponant role in the total 
antioxidant aellVtty of red ",;ncs (25) During the age ing process, the ellagitannins 
(Figure 1.15). owing 10 their rapid and I.'lIsy oxidation. prevent oxidation of other wine 
components. These oxidiscd tannins then slowly release hydroperoxides into the "inc 
(21). Generully. the younb'Cr the oak used and the 5maller lhe barrel. the mon: distinet the 
flavour that is imparted \0 the .... ine from the harsh woOO tannins. Older oak imparts a 
mellow character. 
27 
figure 1. 11. Ageing in " ood. 
U. II EAI.TII ASPECTS OF ALCO UO LIC IIE \ £ HAfa:s. \\ IT II FOCUS ON 
\\I"E 
This SCl.110n proVide .. inrormatJOn on alcoholic be\CrJgl:5. particularly "'"IC, and 
lk<.Cri~~ tl~ pok.'tlual healtll Nncfil, of con'iUml nl! alcoholic bc\'crages 
1.2.1. IJado:ground 
'J'I\eno IS lillie doobl rlla! heavy COIl'iUmplion of alcohol i~ hannful 10 health. WI 
"oclocr moder-... " COfl~mpllon lIib NneflCial effecr~ has cauSl;'d muc h comro,cr.y 
IIlppocr.llc,., the Grecl phy,'cian and f~I""'r of We~t~rn medicioe (26) ,ugge.<;I~d nearly 
2JOO year":1&0 llI:il Mf(lOd iii.' your medicine and medici nc" your food". Hc u.cd ... inc for 
many ailmcnl<; including dmrrllOl:a and Icillargy. Pamccl§us {1 ';93-15~1 ). too Swiss 
p/l).ician .• uggesrcd llial food can be a drug or a poison. aod Iltat the difference is a 
maner of dosage. and tlien appl'Qximalcly 400 ycar~ afl .. r tltat. PaMcur (1822-1895), the 
F",ncll chemht. dC!oCribcd wine u .. the healthi .. ' 1 and mml lIygicnic bc\·eno.gc:. Dunng the 
19'" century, III<: to>!" eITccb of alcohol hccm nc C"ldeOI and doctors ... ·ere loalhc 10 
prolll()l<' ii' ~...,n.",mpl ion . Evidence of hc~ll h bc:ncfilS of ronsumplJon of akoholic 
be ,er~!:<,.<; only I\'a ll )' began IlCcunm latmg in llie 2r.r cenlUry. "Ith a large nu mber of 
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studies taking place in the 1990s. To date this accumulated evidence shows paradoxical 
results: heavy drinkers suffer predominantly harmful results (27) while abstainers may 
fare less well than regular moderate drinkers in the risk for coronary heart disease (CHD), 
strokes and total mortality. Moderate drinking is now generally accepted as 10-35g 
alcohol/day (28,29). The risk of all-cause mortality in moderate drinkers is 20-30% 
lower than in abstainers (30). There are several problems associated with proving whether 
wine or any other alcoholic beverage has health benefits. To be effective, epidemiological 
studies should ideally be carried out over a number of years, because diseases against 
which alcoholic beverages may confer protection, e.g. cardiovascular disease (CVD), 
develop slowly. Similarly, harmful effects may only be evident in the long term. The 
changes in the body or health outcomes that are being studied may require large sample 
numbers to demonstrate an effect. Many studies rely on self-reported drinking data, and 
alcohol consumption is often under-reported (29,31). Patterns of drinking are also often 
very variable and therefore potential benefits and risks are accumulated only over long 
periods of time. There is also the problem that factors such as economy, gender, age, diet, 
smoking, social class, ethnicity and education play a role in population health and may 
therefore act as confounders in studies of effects of alcoholic beverages on health. The 
Atherosclerosis Risk in Communities Study (31) found contrasting associations between 
alcohol consumption and incidence of coronary heart disease (CHD) in White and Black 
subjects with an inverse association for White men and a positive association for Black 
men for l3g1day ethanol consumed as wine, beer and spirits. This might raise the 
question as to whether alcohol really has a cardioprotective effect or if the effect is 
confounded by lifestyle characteristics. Correlations between wine consumption and 
other health-promoting dietary factors have been reported (32). 
1.2.2. Effects of aleohol 
The effects of alcohol may appear as soon as 10 minutes after consumption, and peak 
within 40-60 minutes. Absorption of alcohol depends to a large extent on the amount and 
type of food in the stomach, for example high fat and carbohydrate foods reduce 
absorption rates and carbonated alcoholic drinks promote a faster absorption rate. The 
bulk of the absorbed alcohol remains in the blood until it is metabolised by the liver. If 
29 
the consumption of alcohol occurs at a faster rate than it can be metabolised by the liver, 
the blood alcohol concentration increases. 
South African drinkers consume amongst the highest volumes of alcoholic beverages in 
the world, at approximately 50mL ethanol per drinker per day, making alcohol abuse one 
of South Africa's top ten health and social problems (33). The South African legal blood 
alcohol limit is 50mg IIOOmL (34) and the corresponding breath alcohol limit is 
0.24mg/L. If a pregnant woman abuses alcohol, alcohol can cross the placenta to the 
fetus, and this can cause fetal alcohol syndrome (F AS). The fetus then develops 
congenital defects and growth retardation. Facial abnormalities, reduced mental 
functioning, central nervous system dysfunction and delayed development are 
characteristic of this syndrome. The highest prevalence of F AS in the world occurs in the 
Western Cape (35). 
The Widmark formula is an estimation of the amount of alcohol consumed from a 
single measurement of a person's blood alcohol concentration (36). Saliva alcohol 
analysis correlates significantly with blood alcohol analysis and can therefore be used as 
an independent test for sobriety in place of blood or breath testing. The advantage of 
saliva is that it is obtained in a non-invasive manner (37,38). 
The pharmacokinetics of alcohol metabolism have been studied extensively. Alcohol 
dehydrogenase reversibly oxidises primary and secondary alcohols to their corresponding 
aldehydes and ketones, much of which takes place in the liver. Aldehyde dehydrogenase 
(AcDH) oxidises the potentially reactive aldehydes to acetic acid. The reactions are 
summarised in Figure 1.12. ADH is found in animal retinas and liver and oxidation by 
liver ADH contributes to clearance of blood ethanol. 
NAD+ NADH + H+ NAD+ NADH + H+ 
~L 
ADH 
~ J. CHCOOH 
AcDH 3 
acetaldehyde acetic acid 
Figure 1.12. The metabolism of ethanol by ADD and AcDH. 
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There are 3 types of liver ADH: ADH1, 2 and 3. ADH 2 and ADH3 have polymorphisms 
that result in isoenzymes with particular kinetic properties. Epidemiological studies have 
shown an association between homozygosity of the fast-metabolising ADH3(l) allele, 
and alcohol-related diseases such as alcoholism and oropharyngeal cancer (39). Moderate 
drinkers showing homozygosity at the ADH3 locus for the allele associated with a slow 
rate of ethanol oxidation (ADH3(2», have been found to have a significantly decreased 
risk of myocardial infarction (40), and higher high density lipoprotein (HDL) levels 
compared with non-drinkers who have the same genotype (41). 
1.2.3. The controversial issues of alcohol consumption and health 
Although the balance of epidemiological evidence is in favour of moderate 
consumption of alcoholic beverages being conducive to good health, the central questions 
are still largely unanswered. It will be difficult to resolve the question of whether wine 
has additional health benefits (for example cardioprotective effects) compared with beer 
or spirits and if so, whether red wine is better than white wine. It will also be difficult to 
resolve the different contributions of alcohol and phenols to health and the specific 
effects of the different polyphenols in wine as well as their nett effect, without resorting 
to interventional studies or experimental evidence. 
1.2.3.1. Does wine have more health benefits than for example beer or spirits and if so, 
is red wine better than white wine? 
There is still dispute over whether any particular one of the alcoholic beverages offers 
more protection than the others. Many reports support the proposal that wine has 
especially-beneficial effects on health, relative to the other alcoholic beverages 
(28,30,42-45). Wme and beer are complex mixes of compounds. Beer, like wine, is 
produced by fennentation. Both beverages comprise water, ethanol, acids, esters, 
aldehydes, ketones and phenolic compounds, although many of their phenolic compounds 
are different. Beer generally comprises 3-6% ethanol and wine 10-14%, whereas spirits, 
usually prepared by distillation, contain approximately 40% ethanol. Sherry and port are 
"fortified" by additional alcohol to approximately 20%. Wme is also reported to be less 
harmful than beer and spirits in that it contains far lower concentrations of nitrosamines, a 
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group of N-nitroso compounds such as nitrosodimethylamine that are broad-acting and 
potent carcinogens (46,47). Vliegenthart et al (48) showed the individual relative risk of 
CAD after consumption of wine to be lower than that after consumption of beer or spirits, 
in asymptomatic subjects. However, some studies have found benefits with all the 
alcoholic beverages on the risk of CHD and mortality (49-52) while others have reported 
a greater beneficial effect from spirits than wine and beer (53). Because different diets are 
often associated with consumption of different alcoholic beverages, it may be difficult to 
attribute the benefit to the beverage. It has been suggested that perhaps wine and beer 
have similar physiological effects, but that differences in the risk factor patterns amongst 
those who drink these beverages could create the differences (54), for example wine 
consumption is associated with a higher intake of healthy food such as fruit, vegetables, 
fish and olive oil (32,55). Additionally, in communities with higher alcohol consumption, 
alcohol--related diseases may be the reason for abstention. Wme drinkers have been found 
to have higher IQs, to smoke less, exercise more, to be better educated and have a higher 
socio-economic status than beer and spirit drinkers (55-57). Red wine is often reported 
as having greater health benefits than white wine, and this is usually attributed to the 
higher total polyphenol content of red wines (58). Some studies have shown that red 
wines have greater antioxidant activity than white wines (59,60), whereas other studies 
have found white wine phenols have a greater antioxidant effect than those from red 
wines (61). However, some white wines that have an increased extraction of grape skin 
polyphenols, have similar antioxidant characteristics to red wines (11). Studies by 
Glidewell et al (62) suggest that if superoxide-scavenging ability determines health 
benefits, then white wine is at least as effective as red wine, as measured by spin-
trapping electron paramagnetic resonance spectroscopy. The interpretation of reported 
differences in health benefits of the different alcoholic beverages should be viewed with 
caution until confounding effects have been clearly ruled out or mechanistic differences 
are evident. 
@ it the alcohol or the polypheno/s in the wine thot is more be"q.cial? 
The influence of the ethanol in alcoholic beverages has not been fully established and 
reports are contradictory. Ethanol influences metabolism in a number of ways, by acting 
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as a fuel source, altering fluid balance, increasing HDL concentration (63,64) and 
reducing platelet aggregation (65). Ethanol has also been found to increase elimination of 
polyphenols from the plasma compartment (63). Doll (66) reported that it is the ethanol in 
alcoholic beverages that is responsible for the beneficial health effects rather than the 
other characteristics of the beverage. Likewise, a review by Rimm et al (49) concluded 
that most of the benefits of alcoholic beverages derive from the alcohol rather than the 
other components of each beverage. This is refuted by a number of studies which 
demonstrate that the beneficial effects of wine in particular are derived from the non-
alcoholic fraction, for example Wallerath et al found that an increase in expression of 
endothelial nitric oxide synthase (eNOS) by red wine was not associated with ethanol 
(67), (although a study by Abou-agag et al has subsequently proved that ethanol can 
increase eNOS (68». eNOS is an enzyme responsible for the production of nitric oxide 
(NO), which enhances vasodilatation. Endothelium-dependent vasodilatation was found 
to increase after consumption of250 mL dealcoholised red wine (69) and the ingestion of 
113 mL of dealcoholised red wine increased plasma antioxidant capacity (70). Sato et al 
(71) also demonstrated the cardioprotective effects of ethanol-free red wine extracts, in 
their ability to improve post-ischaemic ventricular function. Short-tenn (7 days) 
treatment of red wine polyphenols was shown to decrease blood pressure and reduce 
infarct size and oxidative stress in ischaemia-reperfusion in rats (72). Consumption of 
alcohol-free red wine extract, equivalent to 375 mL red wine, inhibited ex vivo copper-
induced LDL oxidation (73). Sato et al found that both the polyphenols and the alcohol in 
red wine reduce the incidence of CHD, but by different mechanisms. Polyphenols such as 
resveratrol and proanthocyanidins acted as in vivo antioxidants, while the alcohol adapted 
hearts to oxidative stress. Both then triggered a reduction of proapoptotic transcription 
factors, resulting in reduced cardiomyocyte death (74). 
1.2.3.3. What are the specific effects of the different polyphenols in wine and what is their 
neU effect? 
Since the 1990s, potential benefits of specific non-alcoholic components of alcoholic 
beverages, in particular red wine, have received attention. Although many studies show 
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an added advantage from red wine with its high concentration of polyphenols relative to 
white wine and spirits, there is as yet no epidemiological consensus. &. action of polyphenols andjlavonoids 
i At the cellular and molecular level, polyphenolic compounds have a broad range 
of biological activities that depend on the individual structural characteristics: 
Their antioxidant action may prevent activation of carcinogens (75) and inhibit 
cell and tissue damage due to free radicals (76), leading to reduction of 
development of atherosclerosis and inflammatory diseases. 
- They have been shown to inhibit growth and induce apoptosis of several cancer 
cell lines, including colorectal cancer cells, at nM and ~M concentrations (77-79), 
and human breast and lung cancer cell lines (80,81). These concentrations are 
potentially achievable in vivo. 
- Flavonoids are lipid-soluble and can be incorporated into cell-membranes, 
sometimes interfering with normal membrane functioning. 
- They may interact with a number of enzymes for example receptor kinases and 
protein kinase C (82). 
- In many organisms, calorie restriction leads to a reduction of the ageing process 
and a subsequent increase in maximum lifespan. It has been postulated that a 
number of the effects of polyphenols (in particular resveratrol) might be due to 
their action of mimicking the calorie-restriction response mediated by sirtuins. 
Sirtuins are a family ofNAD+ -dependent protein deacetylases. SIRT1 is one such 
human deacetylase that has been found to negatively regulate the p53 tumour 
suppressor (by deacetylating lysine 382 of p53), leading to increased cell survival 
(83). 
The polyphenols quercetin and resveratrol in wine have both been found to be 
cardioprotective (84,85). Polymeric proanthocyanidins in red wine have also been found 
to protect against myocardial complications subsequent to ischaemia and reperfusion 
(86). As described in Section 1.3, there is a wide range of different polyphenols in wine, 
and there is also large variation amongst these polyphenols, especially the flavonols, in 
the different wines (87). One of the most important of these is the antioxidant 
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hydroxystilbene, resveratrol (Figure 1.19). It is found mostly in red wines, but to a lesser 
extent in white and rose wines (88), and recently, for the first time, permission was given 
by the United States government to label bottles of two different pinot noir wines, which 
have high concentrations of resveratrol, with their antioxidant information (89). 
Resveratrol, along with its hydroxylated analogues, has been found to have a number of 
health benefits, mainly in the field of cancer research (90). It may act as a phytooestrogen 
by binding to oestrogen receptors and thus blocking the mitogenic response of oestrogens 
(31,91). Reports in 1997 and 2005 summarised the anticancer activities of this compound 
(92,93): it has cytostatic properties via inhibition of initiation, specifically inhibition of 
free radical formation, promotion and progression of carcinogenesis; it reduced the 
incidence of carcinogen-induced cancer development in a mouse mammary gland culture 
and in a mouse skin cancer model; it induced differentiation and apoptosis in a number of 
different tumour cell lines, such as human breast cancer (94), human leukaemia (95) and 
oesophageal cells. It has been shown that resveratrol may be converted to piceatannol, a 
known stilbene anti leukaemic compound, by the cytochrome P450 enzyme CYB IB 1 
found in human tumours (96). In 2000 it was reported for the first time that resveratrol 
had a direct antimicrobial effect when it was found to inhibit the growth (in vitro) of 
Helicobacter pylori (Hpylori); a bacterium associated with gastric cancer (97). 
Resveratrol is able to inhibit platelet aggregation (84,98,99). Resveratrol also has 
antioxidant properties: it inhibits peroxidation of lipids in cell membranes mainly by 
scavenging peroxyl radicals in the membrane (100). It is also able to reduce iron-induced 
lipid peroxidation of rat liver micro somes (101). That resveratrol inhibits oxidant-
induced peroxidation of LDL was first reported in 1993 (102) and corroborated by a 
study in 2002 (103). Resveratrol and its analogues, for example astringinin (104), protect 
against ischaemia-reperfusion injuries in rat hearts (105,106) by preventing superoxide--
dependent inflammatory responses (such as endothelial barrier disruption) brought about 
by reperfusion. Resveratrol however, is usually found in low quantities in the diet, and 
might be inefficient at normal nutritional intake concentrations. Resveratrol may itself be 
oxidised to a phenoxyl radical which forms quinine, a highly reactive prooxidant which 
exerts cytotoxicity (107). The half-life of resveratrol is short (human plasma half-life is 
9.2 ± 0.6 hours), and much may be lost before absorption (108,109). 
35 
Studies have shown that catechins induce regression in tumours, both in vitro and in 
vivo, by seveml mechanisms, only some of which have been characterised. Doss et af 
(110) showed that catechins are scavengers of the growth factors that promote 
carcinogenesis. 
1.2.3.4. What constitutes moderate drinking? 
The definitions of moderate and heavy drinking are arbitrary, as is the definition of a 
'glass' or a 'drink'. A moderate intake of alcohol has been reported as much as 2-S 
glasses per day (111), as little as 1 glass (112) or more usually ~ 2 drinks daily for men 
and ~ 1 drink daily for women (113). "Anstie's Limit" is still sometimes quoted, setting 
the upper safe limit of sensible drinking to approximately 4SmL ethanol per day (114). 
Studies examining the impact of alcoholic beverages on health, report the intake variably 
as units or grams of alcohol, representing almost pure ethanol, per day. A unit of alcohol 
is defined as approximately 109 ethanol, which is equivalent to 1 drink (100mL wine, 
200mL beer, SOmL fortified wine and 2SmL spirits (48). The fermentation process that 
yields wine and beer is limited by the sugar content and the alcohol concentration, since 
the latter will eventually inhibit fermentation. Red wines average 13% and white wines 
12% alcohol. Spirits have higher alcohol concentration due to distillation. The "proof" is 
a measure of the alcohol (ethanol) concentration of alcoholic beverages, being twice the 
percentage of alcohol by volume. Sherry and port are "fortified" by additional alcohol. 
~ Data from many studies summarised in the I-shaped curve (Figure 1.13) suggest that an 
increase in all-cause mortality, all-stroke and CHD relative risks, may be evident from 
approximately 3Sg alcohol per day, and that "moderate drinking" could be defined as 
approximately 10-3Sg alcohol (11S). 
1.2.4. Studies of health benefits of alcoholic beverages 
Evidence for the beneficial effects of the consumption of alcoholic beverages on health 
may be derived from epidemiological or experimental research. In the absence of a 
controlled interventional study, there should be strong evidence from both avenues of 
investigation, and the benefits should exceed the harm before public health 
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recommendations can be made to include the consumption of alcoholic beverages in daily 
living. 
To date there have been numerous epidemiological as well as experimental studies 
showing the compelling evidence of health benefits of alcoholic beverages, in particular 
wine, and their various components. The limitations of epidemiological studies include 
the lack of validated biomarkers, lack of long-term controlled clinical studies, and lack of 
sufficient knowledge of bioavailability for relevant control in in vitro and in vivo studies. 
Many of the conclusions from epidemiological studies are based on results from meta-
analyses, a term coined in 1976, where associations are often tenuous at best. According 
to Shapiro (116), meta-analyses are based on studies that are often incomplete and 
disputed. He suggested that meta-analysis of all observational studies be stopped. 
Greenland however, suggested that analysis of these studies acts as a means to compare 
the studies and should be used to identify patterns amongst results (117), while Taubes 
(118) suggested that results from epidemiological studies should be treated with a 
measure of scepticism and an awareness of inappropriate associations. 
1.2.4.1. Epidemiological studies 
In 1926, the first finding of a V-shaped association between all~ause mortality and 
consumption of alcoholic beverages was reported by Raymond Pearl in a book called 
Alcohol and Mortality (1l9,120). Since then, a large number of epidemiological studies 
have shown a V-or J-shaped association between alcohol consumption and all~ause, 
particularly cardiovascular, mortality (Figure 1.13). This relationship may be influenced 
by factors such as drinking patterns, age, gender and genetics. The shape indicates that 
moderate daily alcohol consumption results in a significant reduction in mortality 
compared with individuals who abstain or drink alcohol to excess. 
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Figure 1.13. All-cause mortality, alI-stroke and CHD risk in relation to alcohol 
consumption. Data reftect the means and SEM from 7 all-cause, 11 alI-stroke 
and 11 CHD studies respectively. 
Results from worldwide epidemiological studies show that the beneficial effects of 
moderate consumption of wine may be divided into several areas of health: 
• Protection against CHD and stroke: 
Worldwide, CVD is the leading cause of death. responsible for approximately 30% of all 
deaths globally. Arteriosclerosis is the most significant factor contributing to the 
pathogenesis of CHD. People with CHD typically become symptomatic after age 40 
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years, but it is thought that CHD begins much earlier. In one study of cardiac transplant 
donors, 17% of those aged <20, 39% of those aged 20-29, and 85% of those aged 
>50years, had demonstrable lesions of atherosclerosis (121). Moderate consumption of 
alcoholic beverages, especially red wine, is associated with a decreased risk of CHD of 
up to 500/0, relative to abstainers (30,122), but the causal mechanisms are not fully 
understood. It has been suggested that, because inflammation plays a role in the initiation 
and progression of atherosclerosis, the protective role of red wine may be due to a 
reduction in inflammation. Some studies have shown only a moderate reduction in certain 
markers of inflammation, for example serum fibrinogen (a protein that plays a key role 
in thrombosis, also appears to reflect an inflammatory state (123), and which is associated 
with CHD in older adults (124,125» and C-reactive protein (CRP) (also associated with 
CHD (125,126», whereas other studies found lower levels of CRP (127,128) and 
fibrinogen (126,128) among healthy moderate drinkers. 
Epidemiological studies over the last three decades have established a strong inverse 
relationship between alcohol intake and fatal or non-fatal CHD (30,122,129-134). The 
vast majority of research results concerning the health benefits of alcohol consumption, in 
particular wine, concern the benefits to vascular disease, in particular CHD. In 1979, St. 
Leger et al showed the strong inverse relation between alcohol, especially wine, 
consumption in developed countries particularly France, and ischaemic heart disease 
mortality (135). The 'French Paradox', a sometimes controversial phenomenon reported 
in 1991 in an American television programme, and described by Renaud and de Lorgeril 
in 1992 (136) describes the lower rate of mortality from CHD among the French 
compared with other developed countries, despite similar dietary intakes in these 
countries. The explanation has been that their relatively high consumption of red wine 
protects the French from heart disease, and that the resveratrol in the wine was 
specifically responsible (102,137). However, it has been suggested that the paradox may 
partly be due to incorrect statistics and recording of mortality data (at that time France 
was known to under-report ischaemic heart disease deaths (135» and partly because of 
the influence of past, rather than present, fat intake, leading to a ''time lag" in influencing 
the risk for heart disease (138). This time lag theory generated much discussion amongst 
clinicians and scientists, who suggested that the rates of CHD are in fact the same in 
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France as in other countries in Southern Europe but these rates are all lower than in 
Northern Europe; that the effect of high plasma cholesterol concentrations on CV risk in 
populations from Southern Europe is not the same as that from Central or Northern 
Europe or the United States, and that after allowance has been made for effects of past 
animal fat intake, there is a significant association between wine consumption and 
mortality from heart disease (139-142). There was after this, however, an increase in the 
number of studies seeking to provide information on the health benefits of wine 
consumption. A study by Wannamethee et al (143), however, has since found that non-
drinkers, with or without CUD, should not be encouraged to take up regular drinking of 
alcoholic beverages, due to the increased risk of non-cardiovascular mortality with no 
reduction in CUD. Moderate alcohol consumption may reduce the risk of fatal 
myocardial infarction in people with ischaemic left ventricular systolic dysfunction (144). 
In addition, moderate alcohol consumption reduced the risk of cardiovascular 
complications, such as CUD recurrence, unstable angina, cerebral stroke and peripheral 
embolisms, after recent myocardial infarctions (145). 
A number of studies in the 1990s reported a reduced risk of myocardial infarction after 
alcohol consumption and a reduction in atherosclerotic mortality (45,49,52,135,146). 
VariollS other studies have reported a reduction in total and ischaemic stroke (147) and a 
reduction in vascular deaths (coronary thrombosis and ischaemic stroke) of between 3(}-
50% (148,149). Alcohol consumption was found to provide possible benefit to those with 
pre-existing cerebrovascular disease (150). However these are merely associations, and 
do not resolve the question as to whether it is the alcohol consumption itself or other 
factors that are responsible for the benefit of decreased mortality. There have been a 
number of studies showing a positive correlation between alcohol consumption and 
stroke, but most have been after heavy and few after moderate consumption of alcohol 
(133). Also, approximately 80% of strokes are ischaemic in nature (151,152) and 
consumption of alcohol is reported to affect the 2 types differently. Several large 
epidemiological studies have reported an increased risk of haemorrhagic stroke but a 
lower risk of ischaemic stroke (133,153,154). The protection towards ischaemic stroke 
may be due to the effect of alcohol on UDL~holesterol (43). Strokes are also more likely 
to occur in life-long abstainers than current non-drinkers (155). 
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• Prevention of cancers: 
Data for effects of moderate alcohol consumption on cancer are inconclusive. Alcohol 
consumption, in particular heavy drinking, especially of beer and spirits, has long been 
associated with an increased risk of cancers of the upper digestive tract (156-158), 
although it has been reported that cancers of the head and neck areas, and of the 
oesophagus, might be related to confounding factors in that heavy drinkers are invariably 
smokers (43,159), and oesophageal cancer is unusually sensitive to environmental factors 
and diet (160). There is less certainty about the association of alcohol consumption with 
other cancers. Moderate consumption of red wine has been found to protect against lung 
cancer (44). A review by Longnecker et al (161) of a number of epidemiological studies 
concluded that alcohol consumption may be associated with mouth, pharynx, larynx, 
oesophagus and liver cancers. The association was unclear with breast and large intestine 
cancer but appeared not to increase the risk of melanoma or cancers of the stomach, lung, 
bladder, prostate, ovary or endometrium. A meta-analysis of data from 38 studies on 
alcohol and breast cancer showed that even though the results varied widely, the relative 
risk, compared with nondrinkers, increased linearly by 7% (162) and 11% (163) for daily 
consumption of 1 alcoholic drink. Pooled analyses from 6 prospective studies also 
showed a linear increase in incidence for women consuming approximately 1.5--60g 
alcohol per day (164). However, in the Framingham Study, with a follow-up of more 
than 40 years, consumption of alcohol of up to 15g per day was not associated with an 
increase of breast cancer in women (165) nor in premenopausal women consuming up to 
llg alcohol (166). 
• Risk of hypertension: 
Epidemiological studies have shown the association between alcohol drinking and 
increased blood pressure (BP). Regular heavy consumption of alcohol is associated with 
epidemiological evidence of raised BP and seems to be independent of the type of 
alcoholic beverage (167). There seems to be a threshold dose of20--30g ethanol per day, 
above which BP unequivocally increases. 
• Reduction in the risk of dementia: 
Compared with abstention, moderate consumption of alcohol, particularly wine, is 
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associated with better cognitive function and memory in the aged (approximately 65 
years and older), while excessive drinking increases the risk (168-170). 
• Type 2 diabetes mellitus (DM) and the riskfor CVD: 
Diabetics are a group at high risk for CVD. Results from the Physician's Health Study 
showed a decreased risk for type 2 DM in healthy men who consumed moderate amounts 
of alcoholic beverages (171,172) and a similar risk for CHD among diabetic and 
nondiabetic volunteers after moderate alcohol consumption (173). Solomon et al found 
moderate alcohol consumption was associated with reduced CHD in women with type 2 
diabetes (174). Two large studies found a positive association between moderate to high 
alcohol consumption and the incidence of DM in Japanese men (175,176). Wannamethee 
et al found a U-shaped association between alcohol consumption and risk of DM, with 
moderate drinkers showing the lowest risk (177). Various other epidemiological studies 
have found a lower prevalence of DM amongst moderate drinkers compared with 
abstainers (178-181). However a systematic review by Howard et al (182) found 
moderate alcohol consumption to be associated with a decreased incidence of diabetes 
and a decreased incidence of heart disease amongst diabetics. 
• Decrease in bone mineral density: 
Bone density was found to be significantly higher in postmenopausal women who 
consume moderate amounts of alcohol compared with noIHirinkers (183,184) but results 
showed that heavy drinking was associated with low bone density and a subsequent high 
risk of fracture. 
1.2.4.2. Experimental studies 
Experimental studies with alcoholic beverages have shown a variety of potentially 
favourable effects: 
• Ethanolic preconditioning: 
Chronic low dose consumption of ethanol was found to maintain the heart in a protected 
state in a rat heart model, so that when ischaemia occurred, damage as measured by 
infarct size, was reduced (185). 
• Reduction in oxidation of low density lipoprotein (LDL): 
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That oxidative modification of LDL is implicated in atherogenesis was :first published in 
1989 by Steinberg et al (186). Frankel et al were the first to show the protective effect 
from red wine on oxidation ofLDL (187-190). 
• Vasoprotective effect: 
After red wine consumption the resting brachial artery diameter and resting blood flow 
increased significantly but were unchanged after dealcoholised red wine which led to the 
significant increase of flow mediated dilatation (FMD) of the artery (69). Red wine and 
red wine polyphenols, as well as white wine (191), have been found to improve 
endothelial function in human volunteers (192-195) by increasing the expression of 
eNOS (196). Martin et al studied the mechanisms whereby red wine polyphenols 
(including anthocyanins, catechins and flavonols) effect an increase in NO and reported 
that this was via Ca 2+ -dependent pathways and activation of the tyrosine kinase and 
phospholipase C pathways (197). French red wines were found to be more active than 
German red wines in upregulating the eNOS gene in human endothelial cells (67). 
However, this study highlights one of the shortcomings of experimental studies and that 
is their relevance. Incubation of red wine with human cells is not clinically relevant and 
does not reveal what really happens when humans consume the wine. This is because 
plasma and tissues are exposed to polyphenols in vivo only after they have undergone 
extensive modification during first-pass metabolism (Section 1.2.5). At this stage the 
polyphenols are very seldom aglycones, although deconjugation to produce aglycones 
may occur, but only at certain sites. A second factor that highlights the shortcomings of 
experimental studies is that the concentration of wine or polyphenols used is often not 
physiologically relevant. It should be of the same order as the maximum plasma 
concentrations found after a polyphenol-rich meal (approximately 0.1-1 O~mollL (198). 
• Effects on lipids and lipoproteins: 
A high serum HDL concentration is associated with a decreased risk of CVD, and HDL 
concentrations are significantly and consistently increased in humans and other animals 
after consumption of wine (199,200), and alcoholic beverages (52,136,199,201). It is 
well-documented that ethanol causes elevated concentrations of plasma HDL (202,203) 
and to date, no other diet or lifestyle factor is able to do this so consistently. The response 
of the major HDL subfractions to alcohol consumption is not clear, and variable 
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responses have been reported (202, 205). Consumption of alcoholic beverages raises 
plasma triacylglyerol (204-206), raises total cholesterol levels but decreases lipoprotein 
(a) (Lp(a» (199,207-209). Atheroslerotic lesions may be accelerated to advanced plaques 
by the formation of new blood vessels, which supply the neighbouring cells with oxygen 
and nutrients. Red wine polyphenols are able to prevent this neovascularisation by 
inhibiting activation of matrix metalloproteinase 2, which is expressed abundantly in 
atherosclerotic lesions (210). 
• Risk of hypertension: 
Experimental studies on humans have corroborated the results from epidemiological 
studies of increase of BP from alcohol consumption and the subsequent decrease of BP 
upon alcohol withdrawal (211). The direct pressor effect of alcohol has been proposed as 
the basis of the association of alcohol consumption with increased BP (212). In a 
randomised, controlled intervention study, consumption of approximately 40g red wine 
and beer elevated the BP (213). However, consumption of2.5-10g alcohol was found to 
be associated with a decrease in risk, relative to abstainers (214). 
• Inhibition of platelet adhesion and aggregation: 
Platelet aggregation influences the development of atherosclerosis by the formation of 
blood clots in arteries and there are a number of studies demonstrating the anti-
aggregating effect on platelets of alcohol (51,136,215-217); red wine (208,218,219); 
dealcoholised red wine (218,220), where polyphenols interfere with arachidonic acid 
metabolism, and resveratrol and quercetin in a dose--dependent fashion (84). 
• Effect on plasma homocysteine: 
A raised homocysteine concentration is associated with vascular risk and is thus a risk 
factor for CVD. High alcohol consumption is associated with increased homocysteine 
concentrations (221), but low to moderate consumption, in particular red wine 
consumption, has been found to lower homocysteine concentrations in obese adults, 
where obese people have an increased risk of vascular morbidity and mortality (222). 
Moderate consumption has also been found to lower the levels, but not significantly, in 
the elderly (223). 
• Antimicrobial effects: 
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Red wine and resveratrol have an in vitro activity against Chlamydia pneumoniae, which 
is associated with the development ofCHD (224). 
Red wine has also been found to have a bactericidal effect against H pylori infections 
(225), and spirits and beer consumption, although not as effective as wine, also have this 
effect (226). 
• Anticarcinogenic effects: 
Certain flavonoids such as quercetin, kaempferol and myricetin (Figure 1.22) have been 
found to be clastogenic and mutagenic at high concentrations in short-term in vitro 
human cell experiments, and are therefore potentially carcinogenic (227). The 
mechanisms are not fully understood. Quercetin is known to be unstable in the presence 
of oxygen, subsequently reacting with DNA, and it is this instability that is thought to 
cause quercetin's cytotoxic effect (228). Red wine polyphenols (catechin, resveratrol 
(Figures 1.21 and 1.19) and quercetin) inhibited the proliferation of 3 different breast 
cancer cell lines (229). Inhibition of growth by low concentrations of various components 
of red wine such as gallic acid (Figure 1.18) quercetin, catechins and resveratrol on 
prostate cancer cell lines have been found, where prostate cancer is a very commonly-
diagnosed cancer in the USA and in Europe (230,231). There are conflicting reports 
about the health benefits of quercetin as shown by for example in vitro as well as in vivo 
testing for DNA damage (8). These studies demonstrated both the mutagenic and cancer-
preventive effects of quercetin. In a study investigating the growth effects of flavonoids 
on colorectal tumours, quercetin was a strong inducer of growth inhibition (mainly via 
inhibition of epidermal growth factor (BGF) receptor kinase, where EGF receptor plays 
an essential role in growth regulation) and apoptosis (232). Results from animal, human 
and cell culture studies show possible mechanisms whereby ethanol has an enhancing 
action on mammary carcinogenesis, such as an increase in circulating oestrogens and 
androgens and an increase in potential for invasiveness of breast cancer cells (233). 
• Decreased risk of type 2 diabetes mellitus : 
Clinical and experimental data show an association between oxidative stress and both 
types of diabetes mellitus (234). An analysis of the literature shows the protective effect 
from moderate and regular alcohol, in particular wine, consumption (235,236). Red wine 
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has been found to prevent meal-induced oxidative stress in diabetic subjects. which 
protects them from heart disease (237) 
1.2.5. Bioavailability. 
The health benefits of polyphenols depend on the particular polyphenols. the amounts 
consumed and their bioavailability. At high doses, or at higher levels obtained from an 
average vegetarian diet for example from supplements where gram doses are often 
recommended, they may be mutagenic or act as pro--oxidants that generate free-radicals 
(238). In the diet, phenolic acids account for approximately one-third and flavonoids 
two-thirds of the total intake of phenolic compounds (239.240). the total intake of which 
is usually quoted as 1-1.5g per day (although the worldwide figure is estimated to be 
much lower at approximately 7Omg), depending upon the individual food choices. 
The approximate dietary intake of flavonoids in the USA was described in 1976: 
catechins 22%, flavonols, flavones and flavanones 16%, anthocyanins 17% and biflavans 
(for example procyanidins) 45%. These figures continue to serve as reference data (241). 
The average human consumption of flavonoids is usually estimated at 191day per person 
(242). but by some is estimated at approximately 23mglday (243). The most abundant 
flavonoids in the diet are the flavanols (catechins and proanthocyanidins) and the 
anthocyanins. The daily intake of catechins is estimated at 18-5Omg (244), but the final 
percentage absorption varies widely between studies (245). Studies show the 
concentration of total catechins in plasma to be approximately 0.1- 1.4j.1mollL (244). 
Bioavailability of the different polyphenols varies a lot and the most abundant dietary 
polyphenols are not necessarily those found in the highest concentrations in the tissues. 
After the consumption of between 10 and l00mg of a single phenolic compound, the 
maximum plasma concentration is still less than 1 j.1g1L, and urinary excretion varies from 
0.3-43% of the ingested concentration of polyphenols, depending on the particular 
polyphenol (244). The average concentration of polyphenols in red wine is 1200-
1700mgIL (246,247) with the total phenolic acids and polyphenols ranging between 900-
2500mgIL in red wine and 190-290mgIL in white wine (248). 
Results from 97 studies show that gallic acid is a well-absorbed phenol, followed by 
catechins. flavones and quercetin glucosides and that the least well-absorbed are the 
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proanthocyanidins and the anthocyanins (244). There are very few results on the 
hydroxycinnamic acids and hydroxybenzoic acids (except gallic acid). Simonetti et ol 
fOlmd an increase in the plasma concentration of caffeic acid (figure 1.17) (a 
hydroxycinnamic acid) after consumption of 200mL red wine, reaching a maximum by 
60 minutes and baseline by 5 hours (246). Bioavailability has important implications for 
the efficiency of the polyphenols in vivo and for the establishment of physiological 
concentrations to be used in relevant investigations. It remains controversial as to whether 
ingestion of the polyphenols in moderate quantities of alcoholic beverages increases their 
concentrations in blood significantly. The polyphenol content of different red wines 
varies widely. Duthie et ol reported 12.51lglmL total phenols (as gallic acid equivalents) 
present in human plasma after consumption of 100mL red wine (249). Basal 
concentrations were reached within 4 hours. Bell et ol (63) showed an increase in plasma 
total catechin concentration (with an average of 0.3% of the total mass consumed) after 
120mL dealcoholised red wine consumption, with the peak at 1-2 hours, reaching 
baseline after 8 hours. A marked increase in human plasma quercetin concentration was 
found 3 hours after ingestion of quercetin, decreasing after 7 hours and returning to 
baseline after 20 hours (250). These returns to baseline within a day indicate the need for 
regular consumption of these antioxidant phenols. Studies with human colonic cell 
mono layers show that radio labeled proanthocyanidin and procyanidin dimers and trimers 
can be absorbed and transported from the apical to the basal side of the cultures (251). 
Modification of polyphenols, for example glycosylation, methylation and 
glucuronidation, greatly determines their absorption and bioavailability (252), for 
example there are marked differences in humans between absorption of quercetin and its 
glycosides (253,254). Quercetin glucosides are more efficiently absorbed than quercetin 
alone. Studies show a high inter-individual variability in absorption of quercetin 
(250,254). All flavonoids except flavanols are found in the glycosylated form in foods 
(241), and these glycosidic bonds hydrolyse with age. (+ )-Catechin and epicatechin are 
found in wine exclusively as aglycones (248). Flavonoids found in plasma and urine are 
usually glucuronidated and/or sulphated with only trace amounts of the native forms. 
Uriruuy excretion of catechin was 3-10% of that consumed from 120mL red wine and 
was present as metabolites almost exclusively (sulphated, glucuronidated and methylated) 
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(255). Quercetin is generally not found in the plasma as the free form or the glucoside 
(256), but as methyl, sulphate or glucuronic acid conjugates, and the position of the 
conjugation is important in determining activity (257,258). Glycosides are the major 
circulating form of anthocyanins, possibly because of their instability in the aglycone 
form (241). Quercetin has a plasma half-life of 11-28 hours. Concentrations in most diets 
are low, at approximately 20-35mg per day. Ingestion of 50mg results in a plasma 
concentration of approximately 0.75-1.5J.1mollL (239,244). Catechin has a much shorter 
plasma half-life (2-3 hours) than the other flavonoids and ingestion of 120mL red wine 
(35mg catechin) resulted in a maximmn plasma concentration of catechin at 1 hour after 
ingestion of approximately 91nmollL (259). It has been previously speculated that 
ethanol may improve absorption of polyphenols by increasing their solubility. However, 
in this study, the plasma concentrations of catechin metabolites were similar after 
consmnption of red wine or dealcoholised red wine. 
Of the total mass of polyphenols ingested, only a small percentage of the flavonoids are 
absorbed across the intestinal membrane. Recent information suggests that the absorption 
of catechins is approximately 3-5%, of flavonols 17-52%, of anthocyanins 4%, of 
flavanones 7-24% and of isoflavonoids 9-35% (260). There is a common pathway for 
polyphenol metabolism. Aglycones can be absorbed from the small intestine, but most of 
the polyphenols are in the form of glycosides or polymers that cannot be absorbed. These 
compounds must be hydrolysed by intestinal enzymes or by microflora in the colon 
before absorption. Colonic flora may further degrade the aglycones, producing several 
phenolic acids, depending on the structure of the original polyphenoL During absorption, 
polyphenols are conjugated in the small intestine and then in the liver, undergoing 
methylation, sulphation and glucuronidation. This is a very efficient process, and 
circulating polyphenols are found as conjugated derivatives, extensively bound to 
albmnin. Polyphenols penetrate tissues, especially those where they are metabolised. 
Derivatives of polyphenols as well as polyphenols are excreted mainly in bile and urine. 
They may also be secreted into the duodenmn via the biliary route, subjected to the action 
of bacterial enzymes mainly P-glucuronidase, and then re-absorbed. This recycling leads 
to a longer presence of polyphenols in the body (241,261,262). 
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An important factor that affects polyphenols and their bioavailability is food 
composition, for example proteins in the food may bind to polyphenols and thereby 
reduce their bioavailability, although the denaturation at gastric pH may result in a loss of 
protein binding. Polyphenol content in plants is affected by environmental factors (for 
example sun exposure, rainfall, soil type and plant stress). Storage also affects the content 
of easily-oxidised polyphenols Browning is one such effect. Food processing also affects 
the content, for example fruit juice processing often involves a clarification stage which 
removes certain flavonoids, and for this reason processed fruit juices often have a 
decreased flavonoid concentration (241). 
Although wine chemistry is complex, detailed descriptions of the composition of the 
different wines would facilitate much--needed in vitro studies on bioavailability and 
metabolism of the specific components of the wine. This would in tum facilitate the 
recommendation of wine as an adjunct to a healthy diet. 
1.2.6. Conclusions 
Atherosclerosis is the dominant cause of morbidity and mortality in developed 
countries and is rapidly rising in developing countries (263). It is preferable to combat 
atherosclerosis by preventive strategies involving lifestyle, including a balanced diet, 
exercise, maintaining an ideal body weight, and no smoking. Epidemiological evidence 
suggests that moderate consumption (1-3 drinks per day) of alcoholic beverages, 
particularly red wine, is associated with an overall improvement in health, especially 
cardiovascular health. Although the epidemiological information is attractive, it is not 
adequately compelling for the deliberate inclusion of alcoholic beverages in the lifestyle 
of westernised subjects. Nevertheless, moderate consumption of affordable alcoholic 
beverages in otherwise healthy subjects will not increase the risk for disease, especially if 
it accompanies a healthy lifestyle. The consumption of large amounts of alcohol is clearly 
ill-advised. The consumption of alcoholic beverages during pregnancy clearly places the 
fetus at risk for developmental abnormalities, and alcohol is not recommended during 
periods of breast-feeding. 
Although several lines of experimental evidence suggest mechanisms by which 
alcoholic beverages may reduce the risk of vascular disease, there is inadequate 
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understanding of atherogenesis to know whether these mechanisms apply to any given 
individual at risk and whether the alcoholic beverage will be of direct benefit. Scientific 
research will hopefully elucidate these mechanisms for specific intervention. If health 
benefits of alcoholic beverages are confirmed, a new avenue may be opened for the 
prevention and possibly the treatment of atherosclerosis. 
Table 1.1. Summary of the beneficial effects of wine: epidemiological and experimental. 
L CVDRisk I Stroke Risk I Total Mortalitt 
Risk 
• Vliegenthart R et aI, • Truelsen T et aI, 
2004 1998 • Burns J et aI, 2001 
• Rimm EB et aI, • Klatsky AL et aI, • Diem P et aI, 2003 
1991 & 1996 1990 • Klatsky AL et aI, 
• Cleophas TJ et aI, • Stampfer MJ et aI, 1990 
1999 1988 • Renaud SC et aI, 
• Mukamal KJ et aI, • Iso H et al,1995 & 1998 & 1999 
E 2003 2004 • Grmtb~k M et aI, 
• Gaziano JM et aI, • Gill JS et aI, 1986 2000 P 1999 • Hansagi H et aI, • Hart CL et aI, 1999 I 
D • Sato M et aI, 2002 1995 
E • Marmot MG, 2001 • Wannamethee SG & 
M • Klatsky AL, 2002 Shaper AG, 1996 
I • Grmtb~k M, 2004 • Hart CL et aI, 1999 
0 • Iacoviello L & • Berger K et aI, 1999 
L Gaetano G, 2003 • Donahue RP, 1986 
0 • Agarwal DP, 2002 
G • Klatsky AL et aI, 1990 I 
• Stampfer MJ et aI, C 1988 
A 
• Klatsky AL et aI, L 1986 
• Diem P et aI, 2003 
• Woodward M & 
Tunstall-Pedoe H, 
1995 
• Burns J et aI, 2001 
• Hart CL et aI, 1999 
• Gr0nb~k M et aI, 
2000 
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ellE!'IIDl.ICS AND FLA VONOIDS 
1.3.1. Background 
Wine essentially comprises water, ethanol, glycerol, various acids, esters as well as 
many different phenols or phenolic compounds, a group of organic compounds that 
contains a hydroxyl group(s) bound directly to an aromatic ring (264). There are several 
hundred different phenolic compounds present in red wine, especially aged red wine, and 
these differ between cultivars and vintages due to variations in the different grapes and 
the different seasonal conditions; must preparation during crushing, pressing and skin 
contact; fermentation, also during skin contact and sulphite addition, and ageing (265). 
The total mass of phenols found in an average-sized glass of red wine is approximately 
200mg compared with that in white wine, which is approximately 40mg. Phenols found 
in wine are also not identical to those found in grapes. 
They have several important functions in wine including the colour of red wine, the 
astringent and bitter tastes of wine, the preservation of wine during ageing and, because 
phenolics oxidise readily, the browning of wine when exposed to air. A number of these 
phenolic substances have also been found to have antioxidant properties, for example the 
tannins, the non-flavonoids, for example stilbenes (resveratrol) and the flavonoids, for 
example flavanols, flavonols as well as anthocyanins (266). These compounds are of 
special interest for the antioxidant effects of wine that are investigated in this thesis. 
W;~e~henols may very broadly be divided into flavonoids and non-flavonoids, 
---cla;~ification of wine phenols has not yet been fully elucidated). Flavonoids make up the 
larger group. Albert Szent-Gyorgi, a Nobel Prize-winning biochemist, who labelled them 
''vitamin P", was the first to describe them in 1936, after working with citrus flavanones 
(242). They were found to enhance the function of vitamin C by improving its absorption 
and also by protecting it from oxidation. They often occur attached to glycosides and 
therefore tend to be water-soluble. There are more than four thousand known flavonoids, 
some found in wine as well as other beverages and fruits (tea, coffee, fruit juices, beer 
and chocolate) and to a lesser extent vegetables and cereals. They are characteristically 
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found in higher plants, in all parts of the plant. Approximately half of the total extractable 
phenols in the grape berry are found in red wines. The distribution in the grape berry is 
illustrated in Figure 1.14. 
The skin yields approximately 30% of the total grape 
phenols including resveratrol,monomeric catechins. 
anthocyanins and quercetin 
Approximately 60% of the phenols are in the seeds. 
including monomeric. dimeric and polymeric catechins, 
and epicatechin gallate 
The juice yields approximately 10% of the phenols, 
including hydroxycinnamates 
Figure 1.14. Diagram of a grape berry showing the distribution of phenols. 
1.3.2. Oassiftcation and chemical structure 
1.3.2.1. Tannins 
A large number of wine phenols include polymeric tannins: condensed and 
hydrolysable tannins. The tenn "tannin" is mostly functional but it is also often used to 
describe high molecular-weight phenolic mixtures. Both wood (in particular oak) tannins 
and grape tannins are responsible for the presence of tannins in wine. Grape tannins are 
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found mainly in the skins and seeds of the grape berry. Fresh tannins from young oak are 
bitter and astringent and may impart this flavour to the wine, and so "toasting" of the oak 
renders the tannins more acceptable. Oak tannin chemistry is poorly understood. 
Condensed tannins are polymeric mixtures of flavonoids in which the polymer is made 
up of flavan units, usually flavanol, linked by 4:8 C-C bonds, for example 
proanthocyanidins (Figure 1.15). 
Hydrolysable tannins, which in wine are derived mainly from wood extraction during 
wine maturation, can be hydrolysed to glucose and gallic acid (gallotannins) or ellagic 
acid (ellagitannins) (Figure 1.15). They are both formed during the Shikimate pathway 
(Section 1.3.3). 
HO 
OH a) 
OH 
OH 
. HO 
OH L ellagic acid __ ----' b) 
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HO 
Ho1J-eo 
HO 
HO 
HO 
HO 
eo 
Lgallic aCid~ 
o 
OH 
o eo-{ tOH 
glucose o-K ~OH 
OH c) 
Figure 1.15. ChemiQI structures of a) a proanthoeyanidin, b) ellagie aeid and e) 
a gaUotannin. 
1.3.2.2. Non-Davonoids 
The non-flavonoids include several classes such as the hydroxycinnamic acids, the 
hydroxybenzoic acids and the stilbenes. 
Hydroxycinnamic acids are major phenols in white wine. In wine making, the most 
important effect of these compounds is their browning effect, producing desirable golden 
colours. The trivial names of the three most commonly found are ca:ftaric, p-coutaric and 
fertaric acids and they occur in grapes as esters of tartaric acid: 
_~ ~ yOOH 
HOVe =?-e-O-?-H 
H H-y-OH 
eOOH a) 
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HO M 7 ~ yOOH 
HO~C ==y-C-O-y-H 
H H-C-OH 
I 
COOH b) 
CH30 
"M ~ yOOH 
HO~C ==y-C-O-y-H 
H H-C-OH 
I 
COOH c) 
Figure 1.16. Chemical structures of a) p--coutaric, b) caftaric and c) fertaric 
acids as esters of tartaric acid. 
They occur in white and red wine also in the free fonn (after hydrolysis) as p--coumaric, 
caffeic (the most predominant) and ferulic acids: 
~~ HO~C==y-COOH 
H d) 
-b-
HO 
H 
- I 
HO ~ /; C ==y-COOH 
H e) 
56 
CHb-
0 
H 
- I 
HO ~ t'l C ==y-COOH 
H t) 
Figure 1.17. Chemical structures of d) p--eoumaric, e) caffeic and f) ferutic acids. 
Concentrations of total hydroxycinnamic acids range from approximately 130mgIL in 
white wines to 60mgIL in red wines (247). 
The hydroxybenzoic acids are mostly degradation products that appear during wine 
ageing and are therefore not usually found in new wines. Hydrolysis again results in the 
free acids in wine. The most important is gallic acid, which is generated from hydrolysis 
of gallate esters of hydrolysable tannins. Concentrations of gallic acid range from 
approximately ImgIL in white wines to 30mgIL in red wines (248). 
HO 
HO-P-COOH 
HO 
Figure 1.18. Chemical structure of gallic acid. 
Stilbenes are minor phenols produced by the grapevine and are found in response to 
attack by fungi such as Botrytis cinera where oligomers of resveratrol called viniferins 
are the actual anti-fungal compounds. The main stilbene in wine is resveratrol and red 
wine contains much more of this compound than white wine, in several forms including 
the trans (predominant form) and cis-isomers. Aglycones and pice ids (glucosides) are 
both found in white wine, rose and red wine (88,99). The total concentration of all forms 
of resveratrol in white wines is approximately O.5mgIL, in rose wines is approximately 
2.15mgIL and in red wines is approximately 7mgIL (247) although there is a wide 
variation (99). There have been many studies reporting that resveratrol has anti-QIlcer 
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properties (Section 1.2.3.3) as well as being able to reduce heart disease and in 200t 
alone there were more than 200 publications concerning this compound. 
3' 
OH 
OH 
Figure 1.19. Chemical strueture of resveratrol. 
1.3.2.3. Flavonoids 
neral chemical structure of the flavonoids 
// 
"hP-<1!f1"I1Cture of flavonoids is based on a fifteen carbon, two benzene ring skeleton with 
a chromane ring carrying the second aromatic B ring in position 2 in flavonoids, position 
3 in isoflavonoids and position 4 in neoflavonoids: 
Figure 1.20. General strueture of flavonoids. 
The A ring in flavonoids from grapes and wine has a characteristic hydroxylation at the 
5 and 7 position. Flavonoids are classified into different classes depending on the 
different substitutions and oxidation states on the C ring. In flavans the C ring is 
saturated; the flavones have a keto group at position 4 and unsaturation between positions 
58 
2 and 3; the anthocyanins have a fully aromatic ring with a positive charge and the 
flavanols (flavan-3-ols) have a hydroxyl substituent on the C ring in the 3 position. 
Members of each class are defined by the B ring substitution pattern. Hydroxyl 
substitutions usually occur at position 4', and additional oxygen substitutions may occur 
at positions 3' and/or 5'. These oxygen substitutions may be hydroxyls or methoxyls. 
There may also be sugar conjugation on the oxygen. Isoflavonoids include isoflavones, 
isoflavanones and isoflavans. 
1.3.2.3.2. Classes of flavonoids 
The flavonoids make up most, approximately 85%, of the phenolic compounds of the 
seeded grape berry and may be divided into the following major classes: flavanols, 
flavonols and anthocyanins. Other classes include flavones, isoflavones and flavanones. 
Flavanols form the largest class and include monomeric catechins as well as 
oligomeric and polymeric proanthocyanidins. Wme flavanols are different from the other 
flavonoid classes in that they are not found as glycosides. Monomeric flavanols are 
sometimes collectively known as "the catechins". These monomers include two 
stereoisomers, trans or (2R, 38) (+)-catechin and cis or (2R, 3R) (-}-epicatechin. Both of 
these are found in grapes and wine but (+ )-catechin is the predominant flavanol in red 
wines, the concentration depending to a large extent on the grape cultivar as well as 
climate. Biflavans, sometimes referred to as proanthocyanidins, are a group of catechin 
condensation products consisting of 1 molecule of a catechin and 1 of a flavandiol. There 
are 2 groups of flavandiols, those without and those with a hydroxyl in position C5. They 
have a protein-complexing and tanning activity (242). Their concentration in red wine 
ranges from 1-2.5g1L. An example of biflavans are the procyanidins, oligomers of (+)-
catechin (catechin) and (-}-epicatechin (epicatechin). Monomeric, dimeric and 
polymeric flavanols are partly responsible for astringent and bitter mouth sensations and 
the astringency increases with the increase in polymerisation (267). Their interaction with 
salivary proteins may lead to a decrease in phenolic bioavailability (268). (+)-Catechin is 
partly responsible for colouring red wine (269). Both forms have catechol substitutions in 
the 3'4' positions on the Bring. 
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HO 
"I OH 
OH b) 
Figure 1.21. Chemical structures of a) (+)-eateehin and b) epigallocatechin. 
Gallocatechins, for example epigallocatechin and epicatechin gallate, have trihydroxy 
substitutions in the 3'4' 5' positions. Concentrations of total monomeric flavanols range 
from 40-20OmgIL in red wines (247), depending on seed extraction methods and 
methods of analysis. 
Condensation of flavanol monomers via covalent linkage yields oligomers such as 
proanthocyanidins and polymeric condensed tannins (Section 1.3.2.1). Total oligomer 
plus polymer concentrations range between 10-50 mgIL in white wines, and 0.5-1.5gIL 
in red wines (247). Owing to their high molecular weight (270) these compounds do not 
seem to be absorbed from the gut (259) and therefore probably do not have many health 
effects. Older red wines sometimes have an insoluble precipitate that is formed by these 
large size polymers. This is most likely the reason for the decrease in concentration of 
phenols after ageing of red wines. 
Flavonols are made up of a varied combination of glycosidic forms, such as the 3-
glucosides and the 3-glucuronides, but essentially the main simple flavonoid structures 
within this class are quercetin, kaempferol and myricetin. 
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OH 
OH 
HO 
OH 0 a) 
OH 
HO 
OH 0 b) 
OH 
HO OH 
OH 0 c) 
Figure 1.11. Chemical structures or a) quercetio, b) kaemprerol aod c) myricetio. 
Levels of flavonols, in particular quercetin, in some red wines have been shown to 
increase dramatically with increased exposure of the grape berry to sunlight (8). Different 
skin extraction techniques affect flavonol concentrations, which range from trace 
amounts to 100mglL in some red wines (259). The concentration of flavonols also seems 
to be an indicator of the quality of the wine as flavonols have been shown to have a bitter 
taste in alcoholic beverages (9). 
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Anthocyanins are found in the skins of red grapes and may exist in 2 fonns: the red 
flavylium cation and a colourless hydrated hemiketal fonn. They show a red colour when 
in an acid solution, as in red wine pH of approximately 3.5 (269). Anthocyanins are able 
to covalently bond with the tannins in the wine to produce pigmented tannins that are 
stable and persist in red wines more than a few years old. In their simplest fonn of 
flavonoid ring structure, these compounds are known as anthocyanidins, which are 
unstable and found in vel}' low concentrations in grapes or red wine. In wine there are 
five main structures: malvidin (the most abundant in red wines), petunidin, peonidin, 
cyanidin and delphinidin: 
HO 
OH 
Rl Rl 
malvidin OCH3 OCR3 
petunidin OR OCR3 
peonidin H OCR3 
cyanidin R OH 
delphinidin OH OR 
Figure 1.13. Chemical structures of the anthocyanidins in wine. 
Anthocyanins are compounds with glycosides, and in wines the glycoside is 3-glucoside. 
There may be further substitution at the 6-hydroxyl group of the glucose, with ester 
linkage of acetyl, coumaryl or caffeoyl groups: 
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HO 
Figure 1.24. Chemical structure of malvidiu-3-g1ucoside. 
Different species of grape and different processing techniques result in variable 
concentrations of anthocyanins (247). Concentrations of anthocyanins in red wine range 
from 20-500mg/L (248). These levels have been found to decrease with increasing age of 
the wine: up to 97% decrease by eight months after fermentation (271). 
Although the range of concentrations of total polyphenols in both white and red wines 
is large, the table below shows the means and/or ranges of quoted values (248): 
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Table 1.2. Concentrations in mgIL orwine phenolic acids and polyphenols 
Redwine White wine 
Non-flavonoids 240-500 160-260 
Hydroxybenzoic acids 0-260 0-100 
p-Hydroxybenzoic acid 20 
Gallic acid 116 (26-320) 1.4 
Total gallates 40 (30-59) 7 
Syringic acid 5 (4.2-5.9) 
Protocatechuic acid 88 
ii.ydroxycinnamic acids 162 (62-334) 130-154 
cis/trans Coutaric acid 20(16-24) 1.8 
cis/trans Caftaric acid 25 (11-47) 5 
i 
Caffeic acid 8.5 (3-18) 2.8 
Coumaric acid 12.6 (7.5-22) 1.5 
• Ferulic acid 19 
Stilbenes 
trans-Resveratrol 1 (0.1-2.3) 0.22 (0.003-2) 
Flavonoids 750-1060 25-30 
Flavonols 98 (10-203) trace 
Quercetin 18.8 (5-53) 0 
Myricetin 16.2 (2-45) 0 
Kaempferol 18 0 
Flavanols 168 (48-440) 15-30 
Catechin 89 (27-191) 17.3 (3-35) 
Epicatechin 57.3 (21.4-128) 13.6 
Procyanidins 171 (29-333) 7.1 (5-10) 
Anthocyanins 281 (20-500) 0 
Delphinidin 3-
monoglucoside 22 0 
Cyanidin 3-monoglucoside 20 0 
Petunimn3-mono~ ______ ~1~8 ______ -+ ________ ~0 ______ ~ 
Peonidin 3-monoglucoside I 32 0 
Malvidin 3-monoglucoside 93 (24-170) 1 
I Total phenolic acids and polyphenols: 1200 (900-2500) 200 (190-290) 
In some instances, only ranges are reported and in others, only mean values without a 
range are reported; - indicates no value found in the literature. 
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1.3.3. Biosynthesis of phenolic compounds, in particular the Davonoids 
The biosynthetic pathway that leads to the generation of phenolic compounds in plants 
is known as the Shikimate pathway. This major pathway generates the aromatic amino 
acids: tryptophan, phenylalanine and tyrosine and can be divided into two main parts: the 
pathway from erythrose-4-phosphate and phosphoenol pyruvate, through 3-deoxy-~ 
arabino--heptulosonate-7-phosphate (DAHP) and shikimate, via 5-
enolpyruvylshikimate- 3-phosphate (EPSP) to chorismate, and then the pathway from 
chorismate, the common compound, to the three amino acids. The pathway from 
phenylalanine leads to the generation of the non-flavonoids and the flavonoids. It is well 
known that all classes of flavonoids are biosynthetically closely related. Chalcones are 
the first detectable CIS compounds that are common to all the flavonoids, including the 
isoflavonoids. Stilbenes are also derived from chalcones. The pathway from phenylalanine 
leads to the generation of other phenyl compounds such as lignin. 
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Carbohydrate metabolism 
~ 
Erythrose-4-phosphate + phosphoenol pyruvate 
-COO 
®-OACH2 1 DAHP synthase 
DAHP 
1 3--Dehydroquinate synthase 
3-Dehydroqudnate 
HXOO-
O~OH 
OH 
3-Dehydroquinate dehydratase 1 8hikirnate dehydrogenase 
Shikimate 
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Shikimate dehydroshikimate 
coo 
a 
OH 
\ Sbikimate kinase 
Shikimate-3-phosphate 
1 EPSP synthase 
EPSP 
--..... gallic acid (Figure 1.18) 
OH l 
eUagic acid (Figure 1.15) 
1 ChorimMe~ 
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1 
Chorismate 
Tryptophan Tyrosine Phenylalanine 
cinnamate 
(cinnamic acid) 
The structures of the non-flavonoids and the flavonoids synthesized from cinnamate in 
wine are most often depicted in the protonated acidic form (272), and so this is adhered to 
here. However, for the purpose of this thesis, which mostly involves wine in 
physiological conditions, involving a pH of approximately 7.4, the dissociated form of 
structures from carbohydrate metabolism to cinnamate is used. Knowledge of the pKa of 
the particular structures would determine in which of the forms the compound would be 
present. 
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cinnamic acid benzoic acid hydroxybenzoic acids 
hydroxycinnamic acids 
-----------~~----------r '\ 
QOH I~ b 
OH 
p-coumaric acid -----i...... caffeic acid ... ferulic acid 
(Figure 1.17) (Figure 1.17) (Figure 1.17) 
--------------. ~  1 lignin 
p-coumaroyl-CoA + 3x malonyl-CoA 
• a chalcone 
HO 
OH 0 stilbenes 
l 
a flavanone 
HO isoflavones 
--.....,...... flavones 
R 0 
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HO 
dibydrokaempferol 
l l 
anthocyanidins flananols 
(Figure 1.23) (Figure 1.21) 
~ 
condensed tannins 
(Figure 1.15) 
OH 
HO 
OH 
~ 
dihydroquercetin 
OH 
---..... kaempferol 
(Figure 1.22) 
quercetin 
(Figure 1.22) 
anthocyanidins 
(Figure 1.23) 
dihydromyricetin 
HO 
myricetin 
(Figure 1.22) 
Figure 1.25. Biosynthesis of tannins, non-flavonoids and flavonoids 
(20,272-278). 
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1.4. FATTY ACIDS, THEIR PEROXIDA TION, AND ANTIOXIDANTS 
1.4.1. Fatty acids as lipids 
Lipids are biomolecules that are insoluble in water but soluble in organic solvents of 
low polarity, for example chloroform. They may be classified into 2 broad categories: 
simple lipids, for example carboxylic acids (fatty acids) and sterols, and complex lipids, 
which are esters of long-chain fatty acids. 
Fatty acids are major structural components in acylglycerols, which include 
triacylglycerols (TO) and phospholipids (PL) and make up the majority of lipids in the 
body. TO are the largest group of complex lipids and occur as esters of glycerol in which 
all three hydroxyl groups are esterified with a fatty acid. TO act as storage reserves of 
energy in animal cells. They provide approximately 40% of the energy requirements of 
man as part of a normal diet. Simple TO have all 3 fatty acids identical while the mixed 
TO have 2 or 3 different fatty acids, with an unsaturated fatty acid usually occupying 
position sn2 in biology. The structure of the different fatty acids is described in Section 
1.4.2.1. 
Phospholipids are major compounds in cell membranes. Fatty acids also form part of 
the structure of PL, the second largest group of complex lipids with one fatty acid in 
sphingolipids, such as sphingomyelin (which do not contain glycerol) or more fatty acids 
(Phosphoacylglycerols, where the 3 hydroxyl groups of glycerol are esterified with 2 fatty 
acids and a phosphate group). The phosphate group of phosphoacylglycerols may itself 
7f be bound to one of several simple organic groups such as the choline in 
phosPllatidylcholine. ~ Phosphoacylglycerols include phosphatidic acid and 
, --~- . 
phosphatidylglycerol, major PL such as phosphatidylcholine (lecithin), and 
phosphatidylethanolamine as well as minor PL such as phosphatidylserine, 
phosphatidylinositol and cardiolipin. Sphingolipids are all based on the amino alcohol 
sphingosine, are derivatives of ceramide and are found in large amounts in nerve tissue 
and brain. Olycosphingolipids, for example gangliosides, also contain sugar residues and 
make up 5-10010 of lipids in plasma membranes. Phosphatidylglycerol is a precursor of 
cardiolipin, a lipid found largely in mitochondrial membranes. 
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Phospholipids form lipid bilayers in cell membranes. They are also components of 
prostaglandins, leucotrienes and ketone bodies. Prostaglandins and leucotrienes are 
important in physiological regulation. They are related structurally and metabolically; 
both being derived mainly from arachidonic acid, a C20 unsaturated fatty acid containing 
four double bonds. Prostaglandins mostly prevent platelet aggregation and clotting and 
usually cause smooth muscle contraction of blood vessels. Leucotrienes are responsible 
for bronchonstriction, modulation of immune hypersensitivity and are chemotactic agents 
(20). Ketone bodies act as an important energy source when carbohydrates are in short 
supply. 
1.4.2. Fatty acid structure, classification and nomenclature 
1.4.2.1. Structure and classification 
Fatty acids consist of a hydrocarbon chain and a terminal carboxyl group with a general 
formula of: 
They occur naturally as esters (for example triacylglycerols Section 1.4.1), and only small 
amounts of non-esterified ''free'' fatty acids are carried on albwnin in plasma because of 
poor solubility, and this also protects cells from their detergent action. Chain length may 
be from 1 hydrogen atom (HCOOH methanoic (formic) acid) to 30 or more carbon 
atoms, although fatty acids mostly occur in the C12-22 range. Short-chain fatty acids are 
more water-soluble. Long-chain fatty acids (> 10 carbon atoms) occur commonly in TO 
andPL. 
With the exception of Cs (pentanoic (valeric) acid), only fatty acids with an even 
number of carbon atoms are found in substantial amounts. 
Fatty acids are classified according to the number of double bonds: saturated when 
there are no carbon-carbon double bonds, monounsaturated (MUFA) when there is one 
double bond and polyunsaturated (pUF A) when there are two or more double bonds, up 
to six in important fatty acids. The double bonds in the more important naturally-
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occurring PUF A are always separated by one methylene group: -CH2, and the double 
bonds are in the cis configuration, for example linoleic acid (Figure 1.26 and arachidonic 
acid (20:4A5,8,11,14) (the A convention is explained in Section 1.4.2.2): 
eOOH a) 
eOOH b) 
Figure 1.26. Structure of a) a cis dienoic unsaturated fatty aCid, linoleic acid, and 
b) a IrtlllS monoenoic fatty acid, vaccenic acid. 
Another group of PUF A has part or all of their unsaturation in a conjugated system with 
cis and trans double bonds (Figure 1.27), where a conjugated system has the double (or 
triple) bonds separated by a single bond. These are not commonly found in animal lipids, 
occurring mostly in some seed oils: 
-e-e=e-e=e-e-e-or~ 
I I I I I I Itt 
cis trans 
Figure 1.27. Conjugated unsaturation in a polyunsaturated fatty acid. 
Fatty acids with conjugated unsaturation compared with their non-conjugated isomers 
exhibit a characteristic ultraviolet spectrum where the greater the extent of diene 
conjugation the greater the increase in absorption at 234nm (279), higher stability 
therefore higher melting points, commonly occurring trans unsaturation and they are 
more reactive towards free radical addition. A third category has double bonds that are 
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not totally in a methylene-separated system. They are known as the non-methylene-
interrupted dienes (NMID) and an example is the fatty acid in tall oil (18:3M.9•12) (280). 
The cis configuration has restricted rotation aroWld the double bond and this reduces 
close packing adjacent to the hydrocarbon chain which results in weaker intermolecular 
van der Waal's forces. Unsaturated fatty acids therefore have lower melting points than 
saturated ones. TG containing trans unsaturated fatty acids as opposed to cis fatty acids 
have their hydrocarbon chains more closely packed and so have higher melting points. 
Two highly unsaturated fatty acids fOWld in fish oils are eicosapentaenoic acid (EPA): 
20:5,u,5,8,Il,14 or 20:5M,8.lI,14,16 or 20:5A5.8,Il,14.17 and docosahexaenoic acid (DHA): 
22:6M •7.IO,13,16,19. 
The two most abWldant saturated fatty acids in mammals are palmitic acid (16:0) and 
stearic acid (18:0), while oleic acid (18:1A~ is the most commonly occurring Wlsaturated 
fatty acid. Linoleic acid (18:2A9,12), linolenic acid (18:3A9.12.15) and arachidonic acid are 
known as essential fatty acids because they are not synthesised by mammals but are 
important in the diet, being acquired from plants. 
Fatty acids may also have branched chains or cyclic structures, although these are 
present in small amoWlts in humans. 
1.4.2.2. Nomenclature 
The most commonly-used systematic nomenclature (the IUPAC system) names the 
fatty acid the same way as the hydrocarbon with the same number and arrangement of the 
carbon atoms, with "oic" in place of the "e" at the end of the hydrocarbon name, for 
example the single carbon methane becomes methanoic acid (the common or trivial name 
is formic acid) as a fatty acid. This is the systematic name. "Anoic" denotes a saturated 
fatty acid while "enoic" denotes a double bond and therefore an unsaturated fatty acid, for 
example hexadecenoic (palmitoleic) acid: 
There are several conventions denoting the position(s) of the double bond(s) in the 
hydrocarbon chain. In the IUPAC and A (delta) conventions, the double bond is 
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numbered from the carboxyl carbon (carbon number 1) whereas in the ro (omega) or n-
(n minus) conventions, it is numbered from the terminal methyl carbon, for example; 
18 13 12 10 9 1 
CH3(CH2)4CH =CHCH2CH = CH(CH2hCOOH 
t 
carboxyl carbon 
1 6 7 9 10 18 
CH3(CH2)4CH =CHCH2CH = CH(CH2hCOOH 
I 
(ro6,C18: 2 or (n-6)-18:2) 
methyl carbon 
Figure 1.28. Double bond numbering conventions of octadecadienoic (linoleic) 
acid. 
1.4.3. Fatty acid biosynthesis and metabolism 
The main sources of fatty acids in humans are dietary and cellular stores. The 
exogenous pathway of TG metabolism refers to the metabolism of dietary lipids 
(including TG, PL and cholesterol esters) which are digested (hydrolysed) by pancreatic 
enzymes to fatty acids in emulsions with bile acids in the gut, followed by absorption into 
the enterocyte and reassembly into TG and subsequent incorporation into chylomicrons 
for transport. These lipoproteins are secreted into the lymphatic system and subsequently 
enter the systemic circulation for distribution to mainly the muscles and adipose tissue. 
Chylomicron remnants return to the liver. Chylomicrons contain mainly TG, and the fatty 
acid composition is that of the diet. Phospholipids, cholesterol ester and free cholesterol 
are minor constituents. The generally accepted composition is 88% TG, 8% PL and 3% 
cholesterol ester. The chylomicrons are the largest and least dense of the lipoproteins, and 
the structural apoproteins include Cii for lipoprotein lipase activation and apoE to 
mediate clearance. The half life is the shortest of all the lipoproteins. The endogenous 
pathway of TG metabolism refers to the secretion of VLDL, the TG-rich lipoprotein 
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assembled on apoB-IOO in the liver. This lipoprotein is smaller and denser but is 
metabolised in a similar manner to chylomicrons. While chylomicrons will contain 
almost entirely dietary fatty acids, the VLDL can contain "recycled" diet-derived fatty 
acids as well as fatty acids synthesised in the body and returning from body stores 
(adipocytes). Exchange of neutral lipids between TG-rich lipoproteins and cholesterol 
ester-rich lipoproteins can occur by virtue of cholesterol ester transfer protein. 
1.4.3.1. De novo biosynthesis (lipogenesis) 
There are big variations among animal species with regard to their fatty acid pathways 
and the substrates for fatty acid synthesis. Most animal cells are able to synthesise fatty 
acids to a level that maintains lipids in membranes. However, liver cells engage in more 
extensive synthesis, which leads to storage of triacylglycerols in adipocytes. The main 
enzymes are expressed in higher levels in cells of liver, adipose tissue, brain, lung, kidney 
and mammary glands of higher animals. Insulin is an important hormone that stimulates 
lipogenesis via several mechanisms, one of which is the activation of acetyl~oA 
carboxylase. 
Fatty acids are synthesised from acetyl~oA and the overall reaction of biosynthesis of 
palmitate is: 
8acetyl (CoA) + 14NADPH +14W ~ palmitate(16:0) + 8CoA + 14NADP+ + 7C02 + 6H20 
• 
1 acetyl unit from acetyl~A + 
7 acetyl units from malonyl~oA 
Fjgure 1.29. Overall reaction of palmitate biosynthesis. 
Palmitate is the precursor of both saturated and unsaturated fatty acids. All mammalian 
PUF A are formed from elongation and/or desaturation of paImitoleic, oleic, linoleic and 
linolenic acids. 
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C16:0 palmitic acid 
(desaturatiOn~ ~2 
C1~1 C1~O 
palmitoleic acid 
C18:1 
vaccenic acid ~ 
linoleic acid 
+ linolenic acid 
~ 
stearic acid ! -2H 
C18:1 
oleic acid 
+ +C2 
C20:1 
+ +C2 
C22:1 
erucic acid 
arachidonic acid 
Figure 1.30. Biosynthesis of some unsaturated fatty acids from palmitic acid 
(281,282) 
1.4.3.2. Fatty acid catabolism (oxidation) 
Fatty acid degradation in man is an aerobic process which provides energy and which is 
brought about almost entirely by ~-()xidation and to a far lesser extent (X- and U)-
oxidation. 
It is initiated by hydrolysis of TG by hormone-sensitive lipases, which occurs when 
protein kinase A is stimulated by high concentrations of cyclic AMP (cAMP) to 
phosphorylate the lipases: 
lipases } TG-------:>:1I> glycerol + 3 fatty acids cytosol 
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Fatty acids are then activated by esterification with CoA to fatty acyl-CoA thioesters by 
acyl-CoA synthetases, located on the outer mitochondrial membrane, with different 
synthetases activating different fatty acids depending on their chain length. These 
synthetases acivate both saturated and unsaturated fatty acids. Fatty acyl-CoAs are 
impermeable to the inner mitochondrial membrane and are therefore transported as fatty 
acylcarnitine after the reaction catalysed by camitine acyltransferase I and II (CAT I and 
II) located on the outer and inner surfaces respectively of the inner mitochondrial 
membrane. Carnitine is widely found in the body, particularly in muscle, kidney and liver 
and is synthesized from lysine. 
P-oxidation, a cyclic process, takes place in the mitochondrial matrix, after re-
formation of fatty acyl-CoA. The fatty acids are degraded stepwise from the carboxyl 
end by removal of 2 carbon atoms per turn of the cycle. The 2 carbon atoms are removed 
as acetyl-CoA and the J3-carbon is oxidized: 
HS--CoA 
R-CH~H2-Co-SCoA 
fatty acyl-CoA 
------->~ R~~A 
fatty acyl-CoA 
Figure 1.31. p..-oxidation reaction. 
+ CH:rCo-S~A 
acetyl-CoA 
P-oxidation of unsaturated fatty acids requires further enzymatic stages in order to 
move the double bonds. Complete oxidation of unsaturated fatty acids yields fewer A TP 
molecules than the corresponding saturated fatty acids due to the fewer hydrogens in the 
unsaturated molecules. a-Oxidation is a process that takes place in brain tissue, where 
there is removal of 1 carbon at a time from the carboxyl end of the fatty acid. CoA 
intermediates are not found. U>-Oxidation involves hydroxylase enzymes and cytochrome 
P450 in the endoplasmic reticulum and is a very minor pathway of fatty acid oxidation. 
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1.4.3.3. TG and PL assays 
1.4.3.3.1. TG assays 
Triacylglycerols are hydrolysed to free fatty acids and glycerol by the action of 
lipoprotein lipases. The glycerol is converted to glycerol-3-phosphate and ADP by 
glycerokinase and ATP. In the presence of oxyg~ glycerophosphate oxidase converts 
the glycerol-3-phosphate to dihydroxyacetone phosphate and hydrogen peroxide. Two 
molecules of the peroxide, in the presence of 4-chlorophenol and 4-aminoantipyrine, are 
used by peroxidase to generate red quinoneimine hydrochloride and water. The 
absorbance of the red colour may be read spectrophotometrically at SOOnm. The method 
is detailed in the Appendix. 
1.4.3.3.2. PL assays 
The phospholipid assay measures phosphatidylcholine, the major PL in blood PL are 
hydrolysed by phospholipase D to choline and phosphatidic acids. In the presence of 
oxygen and water, the choline is converted to betaine and hydrogen peroxide by choline 
oxidase. Two molecules of the peroxide are converted by peroxidase in the presence of 
4-aminophenazDne and phenol to red 4-(p-benzoquinone-mono-imino }-phenazDne and 
water. The red colour may be read spectrophotometrically at sOOnm. The method is 
detailed in the Appendix . 
1.4.4. Lipid peroxidation 
Free radicals have been extensively researched in recent years. They are derived mostly 
from oxygen as reactive oxygen species (ROS) and are generated in vivo by various 
endogenous processes, exposure to various physiochemical conditions or 
pathophysiologiaJ. states (283). Lipids, which are prone to free radical attack, may be 
altered by these free radicals, resulting in lipid peroxidation which has been implicated in 
various diseases. 
Oxidation of the unsaturated fatty acids in lipids is one of the most fundamental 
chemical reactions and generates a very complex set of volatile oxidation products that 
can cause spoiling or rancidity in compounds such as foods. The oxidative decomposition 
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products such as lipid hydroperoxides (LOOH) and thiobarbituric acid reactive 
substances (TBARS) may also cause cellular damage in the body, as in atherosclerosis, 
cancer, various inflammatory diseases and ageing. 
There are several mechanisms of lipid oxidation. Lipid peroxidation (or autooxidation) 
of lipids is a process where electrons are removed from the lipids by free radicals, 
resulting in the increased production of more free radicals. This involves a catalytic 
chain reaction where hydroperoxides are formed via loss of a hydrogen radical in the 
presence of trace metals, light or heat. Photooxidation of lipids occurs when the oxidation 
reactions are induced by light, resulting in the loss of 1 or more electrons as a result of 
photoexcitation. Oxidation by singlet, and triplet oxygen proceeds by a different 
mechanism from free radical auto oxidation. 
Since the early 1960s a lot of research in this field has been carried out, leading to a 
considerable increase in the understanding of the process of lipid peroxidation and the 
role it plays in the decomposition of lipid hydroperoxides, which are the precursors of the 
volatile secondary products. Although there have been huge advances in this field, the 
methods used are often still very non-specific and unreliable. Lipid peroxidation is often 
studied under drastic conditions with simplistic models that do not mimic complex 
biological or food systems. For the purposes of the studies in this thesis, lipid 
peroxidation will refer to all the changes in PUF A that are found to differ from the usual 
biological state of these fatty acids, including conjugated dienes (CD) (in which there is 
no change in oxidation states), LOOH and more advanced products including aldehydes 
(TBARS) and fragments oflong chain fatty acids. 
1.4.4.1. The process of Upid peroxidation 
The autoxidation of PUPA proceeds via a free radical chain reaction (Figure 1.32). 
Reversion can occur at the stage of the CD radical. Compared with the original 
biologically-derived fatty acid, the methylene-interrupted double bond is now altered to 
a CD and its conformation is no longer enzymatically determined and merely follows 
entropy. In this context a CD reflects free radical attack of a biological fatty acid and 
promotes the reaction with ROS. 
80 
H 
RH 
R lUITIII1gemenl ~~COOH" ( COOH 
H - conjugated dlene radical 
R- tJ' 
\ F\F\ F\ hydrogen 8bSn:" 
v Y A COOH 
H H 
o 0 _ 1-' _ 0-0-H~H"''''I----~-( - COOH ...... t----R~COOH 
malondlaldehyde endoperoxide peroxyl radlcil jH 
abstraction from 8 fatly ackI r 
H OOH ~+R­
COOH 
ROOH 
lipid hydroperoxlde 
Figure 1.32. The overall process of lipid peroxidatioo (adapted from (284) aod 
(285). 
The chain reaction may be described in tenns of an initiation stage, followed by 
propagation, branching and a tennination stage (286,287): 
• The initiation process involves all the primary reactions that generate free 
radicals, resulting in a nett increase in the number of active free radicals, as 
opposed to the propagation stage where the number remains the same, and the 
tennination stage where there is a nett decrease in the number of free radicals. 
One of the main products of lipid peroxidation, lipid hydroperoxides (LooH), 
may also be a source of active free radicals, via a specific stage of the initiation 
process known as "degenerate chain-branching": 
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trace metals 
LOOH -'~r---------". 
'-..r H· 
• LOO 
(peroxyl radical) 
The peroxyl radical, the principle chain-carrying free radical, may act as an 
initiator for oxidation in the following reaction: 
• 
LOO 
LH --.------....;)1.... L· + LOOH 
(unsaturated lipid) ~ H • (alkyl radicaij 
Trace metal ions such as iron and copper, heat and ultraviolet radiation, may also 
act as initiators of lipid peroxidation, and when the oxygen concentration is high 
enough, peroxyl radicals are fonned: 
hydrogen abstraction • 
M + LH + O2 "",,=. • LOO 
H (metal initiator) (unsaturated lipid) 
• The propagation stage: 
• L + 
• 
------3..... LOO 
• • LOO + LH ------3)1 .... LOOH + L 
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The hydroperoxides are the precursors of the volatile secondary products such as 
MDA (Figure 1.33). 
• The termination stage: 
In the tennination stage, the peroxyl radicals react with each other and self-
destruct, fonning non-radical products . 
• • 
LOO + LOO ----'l...... non-radical products 
1.4.4.2. Determination of the products of lipid peroxidation 
Lipid peroxidation of fatty acids in food during storage and preparation is discussed in 
Section ·2.1. Continuous monitoring of lipid peroxidation or collection of individual 
samples from the reaction are both used to determine the concentration of products. 
Evaluation of lipid peroxidation as CD and TBARS constitute the most popular assays. 
The methods below are all detailed in the Appendix. 
1.4.4.2.1. CD and the CD assay 
A CD is an alkene whose double bonds are separated by a single bond in the molecule: 
for example H2C=CH-CH=CH2. CD are the initial markers of oxidative stress. Molecules 
that contain CD absorb maximally at 215-25Onm, depending on the presence of 
substituent groups nearby. Lipids with CD are characterised by a peak of absorbance at 
approximately 233nm, with a lesser peak at 260-280nm. The concentration of CD is 
detennined by the extinction coefficient of 2.95 x 104 M""l.cm-l. A potential problem with 
measurement of CD in biological samples is the interfering background absorption from 
PUF A, haem proteins, purines and pyrimidines. 
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1.4.4.2.2. LOOH and the LOOH assay 
The steady-state concentrations of LOOH in human body fluids is very low (less than 
100nM), as measured by methods that directly determine the concentration of ''real'' and 
not artefactual LOOH, as used by Holley and Slater with HPLC-chemiluminescence 
(288). The FOX (ferrous-oxidation xylenol orange) method, however, is ideal for 
comparison of concentrations and measures the oxidation of Fe ++ to Fe +++ by LOOH in 
dilute acidic conditions. The antioxidant BHT is added to prevent further oxidation 
during the reaction. In the presence of xylenol orange, Fe +++ forms a coloured xylenol 
orange-ferric ion complex which absorbs maximally at 560nm. Phosphines also react 
specifically with hydroperoxides, and their fluorescent derivatives (for example 
diphenyl-I-pyrenylphosphine) have been uSed for assays as well. 
1.4.4.2.3. TBARS and the TBARS assay 
In the presence of iron and copper complexes, LOOH break down to produce a variety of 
aldehydes such as malondialdehyde (MDA). MDA is one of the most important TBARS 
in lipid peroxidation. TBARS produce a red product when they react with thiobarbituric 
acid (TBA) (Figure 1.33). The spectrophotometric method, although sensitive, is also 
non-specific because compounds such as bilirubin, amino acids, oxidised proteins, acids, 
aldehydes, ketones and esters may also react with TBA. Another potential problem is that 
significant amounts of MDA might be lost via volatilisation or cross-linking with 
proteins. Additionally, the heat required for the reaction can promote the formation of 
new TBARS during the assay. Ferric chloride is added to the assay to promote the 
oxidation reaction. The assay involves the heating of the sample at an acid pH. The 
coloured product is read at 532nm and the concentration of the TBARS is determined by 
the molar extinction coefficient of 1.56 x lOs M""l.cm-l. 
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U yrN 0 I I + 2 H~ HN .0 
MDA OH 
H+ heat j TBA 
H~~NrO HOyNyS 
HN~(NH 
o 0 
red-coloured product 
Figure 1.33. The TBARS reaction. 
BHT, a free radical scavenger antioxidant, may be added to reduce in vitro lipid 
peroxidation. To improve the specificity of the MDA-TBA adduct, a number of HPLC 
methods have been devised where non-MDA contaminants are separated out during the 
chromatography stage. The determination of plasma MDA by a number of authors has 
shown the range of concentrations to be 590-4570nmol/L (285). The TBARS assay, 
despite its problems, has been found to correlate well with other markers of lipid 
peroxidation (289). Young and Trimble (289) found that plasma TBARS samples were 
stable during storage at 4°C for 10 days, at -20°C for 3 weeks and at -70°C for longer 
storage. 
1.4.4.3. ANTIOXIDANTS 
An antioxidant is a substance that significantly delays or prevents oxidative damage to 
a substrate, for example a PUPA. The interest in antioxidants increased in about 1990 
when it became recognized that the beneficial health effects of beverages and foodstuffs 
such as red wine, tea, fruits and vegetables, depended largely on their antioxidant 
activities. This resulted in the development of a number of new methods to determine the 
total antioxidant capabilities of the individual antioxidants as well as that of blood serum. 
Antioxidants may be primary, reducing the rate of production of radicals that start the 
new oxidation chains during lipid peroxidation, reducing production of hydroperoxides or 
chelating the metal ions that catalyse oxidation reactions, or they may be secondary 
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antioxidants, which trap radicals, such as peroxyl radicals (the main chain-carrying 
radicals during lipid peroxidation (290» and hydroxyl radicals, directly and so reduce 
chain propagation and amplification. However, the majority of antioxidant compounds 
has multiple antioxidant properties. There are various in vivo antioxidants such as 
transferrin, superoxide dismutase, catalase, glutathione peroxidase and reductase, urate, 
vitamin E (tocopherols and tocotrienols) as well as various dietary compounds such as 
plant phenolic compounds, vitamin A and vitamin C. Flavonoids are regarded as "high-
level" antioxidants based on their ability to scavenge free radicals such as superoxide and 
hydroxyl radicals, as opposed to the chain-breaking a-tocopherol which is considered a 
"low-level" antioxidant because it stabilises radicals that occur later in the oxidation 
process, such as peroxyl radicals. To be an efficient radical scavenger, a flavonoid must 
have ortho--dihydroxy groups in the B-ring and secondly, there should be a 2-3 double 
bond conjugated with the 4-oxo group in the C-ring, which contributes to electron 
delocalisation in the B-ring, and thus stability (261). Thirdly, for maximum radical-
scavenging ability, the flavonoid should have 3- and 5-hydroxyl groups. The antioxidant 
capacity of any antioxidant is determined by its reactivity with the oxidant substrate, its 
concentration, metabolism, mobility and distribution, its possible pro-oxidant effects 
under certain conditions, synergistic reactions with other antioxidant compounds, and the 
means of determining the antioxidant capacity (290,291). 
Future antioxidant research includes the use of gene therapy to produce different 
antioxidants in vivo, the use of genetically engineered plants with higher concentrations 
of antioxidants, synthetic antioxidant enzymes and the use of functional foods with higher 
concentrations of antioxidants (283). 
1.4.4.3.1. Antioxidant assays 
Methods for determining the concentration of chain-breaking antioxidants, such as 
BHT and Trolox, may be direct or indirect. Direct methods determine the effect of the 
antioxidant-containing substance directly on the oxidation of the testing system, for 
example the effect of wine on the oxidation of LDL and the ORAC (oxygen radical 
absorbance capacity) method. Indirect methods include the TRAP (total radical-trapping 
antioxidant parameter), FRAP (ferric reducing ability of plasma), and the TEAC (trolox 
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equivalent antioxidant capacity) tests. These are methods that detennine total antioxidant 
capacity. 
• The TRAP (total peroxyl radical-trapping antioxidant parameter) assay, as 
described by Wayner et 01 (292), measures oxygen consumption during 
thermally-controlled lipid peroxidation of ABAP (2,2'-azo-bis (arnidinopropane 
hydrochloride)), a water-soluble peroxyl radical generator. Trolox, a water-
soluble a-tocopherol, is used as a standard in the assay. The TRAP assay has been 
found by some authors to be reliable and reproducible (291,293), while others 
found it an imprecise method, based on the instability of the oxygen electrode 
over the time of the assay (294). 
• The FRAP assay, described by Benzie and Strain (295), measures the ability of 
antioxidants, in particular phenolics, to reduce ferric tripyridyltriazine to a 
coloured ferrous tripyridyltriazine complex. This is a simple assay but it is not the 
ideal assay for all antioxidants, such as glutathione, because not all antioxidants 
have this reducing ability. 
• The TEAC assay, also referred to as TAS (total antioxidant status), and described 
by Miller et 01 (296,297), is based on the ability of antioxidants to inhibit the 
absorbance of ABTS (2,2'-azinobis-3--ethyl benzothiazoline-6-sulphonate). 
• The ORAC assay described by Cao et 01 (298) and revised by Ou in 2001 (299) is 
the most recent and commonly-used of these assays. The details of the assay are 
described in the Appendix. The method is very specific, can test for numerous 
antioxidants, and is the only assay that takes the free radical action to completion. 
It uses a peroxyl radical generator, AAPH (2,2'-azobis(2-amidinopropane) 
dihydrochloride) as a pro-oxidant. The calculated area under the curve is used to 
detennine total antioxidant capacity. 
The photography in this section was carried out by the author with the assistance of 
Natalie Payne at the Distell Winery, Stellenbosch, South Africa, unless otherwise 
stated. 
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CHAPTER 2. A NOVEL OIL-BOIL METHOD TO DETERMINE THE 
ANTIOXIDANT EFFECTS OF RED WINE 
2.1. Background 
Edible oils contain 98-99% triacylglycerols and 1-2% non-saponifiable compounds, 
such as sterols and fat~luble vitamins. The chemistry of triacylglycerols is described in 
Chapter 1. Worldwide, the consumption of oils and fats has grown steadily over the last 
25 years, with an average annual growth rate during 1999 to 2004 of 3.8% (300). The 
approximate total world production of major oils and fats from 1995 to 1996 was 82 
million metric tons, with the production of canola oil being the highest, followed by 
sunflowerseed (sunflower) and cottonseed oils (301). In South Africa, sunflower oil is 
used extensively. In 1994 in the USA, approximately 2.5 billion kilograms offats and oils 
of a total of 5.4 billion kilograms consumed, were used for flying or baking, with deep-
fat flying at high temperatures being the most common method (302,303). 
The safety of thermally -stressed unsaturated fatty acids has been the subject of research 
for many years. Food that contains PUF A is very susceptible to lipid peroxidation and the 
greater the degree of unsaturation of the fatty acid, the more susceptible it is to oxidation, 
particularly during cooking. Heating oils causes an increase in the concentrations of free 
fatty acids and polymers, and a decrease in antioxidant content (304). The concern when 
flying food in oil is the possible interaction of the food, especially protein, with the lipid 
peroxidation products, forming new compounds that are potentially toxic. The chemistry 
of autoxidation has been discussed in Section 1.4.4.1. Lipid peroxidation leads to the 
formation of hydroperoxides, which are unstable and decompose rapidly to form 
secondary products such as malondialdehyde. Lipid peroxidation relating to cooking 
processes may result in changes to the oils and fats. Apart from changes in palatability 
(rancidity), that may affect food preference, alterations from cis to trans isomers may 
occur. These changes are accepted as unfavourable to health. Whilst aldehydes may cause 
polymerisation that could merely make fats indigestible, these and other chemically 
reactive species may harm the lining of the alimentary tract and could potentiall' also be 
transported in the circulation where vascular endothelium may be affected adversely and 
may also harm the organs or tissues of final destination, including the liver, muscle and 
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adipose tissue. Early studies indicated toxicity, but unfortunately very few analytical 
details were given. Animal studies have shown that the products of lipid peroxidation are 
well absorbed via the lymphatic system into the systemic circulation (305): Sanchez-
Muniz et af (306) found that oxidised lipids are actively absorbed in rats and 
Naruszewicz et af (307) found an increase in TBARS in human plasma after consumption 
of thermally-oxidised oil. Liver TBARS were found to be significantly increased in rats 
that ingested thermally-oxidised oil (308-310), while there was also evidence of 
significant liver necrosis (311). Liver metabolism was affected by consumption of 
oxidised oils (312). The absorption of fatty acids in heated oils was significantly lower 
than in unheated oils (313,314) and the authors ascribed this to an increase in polymer 
formation in the heated oils. Some studies found short-term changes in the 
gastrointestinal tract such as diarrhoea, while longer-term changes included growth 
retardation, liver damage and death (312,315-320). The susceptibility of tissue to iron-
induced lipid peroxidation was increased by ingestion of heated sunflower oil (321). 
Malondialdehyde was found to be unequivocally mutagenic (322) and carcinogenic 
(323). Peroxidation products may also contribute to the pathogenesis of degenerative 
diseases, cancers and the ageing process (324). Consumption of a meal containing used 
cooking oil resulted in impaired endothelial function (325). Chapter 5 describes the effect 
of red wine on endothelial function of the brachial artery 
Autoxidation is therefore a critical factor that affects the quality of oils. It is one that is 
difficult to prevent, given that it takes place even at low temperatures in the dark (326). In 
oils, this process is slow, until their antioxidant potential is exceeded. Oils have their own 
natural antioxidants and are also protected from oxidation by the addition of antioxidants 
such as the chain-breaking tocopherols, and BHT (327). When these are depleted, 
peroxidation accelerates and becomes rapid. The time taken for this to happen is known 
as the induction time, and this may vary between different oils. An increase in the 
unsaturated nature of the fatty acids in an oil reduces the induction time and increases the 
rate of oxidation (326). 
Frying in oil is one of the most commonly-used cooking methods in food preparation. 
Frying conditions increase the rate of oxidation in oil, and antioxidants in the oils tend to 
decompose rapidly. Degradation products, such as polar triacylglycerols and polar and 
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non-polar polymers, tend to accumulate, and when the concentration of polar compounds 
reaches approximately 30% (the threshold concentration of di- and polymeric 
triacylglycerols in oils is 10% by mass (328», the oil should be discarded. At this stage, 
the oil has usually darkened in colour and there is an increase in viscosity and foaming. 
A large number of studies indicates the beneficial effects of alcohol in beverages, as 
described in Chapter 1. These effects are thought to be due, at least in part, to the 
presence of polyphenols. Section 1.2.3.1 describes a number of studies that found a 
greater beneficial effect from red wine compared with other alcoholic beverages. Wme, 
in particular red wine, contains a number of different polyphenols, including flavonoids, 
which have beneficial antioxidant effects and antioxidants play an important role in 
potentially preventing lipid peroxidation. Previous methods used to evaluate antioxidant 
activities of wine have generally been based on the ability of the wine to reduce in vitro 
oxidation of LDL. This is not a physiologically appropriate comparison as in vivo LDL 
will not be exposed to the same complement of chemistry. The antioxidant capacity of 
wines is determined by a number of factors including the grape variety, the wine 
processing techniques and by the reactions that occur during ageing of the wine. Some 
older wines have been found to have greater antioxidant capacity, attributed to the 
increase in tannins during ageing in oak (329). The objectives of this study were: 
i) To determine the concentration of 3 different peroxidation products in edible 
oils, (CD, LOOH and TBARS), and to select a suitable, probably PUF A, oil 
for use in further testing; 
ii) To detennine the extent of lipid peroxidation in a thennally-stressed PUFA 
oil at 100°C, the temperature that would apply to cooking foods that contain 
water. 
iii) To establish an "oil-boil" method that would reliably determine and compare 
the total antioxidant effect of different wines in a food-relevant 
pseudomonophase using thennally-stressed PUF A oil. A macro-method 
using relatively large volumes of oil and wine was established first and then 
compared with a micro-method using smaller, more convenient volumes in 
order to accommodate larger sample numbers. To my knowledge, this method 
has not been used before in the published literature. 
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iv) To determine the antioxidant capacity of each of the wines by the ORAC 
method, and to compare the results with the antioxidant capacity of the wines 
as determined by the macro and micro oil-boil methods. 
2.2. Methods 
2.2.1. Lipid peroxidation status of edible oils in South Mrica 
Thirty three commercially-available edible oils were purchased without reference to 
age or storage conditions, which would have reflected possible lipid peroxidation. These 
oils included 17 different brands of olive oil, 9 of sunflower oil, 2 of canola oil, 2 of 
sesame seed oil and 1 each of flax, grapeseed and peanut oil. The relative fatty acid 
compositions are shown in Table 2.1. The oils were classified as MUF A and PUPA 
according to the dominance of these fatty acids. The MUFA included the olive, canola 
and peanut oils, and the PUPA included the flax, sunflower, grapeseed and sesame oils. 
The spectrophotometric assays of the peroxidation products as described in the Appendix, 
were used to determine the concentration of the CD, LOOH and TBARS, both total and 
free (tTBARS and ffBARS), from 6 values, 3 determinations each on 2 days. The results 
were expressed per gram of oil. 
Due to the popularity of sunflower oil as a first choice of cooking oil in South Africa, it 
was decided to use sunflower oil for further testing in re-heating, and in the macro and 
micro oil-boil experiments. Sample 4 of the sunflower oils was used as it is an oil that is 
readily available, inexpensive, and the peroxidation products in several different samples 
were consistent, with an inter-assay CV of < 10% for all the assays. The CD, LOOH and 
TBARS of this oil were similar to the means of all the 9 sunflower oils: per gram of oil, 
the CD content was 22.0 J.Ullol in sample 4 compared with 21.0J.Ullol for the total mean; 
the LOOH content was 5.6 compared with 5.4 J.Ullol; the tTBARS content was 181.3 
compared with 200.5 nmol and the ffBARS content was 0.6 compared with 1.5 nmol. 
The chemical composition of this oil was not declared by the manufacturer. 
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2.2.2. Lipid peroxidation in thermally-stressed PUF A oil, re-heated over 75 hours 
Twenty five mL volumes of sample 4 sunflower oil were placed in 100 mL glass 
beakers (with a surface area of 2206 mm2) and heated on thennostaticallY--1:ontrolled 
Freed electric heater/stirrer modules for 3 hours whilst exposed to room air. One mL 
samples of each oil were taken before heating, at time 0 minutes (baseline) when the oil 
reached lOO°C, and at 1, 2 and 3 hours. After 3 hours, the oil was removed from each 
beaker and stored at 4°C overnight in the dark. In order to simulate re-heating conditions, 
after 24 hours the oil was again heated to 100°C and 1 mL samples were taken at time 24, 
25,26 and 27 hours, relative to baseline. Heating was stopped, and the oils were stored 
overnight as before. The oils were again heated, and 1 mL samples of oil were taken at 
72, 73, 74 and 75 hours. Concentrations of CD, LOOH and TBARS were determined for 
each of the 1 mL oil samples by the assays described in the Appendix. 
2.2.3. Lipid peroxidation in thermally-stressed oil heated with copper and red wine 
2.2.3.1. The macro-method 
Twenty five mL of the oil were heated to 100 ± 5°C over 3 hours on Freed electric 
modules as above, alone, in a pseudomonophase with 25 mL deionised H20 as a control, 
in a pseudomonophase with 25 mL of 20 J.U11ollL CUS04 in deionised H20, in a 
pseudomonophase with 25 mL red wine, and with 12.5 mL red wine with 12.5 mL 40 
J.U11ollL CUS04. Heating was carried out in 100 mL glass beakers as in Section 2.2.2. 
Analyses of CD, LOOH and TBARS were carried out on 1 mL samples at baseline and at 
3 hours. As the macro-method was established before the micro-method, it was 
considered necessary to determine the concentrations of all 3 peroxidation products, as 
only 1 product might not be representative of the peroxidation process. There was very 
good correlation between CD and LOOH, as shown in Figure 2.5. A maximum of 3 
samples of wine could be tested in triplicate at the same time by this macro method, 
owing to the limited number of heating devices. The advantage of the macro-method was 
the ability to control the heating temperature of the different conditions, as heating of 
each condition was carried out on a separate heating module. 
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Figur., 2. 1. Heated oil and CUSO, solution un .. Freed hl'3terfslir~r module. 
A tolal of 1,1 red wioe, "a, tesled. each III tri plicate. I" addition. 2 wlne~. a Cha(~au 
Libena~ Md a Pioolagc. wen.' stored. corl ed. for 6 w'o:cb in the dark at 4°C. and tcsted 
fot their antioxidant cap.leity by the mocro-melhod over Ihis lime. T"clvc oonles of tile 
~ome cult;v;!/" and vintage. 8 19'17 O'3tC3J.' Libcrtas, were compared by the macro-
method. ~ was (he ~me cultivar but different vintages ( 1990. 1991, 199-1 , 1996, an.d 
1999) of one of the wines. a r..lcrlot . 
2.2.3.2. Th., micro _method 
This method was tievisW in or<kr that productivity could be improved; by i nnea~ing 
the sample number. aoo decreasing tile ,"olulnc of oil aoo putative amioxidanl liquid to a 
(Olalof I mL per sample. ill borosilicate 13 x 100 mm tubes. using the same conditions 
and rutios of rt:aetants 11$ !he macro-method. JI,'lagncu in cach lube were used to cmne a 
~udomonoprose and II glass marble was placed at the top of cach tube 10 reduu 
e'1q)Ofation of these It:lati'ely !iI'T1all volumes.. lind limit the e.'(posure to lIir o'<er a surfacc 
area 0(95 flIm!, T"etIty samples o f "inc: could be tcstro in lriplicale al lhe same time b} 
Ihis method. Heating "as carried out in a Pierce Rcacti- !henn healing! slirring module 
and monitored by means of D digital DigitlUn thermocoupk !hermomcter "ilh B 
Ph)'silcmp micro-probe. for 2 hours al lhe fullowing temperatult:s (mean oi SD): (lit 
alOOl:. 102.9 oi L8"C; oil "ith CuSO •• 99.3 oi 3.I"C; oil "i th "ine. 96.6 oi l.1 "C and oil 
"ilh "inc 900 CuSO., 96.6 oi 1.1"e. CD analysis was used to deu:nnine !he IInli(l)(idam 
capabilil~ of the wine. Each samplc was cenlri fuged at 14 000)( g for 10 minutes in II 
JOllan MR microfuge to sq,a.rate the oil frum the aqueous phase. CD anal)'sis is quid and 
....,Iiable bul mon: impol'lllntJ),. it was established that it has good COITClation "i th the 
Lootl 9SSi1) (~- 0.62) (Figult: 2.5). 
The antioxidant "tTl...:t of each "ine was determined lIS a percenlab'C reduction of CD 
n:tall,e 10 Ihc cllange brought llbout b) o~idat ion by copper. 
A - {concentration of prnl~idation product from oil "ith Cu- al 180 minutes (macro) Or 
120 minutes (micro» - (concentration of product al 0 minutes): 
U - {concentmlion o f peroxidation product From oil "jth Cu' and wine at 180 minutd 
(macro) Of 120 minutes (miero» - (concenlralion of product at 0 minutes); 
C - (81A ~ IOO) 
All I f"~jd",, 1 e" I,,,dfy ur Ito ..... j ll ~ - J Illl-C 'Y •• 
2.2.3.] . The ORAC defemlin~tion of red winf 
The method ofOu el (JI (299~ as descrilx,d in the Append1.'\:. was l&.'d. Aricfl y, the winc 
samples were diluted in phosphate buffer pH ... 7.4. FlllOrcscein ~nd AAPH were added 
and the reactions were allo"cd 10 go to completion. after whic h they were compared with 
II. standard reaction ofTrolo.' . This relatively moll.' watcr-soluble deri\'olh'e of tO(:opherol 
provides a useful reference. Samples were analysed in tri plicale . The It:sults welt: 
c:\pressed as mmol lro lo~ equivalents (I'EYL "'inc. and then compared with lhe 
orAioxidant capability of the "';nt.'S detennincd hy the macro nnd the micro oiJ-boi l 
md"""'-
2.2.4. Statis ti..".1 aowl)'n. 
Dalll are expressed DS ml!lln ± SO. All statistical analyses were pcrfonned with the use 
of Graph pad PKISM software (version 3. Slln Diego. USA). The Student's I !lost was used 
10 analysc thc significance of paired data. and the unpaired I test was used to compare 
unpaired dal3. The PKISM software \\'3S also used to dClenninc correlation eoenicients. 
Stalistical signi ficance \\'as accepted at P < 0.05. 
2.3. R~su lts 
2.J. I. Th~ w ncentl1l tions ofCI) , LOOll ll nd TUARS 10 ~d ibl r (Il ls 
Table 2.2 shows lhe means or 6 values each of lhe inherent CD. LOOH and TBARS in 
)J MUI'A and PUFA oils. Considering all the oils. the mean ± so of the CD was 14.7 ± 
7.0 IIInollg; of the Lool! was 5.8 ± 0.7 flmollg. of the tTllARS was 264.9 ± 5945 
nmollg and ofthc f rBARS was 2.S ± 3.5 nmollg oil. 
Table 2.3 compares the pcro~id;1linn products of the oils scpanued into MUFA and 
PUFA oi ls. The CD and the tOOH "ere significantly dilTerenl (P '" 0.008 and P < 0.00 1 
respectively), while the ITBARS nod ff BARS were nol (P - 0.100 and P ~ 0.597 
respectively). 
J·;gures 2.2 and 2.3 show the varial inn of CD and TBARS in the MUFA and PUFA 
edible oils. There was not much variation in LOOH in the oils and they were therefore 
not graphically presented, 
The full mnge of pcro;.;idruion pmduClS (f;tblc 2.2) showed thal Ihe CD ranged 
approximaldy 6-fold. from 5.3 10 32.4 ~lI11oJlg. LOOH upPfOximatcly 2- fold, from 4.3 10 
7.3 fID1OJlg. the tTSARS approximately 300-fold. from 9.8 10 3472.0 nmollg 3.00 thc 
ITBARS also varied widely, from 0 to 17.9 nmollg oi l. 
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Table 2.1. Satur.l1ed fauy acids (SFA). mllnoun>alUrated (MUFA) - and po]yunsatunJed fatt)· acids (I' UFA) in cdible ui l~ (g "/.). 
The infunnaliun in the tabl~ i~ adapted from Boskon & ElmaMa (326), Gnnstonc el al (280), and N.uf el al (330). 
SFA MUFA PUFA 
14:0 16:0 18:0 20:0 22:0 16: I 18: I 20:1 22: I 111:2 18:3 20:5 22: I 22:2 
Oli,'c 0;1 
, 7.5-20 0.5-5.0 07 < 0.2 0,]·3.5 55-83 <0.5 3.5-21 < 1.5 1.0 
Canola oil 
4.0 1.8 0.2 56 1.7 0.6 20.3 93 
I'unut oi l 
1.0 II 3.0 49 29 1.0 
Flu oil 
3.9 )6 16 15 6ll 
Sunflower 
oil .... 2 5.6-7.6 2.7-6.5 0.2-0A 0.5-1 J (H).3 14-39 (}..O.2 (}..O.2 48-74 0-0.2 a-0.2 0-0.3 
Gra]}c$Cfd 
oil 0.3 5.5-1 I 3.a-6.0 <, 12-28 58-81 < 1.0 
St~amt oil 
0.1 8.0-10 4.Q..6.0 0.5 , 0.1 34-44 06 40-51 0.3-0.5 
I Irae,! 
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"'ABLE 2,2. Cllntenl".li" n (If CU, LOOH Hnd THARS in i\lUt'A a nd I'UFA lI ils, 
6.3 81.7 ~ ..: 
1 
7.5 
36.8 3.2 
" 
6.2 
·0.1 2,2 
II": 
93.-1 
" 
, . 56 
" 
6.' 79,5 
21.9 
I.. 
17.9 
12.3 
22.0 
I .. 
'.3 183.3 
1-1.6 4.9 
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. olive oils 
§ canola oils 
~peanut oil 
. sunflower oils 
C sesame oils 
I Iflax oil 
C]grapeseed oil 
1 2 3 4 5 6 7 8 9 1011 12131415161716192021 22 23 24 25 26 27 28 29 30 31 3233 
oils 
Ml'}'A 1'1 F \ 
Figure 2.2. Cll in erliltl(' oils.. MUF,\ :lml PlII'A ; ~mlIJIt' 2J is SUllnnwH oi l S-;ll11p lc J. 
4000'y---------------------------------------------------, 
3000 • olive oils . sunflower oils n 
2000 :c, -i canola oils ~:J sesame oils 
$'1 peanut oil [ '] flox oil 
[ J grapeseed oil 
'. 
T 
1 2 3 4 5 6 7 8 9101112131415161716192021222324252627282930313233 
oils 
1'1 1.\ 
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Figure 2.4. Concentrations of IX'roxidation products in rl'-htlltro rU FA oil OHr 75 hours. I(e~ulls art' expressed as mean ± S E:\I of 
triplicates. 
101 
2.3.3. Lipid ~roxida.ioo 10 .hermaIlY~' n'S!ied oil heliled with cOPllrr Mod red wlor: 
Iix' oil-boi l mrthod 
Nine diffen:nl red wi ....,s were tested for their antin~ idant C3pabilitiel: in protocting 
thermally-stressed I'UFA sunflower oi l pgainstlipid peroxidation. These y,; nes IUt lisled 
in Table 2.4. 
Table 204 . Re'd .. illt'S 115l'd In 1M mano and mkro oil-boil np"rin~ol~ 
Samp~ Cullh-ar ViOlalt'" 
I • Chateau Libcnas 1982 
2 Shirol7. 19" 
J A Merlol 19" 
, A McrlOl 
'''' 5 • I'inotagc 1996 
6 Shiraz 1996 
1 Cabcmet Sa~, ignon 1991 
• • Chalea~ LibctW 1991 
, 
• M<rl~ 1999 
• used 10 determine inter- bollic vari alion 
t. used t" dctermine vanation bcl \\"e..' n differen! vintages or the same cuiti\lIr 
• used to dC1Crminc the cffecl of seleclivc ageing ofy,ine 011 amioxidant capacity 
The intra-and intcr--ilSS3Y CVs respecti\-.:Iy from the combined macro- and micm-
analysis or thc an tioJ;idanl capabil ity of red wines were as follows: CD < 2% ( intra-
assay) and < 4% (intcr-assa) r. LOOII < 4% Md < 10%. tTIJAKS < 4"-. and < 12% and 
fTBARS < 2% and < 4%. A scatter plot was used to determine the correlation between 
CD and 1.0011 from the macro-method (Figure 2.S).There was good corre lat ion: ~ -
0.62 (I' - 0.024). The ant;o.~idam capabililics of lhe red wines usinllthe macro and the 
micro-methods wen: therefore compan.'!l usi ng CO only. 
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2.3.3. 1. The "llI ... ro -mdhod 
125 
.~ 
'ii 100 • • 
,.2.0.62 
,
0 
• 75 :~ 
,g 
0 50 • , 
x 
0 25 0 
" • 
0 
0 25 50 75 100 
CO% a",!odda"' capability 
Filture 2.5. Corrd:uln" between CIl ~nd LOOII uslnR ~ gntiOKidant c~ l,ahility 
or red wlllt's rrom the macro oil- boil method: ~ '" 0.62. P '" O.OU. 
The protective effect of rcd Wine againSl lipid ~ro~idalion in Ihermally-Slres~d 
sunnower oil wa~ del~nnined, :md lhe CUmulalive resuhs are sh.own in Figure 2.6. 
npres,,",d a, pcrccm manse. mean :s: SD. of lh~ t'<)nccmralion of 6pe ... i(j., prod ..... l, 
relalive to Ihe reading~ of Ille unoooked oil. The baoeline 'Hlues of the oil are Ihooe 
dctennined wilen llle ol l juSI reoclled l009 C. Heal ing lile oi l in a p....,udomonopll:i;;e with 
deionised H;>O as a control ,;howed the following ~('('(:nt difference, compared wilh 
healing oil alOfle: CD -4%. LOOH +23% and 10lal TBARS +02%. Conjugaled dienes. 
LOOH and TBARS were determined for Ihe mxro-method. The m .... ro-meth.od CD 
mults are shown in the block. 
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Figure 2.6. The pn l lo x ld anl e lleel 01 9 fed wines on healed $un llowef o il as Shown by lhe maclo· and m;c , o·melhods ; 
me"n :! SE M. 
"" 
A comparison of the inhibit ion of CD. LOOI I and TBARS foTTt13tioo in thC'nnall) .... 
stressed sunnower oil by red wine. measured by 01. antioxidant capability by the ITI3('ro-
method. is shown in Table 2.5. 
Tabl~ 2.S. ,\ntio.1.idant capability of" nd ... in~ mcaJured by Ih~ir protect ion 
altain~1 the inerr~$ ~ or th~ 81l«';r.~ p~rQ~id B tion IlnlduclJ durlnlt t he ma~ro oil-
boil. 
"-, Ma~ro-ml'lhodl 
ell 83.8:t 2.8 
Looll 89.6:i::8.2 
tTOARS 79.1 :i::J 1.1 
rroARS 79.2:i::1 7.2 
. 
. 
. 
.. 
- v. anlloxidant ~apabilny Idau,~ to copper. mean ± SD 
The results of selc<:t;''C ageing of 2 of the wines. reluti\"e to the frcshlY-OPClled wine. 
sho",'(1,! ionic change ofantioxidant capac it>. with 311 3wrllilc 6.2 :i:: I 5.3% decrease of the 
:lI1tioxi\lant 5lrenl¢l measured fOl" CD. 311 increase of 1.6 :!: 2.2% lor 1.0011. and lin 
a~eT1lgl: decrease for ITSARS of 17.J :t. 20.~. by 6 ""ch. Inter-bon le ~nrimion of !hc 
same cutli,1U IlIld ,image showed linle change of CD IU1d LOOH. \lith lhe CD mnging 
from 77-91~ .. LOOll 7J-95h, tTBARS 22- I()(Wo and nOARS o-Iw,. •. I'i\"c different 
~jmagcs of MerlO! 015(1 showed litdc change:. \Iith CO ranginlll from 81- 95%. LOOIl 
from 77-100v .. ITBARS from 59 l00v. and ITBARS from 56-96'Y .. 
2.J.3.2. Th~ mkrD-fllcthod and Th~ ORAC deTcrminaTion 
lahlc 2.6 shows tho: nlC3I1 (ic SO) ORAC "alUC!i of9 ted wines and al50 shows the 
colttlolion with the IIntioxidarll capabilities of those wines. measured by tile macro and 
micro oil-boil metl.cH.b. Thc ORAC ~'alues ranged from 11.5 to 34.0 mmollL TE. Then: 
WIlS no signifiClint cQrrelation between ORAC and the macro or the micro-methods (~ .. 
0.13. P - 0.)48 lind (- .." 0.06. P - 0.523 respccli'·cly). There was linle colttlation 
'05 
between the CD as dclCnnirlo.,d b} the macro and Lhe mkro-mctllods thcmscl~es. ~ '" 
0.001. P - 0.9J.t (Figur\' 2.7). 
Table 2.6. Mran : S I) and co ttrlllt;<'" orOKAc . mafro ynd miuo oi l boil C D 
resliits from 9 different samllh.'J of red wlnt. 
'" 9 ORAC" l\1 aeru~ Miero· 
1 17.5 
" 
99 
2 18.6 81 8l 
J 29.1 
" " • 24.S " 
81 
, 34.0 79 98 
6 24.1 
" 
96 
7 21.4 S1 9<l 
, 24.9 88 9<l 
9 23.6 81 82 
MClIn ±SD 24.20105.1 83_8", 2.8 90. 1 *6.9 
Cortt la lioll wltb 0.13 0.06 ORAC:~ 
I' ,·. llI t 0.348 0523 
•• mmollt lrolox !:qll;' alc:llIs 
~ - % amio)'idam eapabilil)' n:llIlhe to copper. as dclemuned by CD 
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~ • p ~ ....... ,., p ~-.- 0, Irl 1_ ..... I: .-.. IJ , ~ 0 • _. i . i· I j 
• .L-- • • • • • • • • • • •• • • • • • 
_ !'II\O> 
' '-" 
-.. .- -""" 0-
fl,." 1.1. l 'b "0, ...,10.10. ho ... -.... ,lot "., N ond rh. mi ..... oi l_boil UM)" ud 1 •• ;r l;Cl rrel •• i<J ~ 
,..;,. , ... ORAC .t ll .. , ... d ,,' j ... _ .. , ... oil--btlll .... ,L 
2.4. OitclIs! ion a nd ('(Jnrhlsiolb 
Foods that conca;n pur " are $llSCcpribi<" to lipid pero.\ ioolion. panil;ulany during 
coot;n~ \\hen Ihcrmal-slrtSsing of the faU)' acids may C~ the pruductioo of 
potcrlfiatiy to)l;K compounds such as CD. LOOH and T8 ARS. F.dibk oils containing 
I'UFA a~ used uni-'C'BllJly. and lhen: ~ cornms that the heating of l!lese oils. 
np«iall) in the fast-food indUSlry. may rc:sult in dc:llimcmal health cffet:ts such as 
atherosclerosis and CDnccr, Red winc. "ilh its amio.'l.idam polyphcools. may abrogate 
these effects. either during ils cooking \I;th oil in "'Iro. or while protccting food such lIS 
meal "hen it is C<ded allcr ha~ingbcro marinated in ... i ne (Chapter 3). 
The methods lhal are used to e\'aJuate !he prores.o; of lipid pero.>;idalion in foods are 
vC'ry often non--speci flC. ;lI5Cf\Sl li,"C' and unreliable (Sc<:lion 1.'1.4). The main rum orlhis 
study .... 'lIS 10 u:sc.- a simple. IlO\cI ~hod 10 C" 'a1ualC' lhe III1tio'\"idant ~apadty of 9 
difTerent locall)~prudlJCed red .... ines.. 5 difTerent popular ~u1I;\'at5 of difTerenl , ·inb!."'!. 
in thei r abilily to protect againsl lipid pelUxidation in a simulated eool<inK ell\'ironmcnl 
Ll'iing Ihcrmall~resscd PUFA sunOov.-cr od. Ila:ause Oa'onoKi concentralions haw 
pn:\iously been found 10 dccrellSC d unng heating of .... inc (H I). and also becalM food. 
cxcluding fals. gencr.dly CQntains Wlltc,. ~are was I:u:en 1101 10 heal the oi ls in Ihis study 
10 over l00"C. This ..... as one of 11K: problems ..... hll tIK: micro oil-boil mnhod (discussed 
below). The IIdvDnUlge of the oi l- boi l melhod. in p;iJ1icular the macro-method. is lhat it is 
fairly robU51. uses inexpensivc. casily-pvailabk chemicals. (lnd standanJ laboratOf)' 
equipmenl. il delennines loulllntioxldant capxi!). nnd lhe Icmpeflll\lfe tJSoed during 11K: 
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assay is relevant to cooking conditions wll<:re wlIter is involn:d. The macro-method. 
although mol\: reprodociblc. is nut able to process lIS many samples as the micro-method. 
The I(dler. however. was "cry difficult to control for tempcratull:, be<:~use a number of 
difTell:nt samples with di1Terem condition~ were heated in the same heating block. 
Anothr;:r factor to consider is thut dcionised water is used in thc laboratory. while waler 
used for cooking elsewhere may contai n chlorine (used in the purification of wliter) or 
melal ions soch as Fe -. which may affeClthe pcroxidation of til<: lipids in food. A control 
of oil heated with ddonised H,O showed no prot~'>:tion against the production of lipid 
peroxid.uion products, evidence that the observed antioxidant propcnics may be 
al1ribut~blc to the "ine. II was difficullto maintain cons istent stirring of the samples with 
magnets during the micro-method. because different positions in thc heating block 
promoted different stirring rates. Redocing evaporation in the macro-melhod samples. as 
was done \\;th the micro-method samples. where glass marbles were used. W"<15 dinicuh 
o,,;ng 10 the rather large surfae~ area (2206 mm\ 
There wa.~ variation in the i"herent pcroxidation stat U; within the same classes of edible 
oils. as can be seen in Table 2.2. Sampk'S 12 and 14 of olive oi l. for ~xwnpl~. Ilad much 
greater coneentrat ioos of CD and tTSARS t!\an tile averab'!: olive oil samples 
(approximately 3 and 2.5 times high~'T respectively}. as did fla;< oil sample J, which had II 
f.1r higher conccntmtion ofn'BARS (100 ffBARS than the averuge PUFA coocentrnlions 
(approximately 7 iUld 6 times higher resprxlively) . The current II\-"'I\d for favowing olive 
oil might therefore I10t neccs$W"ily be good for avoiding peroxidation products. There an: 
a number of factors that cou ld influencc the pcroxidation status of iUl oil: the fatty acid 
composition. the diffcrent oil processing methods. different 5tOrnge conditions (pre-
processing (S«ds). anti post-pTOccssing as well as during the processing). and different 
chemicals added 10 lite oils such as tocopherols . 
Hellling sun f1 ow~r oi l at l00'C intenninently over 75 hours allowed the dett'TITIination 
of lhe extent of peroxid31ion during modcrate heating coooitions. relcvant to re-nealing 
of oi l 3 times (the popular recommcndl'<l number). The concent ration of all the products 
increased over 75 houn; relative to the baseline. with linle change during the first 3 hoUTS. 
except for the LOOH. which increased by 86%. Free TI3ARS increased tile most over 75 
hours (108~.). although at low concentrations relative to the tTI3ARS. The CD and 
10' 
LOOH increased by approxim:ltely tm: same amount (44W. and 435% respectively). 
",hile the tTBARS increased the \e.1st (34%). o",ing perhaps to th(,ir d«reasc in 
concentration between 24 and 27 hOlJIl. due possibly to inc reased evaporation of these 
,·olalile prodUCIS. This depiction of tmARS was shon- lived however. and tl1cir 
concentr.uion had ill(reastd again hy 72 hours. 
The 9 ",ines tested showed a consistently powerful antioxidant c3p.1City for both the 
macro and tke micro oil-boil methods. for aU the pe:roxidation products for the macro 
method (79.1-89.6%) and for CD for the micro-method. Ageing did flO! seem to change 
the protecti, e ability of tlte 2 '" ines tested IIOf was there much variation bct"'l!en boules 
of the same cullh·1lI" and vintage. for the CD and LOOH. Different ,intag\'s of the samc 
cull i'·1lI" also sho .... 'ed linle ehange. It would be inl~iog to compare the anlioxid!1l1l 
results of while .... incs. beer IIJ1d spirits. .... ith those of the red wines. Thcrt" W35 linle 
correl:uion between the antioxidant c!!pllCities of the ",iReS IlS tested by !he ORAC 
method and the macro- and miero-method!!.. although the wines shov,·ed linle ,·a';alion 
for both oil - boil asslI)·S. It is JlC)SSibl~ Utat diluting the "'inc might ~ bisser 
diffcrt:lICcs. Tlte number of samples was low. and il ;$ possible that a Luger number of 
wines would show a bener O\crall ,orreJ.1tion betw«n the macro- !1I1d the micro-
methods. The low correlation ",;th the ORAC valli« is possibly JUS! evidence \h31 the 
mCli10ds for IIClcrmining .1ntioxidant capocity Ilrl' often very different, and mc.uure 
different parameters of the peroxidation process. Thc ORAC as-.D.) measult'S the ability of 
an antioxidnntto S(:8vcngc pero.~yl radicals. wh ile the mano-- and micro methods rely on 
the abilil) of the "'inc to chelate thc copper, "hieh would other",ise promotC 
peroxidation. A previous ~udy eompam:! 3 methods for detcrmining tOlal antio~idant 
capacit) ofsenom. the ORAC, and tile TEAC and nt-\!' assays...1nd fO\ll1d tMtlllere ",as 
no correlation bet"'een the ORAC and the TEAC or between the FRA1' and TEAC assays 
(294). 
The rele,·ance orthese oil-boil assays 10 cooking cornlitions maku them apj}Caling for 
testing rood. Their relc\1II1Ce might allow the testing for antlo~idant capacit)' in a range of 
aqurous foods. e\crl homogCflllte'S or "'1II.cr- b3sai foods.. Il!ld I'lOl merely beverages. A 
whole new avcnue or nutrilional in,·estigation ror lipid pcro.~ldation could follow rrom 
applying this l1ll"\hod. 
ro, 
C IIAPn :R J. TilE H FF.crS OF MAKI,"ATI;\,(; K};I) MEAT WITII K~;D WI NE 
3.1. Bllckgru und 
Man is the only anima.! thai consumes food e.~posc:d to higher than physiological 
temperatures. This is pmbably a rdath'dy ~nt evolutionary phenomcnon. f'rtviously. 
cooking may h:!,'c had an ad'-antage owing 10 prelcnlion or [imilation of microbia.! 
spo.'Cies. Longer life cxpect:mc)" 111) .... mmy bring oul adverse effecu of lipid ~roxidation 
in foods. AIl\m)sdo:rosis may be significantly influenced not only by dietary fat and 
plasma lipoprolcins. but also pcro.~idation status. This stimu];ned the inl"e5ligation of 
pcroxidation in meat and the elTeet of marinating in an antioxidant be1.·cragc. 
Wine i$ oHm used Il5 one ofille main ingredienls in the marin:uing of meal. One ofille 
pu!pOscs of tile marin:llk: is to enhancE lhe flu, our of the meat. and the a.!eohol and acid 
in the " 'il'll: olso serve to tcoo.:rise the m<;:nt. 
Meat. 1\ complex food. undergoes signiliclll11 biOl:hcmicaJ changes durin!!: pro«ssing. 
sWI"lIJ.".' and cooting. Bro .... n .'/ ,,/ show~d thai cooliJljj prOl:edurts can drumalic..J ly affect 
the lipid IX--ro_~idalioo of meat (JJ2). They compared the ~ing of beef at 10" (l00"C 
for 20 minutes) and high (25O"C for 22 minutes) tt'mpel".ltu1"l$ and found tll.1t the MI)A 
concenlr.llion in the m<;::lI follo,,;n!!: the [ow tcm~rature cooling WJS 3 - 4 limes higher 
thJn in the meat c.-.:poscd 10 the high temperature. This they IIn ribUlw to the hisher 
degree of l"oJaliliSJIioo of MDA at high temperatures or the incn:1ISIed fonnation of rwn-
TBA reactiI"C MDA-prolein adducts. Lipid pcroxidation is;n itsc[f a complcx process 
in'ol~ing the degrad:llion of I'UFA via the prodOClion of prodOClS such as CD. LOOI [ 
and TBARS ino:luding MDA (333). Ih:ll ure CQIlsidered h:mnfuJ to hwn;m heahh 
(322.3:D) (Sect;on 1.4.4). The products may cause colour. nutntional and fla\our 
detmorntion (rancidi ty) of foodstuffs . Minamoto e. ol (310, n:pQrtw thai ingestion of 
prodUCtS of ftUlo.~idised linolcic acid Slimulated lipid peroxidation in r.II liver. Studies on 
the mechanism, of lipid peroxidution in meal IUl: most often directed towanls cooked 
ralher than raw m<;:at (334). because unoooked meat does not undergo peroxidation :IS 
readi ly. Cookintt promotes this pl'Ol"es$. mostly by the n:lease or rree ferric iron. which 
acts as II pro--oxidpnt (335 ). The l\' is still no ronsensus on the role of haem-iron 'e!"Sus 
non-haem iron. Liu concluded th.1t the cmtDlytie 3Ctivi ty for pcroxidntion in beef 
'" 
oomo~,'cnatc W.IS due 10 bOlh types of iron (336.337). An incn:asc "'35 found in non-Iw::m 
iron ofter coo~iny, belie' cd 10 parJlkl the decrease of haem iron when tIN: haem 
mok-cole from myoglobin. thoc red meat muscle pigment. is broken do'lll during cooking 
(338). 
Severn! fnclors have been found 10 innucnce the mIl' and degrtt of lipid pero:<idation in 
meal. The: pre-mortem fl1C1ors include pniltllli species (339). scx (334) and a!l'= of the 
animn!. Type and quamity of lhe animul f=:l are also important and grnss 01' pasture 
fe«ling has been found 10 increase the conccntrnt ions of n-3 unsaturntcd fany acids 
(i ncluding linolenic acid) lind corputl:ltcd linoleic acid (CLA) in beef. compared with 
concenlrole feed inll (340.341). CLA is formed during rcticulorumen hydrogenation of 
linoleic acid nnd IhroLl8h endogenous dCSa!u r:uion of IrU/t<'-11 octadeeacnoie neid (342). 
CLA. aithougil II CI). has bttn 500"11 10 hale anti atheroi/Cnic. anl i-<:arcinogenic and 
onli-thlOmbolic properties (343). with rumenic acid (the ",1-9. Irons II isol11l:r) being 
the moin natumlJ)'-OCcurrinll CLA in food. 
Post-monem foctors include the type: of muscle "udkd Wilson tl ul found lhal red 
muscles ore mon: susceptible 10 lipid peroxid:uion lhan white muscles (344)_ Badiani tl 
uJ found tl\.lt the JX'roxide \'ahlC ".u lower in the i'!frlupmmus beer muscle compaml 
with the semilencimosU$ muscle ()45). ConditIOns during $lorngc. such :u the 
Icmpcmtun:. time and oXYl/Cn corn:cntmtion. are abo importunt A temperutlll\' of 4"C 
has been found to be lhe maS! imponant factor for leeping lipid pcroxidation 10 a 
minimum. compared \I;th oxygen oonccntmt;oo and $t0rlliC 1;1111:$ (346). A comdation 
between the meat haem-protein pIgments.. myoglobIR (mujorJ and haemoglobin (minor) 
and lipid pctOxldation has been shuI'll (347). Pockaging methods. for c~ample aerobic or 
,";ICuwn packaging. are also important. \lith packagina ItIlItcrials olkn ~lna pcrmcable to 
oXYgl:n. Levels of oxygen in the packaging correlate with lhe extent of oxid.:l.llon or lhe 
meal. and "ocuwn packaging. " ; th its Iov.~ oxygen conccntrlulon (approxirn:l1cly 1%). 
can gmuly extend the shelf-life of raw beef (348). "The cllOCCnlt8l.ion of volatiles. for 
c.''''mpie butane. pentane. hexane. hcpt3l'lC and octane. inc: n:a.sc:s with 510,.. in 
aerobically p:u:kagl .. d meal and there is a posilh'e correlation with these "olati lcs and 
TOARS (339). Irradiation or meal has b«-n fowxl 10 gcnc:r:lle free radicals (349). 
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Increased concentmtions of TIlARS have b«n found in i rmdi~t~-d meat compared with 
non-irradiated mCllt (339). 
~ dtgrtt o f unsatlll1lt ion of the: fauy lICids pla}'S an imponant role in the pell.lxidation 
of mcat (JJ8.339). In beef. lipids conslitutc approximotely IO'Y. of the mass. of I'.hkh 
almost ~ half is unsatufll,ted , Ileeflipid compri ses 41 86"_ sat umted fany acids, 4 54"_ 
l1'"IO!'IOtnOic. 1- 5% di- al)(] tricook:, and 0 0.3% tCll'a- and hcxacnok fatty ac ids (326). 
l'hospholipids. in patlicular phosphatid}lclhaoolllmlnc and 10 a far ksser cxtcn\ 
phosphatid)lcholine. art the major moleculc~ Ihal undcrb'O lipid peroxidalion in cooked 
bed. Phospholipids an: knol'.TlIO po5SCss a PUFA on sn2 (Sect ion 1.4.1). T riacyJglyccro l 
al5() undcq,'OCS lipid pc1'Oxidalion. but 10 a lesser eXlenl (338). Oleic. liookic and 
DllIChidonic acids male signiflCDnl contributions 10 incmlSCd rancidily in cool ed beef 
(lSO). "T'he pn:scnc.: of pro- and antioxidanls (bom cndogenous and exogenous) is 
important. High COl>C('nlral ions of ~i lamin E (pmvidc:d b} grass grazing for eMmple) 
ha,'c been found 10 inhibit lipid pctQxid3tion (3S I). l'>.ilrile acts as a polenl anlioxidant in 
cooled mcal systcms (l3S). Cooling praclice: inlroduces "II)'ing times and lemperatures 
tila! will inl1uenee lipid peroxidation. Microwavc cooking has bccn associaled with less 
pcroxidation of meat lipids than O'CJI mast ing (345) and also produce:s fewer fallyacid 
oompositional clwlges than broi ling(3S2). 
"The: aim oflhi s study W3S: 
il 10 determine ",,'hcther marirnllil1ll "ith red "inc: protects ml meal againsl lipid 
p..'TOxidation '" anal}"Zing CD. LOOH and TSARS in control and marinated meal 
ooolOO in a microw3>e O'CJI. 
.1.2. Methods 
.1 .2. 1. Slud,' dl'Slgn 
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Figure .1.1 . E~pcrin"'nl>ll d esign or 'h~ mea ' p rep>ln,.io n and subSC'luenl"n"I)'s is . 
Twcmy fi\e differenl sample.- of fre~h. unfrozen beef \lCrt' purchase'" from IWO ret"il 
outlets. The ~ample.-. h.1d been ~lOred in Ihe shop aI 4°C in a polystyrene Ix!...e Wilh a 
clingf,,;1 wr.lptlmg. They inCluded v!ltl .. u ....... tS of beef for e~ample pOl'lerhou.<e ' 'ea~. 
rump ~teak and beef fillet and were u;mmro of all surface adipose tissue. Two portiOIL, of 
40g each were cu t from each sample of meal. taking care thai Ihey had a s,mi lar 
appeanmce in ,ize and coment. with the e~clu ~lOn of (issue olher Ihan Mri:lled muscle. 
One portion "'~ marinaled in 70rnL red "ine at 4·C in Ihe Ihrk for 24 oou..". while tile 
other porti .. n >I':ll. <wred under the ..arne condi tioos. bUI unmarinated. The Soulh Airican 
red \lines used in tile study all had 12-14% alcohol by volume. After marinating. each 
portion was divided inlo 2 A 20g samples. re~ulting in 4 ~ 20g samples from each original 
piece of beef. aile sample from t;Jch of the marinated and un marinated portions was 
cooked in u microwave o\cn (ou ipul power IOOOW. frequency 2450 ""Ull.. Model R-
341 6. Sharp. Thailand) for 40sec al 5Q<l, po,,·cr. sufficient to cook but not o\'er-cool:: Ihe 
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meal. \1icro"1IIc cool;ing was selected for its modcna!1' and reproducible cooj,;ing 
conditions. The time of cooking was established b} Is!;;"g laborutOl')' Slaff no[ In\,oll'ed 
in [he projcct. to dccl~ an agreeable taste. Eax-h sample WliS subsequcmly placed on icl' 
for 5min 10 laminall' Ihl' cooking rtaCtion. Thc microwaving proctdUfl' resulted in a corc 
[L'fIlpcrulUrl' of 90 '*' J"C (dc1mnined b) ~ns of I digital thamometff: Digilm<1 
thamocouplc. with I I'hysi[cmp micro-probe) inuncdiPld} after coold!1K. 
J.2.2. /\I ra t u mpl" 
From cach of tile samples. I Ig portion IllIS I'll! from the C<'1lI~ and minced findy with 
scissors and lho:n findy ground in 3mL phosphate butTer (75mmollL. pH 7.4 containing 
O.5mmolll. [DrA and UmmollL Na..'IJ) with. mechanical homogroizcr (VirTis 
handishcar). Aliquots of 2oo ... L from cach sample "ere frozen II - 200C under nitrogm 
fo r gas chromatograph} (GC) 31li11ysis Qf fally acid methyl eslClS. Lipids "'e~ cxtracted 
from the remainder Qf Ihc SIImplc by thc method Qf Bligh & Dyer (353). I modified 
method of Folch (>1 at (354), detailed in the Appendix. Brien)'. lipids "'e~ nlnll:1ed tmo 
p monophasic mixture of chlorofonn and methanol. \\hich was finally scpamled into I\\U 
ph!\Ses by tile addition of chlorofonn and phosphate buffer. an upper aqueous phase 
cOlllaining the Ilon-lipid compounds and an organic phase containing the purified lipids.. 
The orgllnic Illyer was dried under nitrogen gas and the lipid extract was then re-
suspended in 200liL chlorofonn and dil-ided into 10 x 20l'L atiquots in micro-reaction 
viuls. The eXlracts were agllin dried undcr nitrogen h.:adspace as abo\" and stored at 
-200C for Ilpid and lipid pcroxidlllfon analyses. 
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Fi1:urt" 3.2. A hand-hdd handi~ht'llr ~d f..,r h(ll~nl~in~ meal. 
3.2.3. Lipid anal)'st'S 
Meal TG and PL coocerur.uion. " 'm: delCmlined u.,ing en:tymlluc colorimelric ~ i l ~. 
as ~'iCnbed in lhe Appendix llIe C'OOccnlr.llIon of TG IIIId Pl 11'01) dclemllM:d from 
kll()\O.'n .tand:trd~ supplied In the lilS The inter-{h>ay CVs ror bolh TG :lrKI PI. melhod. 
"'ere <)~ 
3.2.4. Lipid peroxidation analyses 
T .. 'Cnly rhoe meal samples lIere anaJy-.cd in lhe rail, cooked IIIId cooked, marinated 
SIlIle. For lechnical ~ns. not :III 2S 1).:lmpl<:~ "'ere complelely lIIlal)"ed for I'll'" 
marinated $Qle. bul at leasl 17 ..ampk. lI'ere lIIlJly'oC'd at all lhe ~~, Concentralion, or 
" Pld pem~;da!lOn prodUCts wt'O'e measured In ~al lipid exlt:lelS lhal had been dried, by 
lho: rollowmg spcctmpholomcllic mcthod> \bing a GBC UVN IS lIIIal)'ser (CD) and 
Ub,ystcms Muhisl:.an MS Analyser (LOOII and TBARS). Concenll'lli ions were 
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calculated using the appropriole molW" e.xtinCliOl1 eodflcienls. T~ methods arc: dCloiled 
in the Appendi;.;. 
Briefly. CD I,ere measurl:d at 234nm lIi'ter approprillte dilutioo in cyclohcxane. The 
imcr-assuy CV was < 2%. 
To octermine LOOH. lipid c;.;tnKts \Ienl assuyed in the pl\:scnee of xylenol"'ilrange and 
Fel ' in the FOX llSSlIy. The inteMlSsuy CV was < j¥ •. 
TSARS were measured b) reaction \\ith TBA in the prescoce of ferric (hloridc in a 
glycine bulfer at pH 3,6 conlaininl sodium dodecyJ sulphate. The inter-assay CV was < 
I2%. 
The fauy add mt'thyl e$1er (FAME) anal)'$is "'3'5 adapted from the ml.'lhod described 
by ChriSlie OSS). The sample was plxed in II stoppered lube and dissoll·ed/suspended in 
I mltolume, otler "hkh l1li internal Sl,ooanl (C I1:0. Sigma Chemical Co, St I..ouis, MO, 
USA) WlIS 1'(\dcd. Two mI ml'lh:molic hydrochloric lICid (S"- HCI ~(y) wlls added and the 
sumple was lell ovemi¥lll in D WlIlerbalh 91 5O"C. After remol'al from the wlIll.'Tbalh. Sml 
NoCl solution (5% w/v ) was added before e;.;tr.lCting the ~ers I"ice "ith Sml n-he;.;anc, 
The 1\l';.;8n(' was then "ashed wilh 4ml potassium bicwbonate liOlution 10 rcmol'C 
unesterified fany lICids lind dried ol'er anhydrous sodium sulpbaie after \\hich it .... as 
C\ aporal00 under 0 stTtom of nilrogen. 01'1«' the SlImplc was dry i1 \\lIS reconstituted in 
n-(kcallC alld inj\."Cted 11'111'1 the GC for analysis. 
GC anulysis was performed on a Varian CP-J&OO gas chromatograph (Varian Anal)1ical 
Instruments, Wal!on"'iln-Thames. UK). The gas chromatograph was fined "im a 30m 
FAMEWAX column (Reslek Corp. Bellefonte. PA. USA) ID O.32mm and tilm thickness 
0.2S,..m. Helium WIIS used as carrier gas 31 a COIlSlalll now rale of 2m 11m in. The i~l."Clor 
arid "l1l'i11.' ioniSUlion &:lcclOr tempemtures Wl're set at 2S0"C. The COIUnlO o~en 
temperature was programmed lIS follo" s. 155"C held for 2 minutes, then rumped 10 
180QC at a rote of S"C/min from "here it WlI5 rnmpl.'d up to 240"C al IO°Clmin where it 
\l'as hoeld for 1 minutes. Splil injection \\'as ~d wilh D split rolio of I :S. Identification of 
fllny lICid methyl cstCf'S "as done by comparing retention t;m<:5 to that of kOO\\ll 
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Slandards (Sigma Chemical Co, SI Louis, MO, USA). Additional ullS.'ltumted fa11y acid 
ide.uific8tion .... 'as deri\cd from the formula for equivalent chain lengths. usi"il retcntioo 
times for C 16:0 and C 18:0 (JS6). 
J.2.6. ORAC dCll'rminMllon or red .. in r 
The method as described by Ou CI II/ (299). and detailed in the A~ndix, was used. 
Briefly. the wine samples wen: diluted in phosp/lrue t>uffer pH '"' 7.4. FILIClfeSCein anJ 
AAPH were added and the reactions .... 'CI'C allowed 10 (:0 10 completion. after whkh they 
were compID'\'d with a standard reaction of Troia". 1l\e results "ere expressed as 
mmollL TE. 
J.2.7. Sl&IislicMI Mnal,.,~ 
Data an: expressed as mean : SO. All statistical :wmJyses ",,,re performed ",;th the use 
ofGraphp:!d PRISM software (\'ersioo J. San Diego. USA). 1l\e Sludenf s I ltsl analysis 
for paired values "''as used for l1oOITI1ally distribuu:d d:lta. The Mann WhHoc)' lesl was 
used to compare the ml' and marinated rn .... d:lta. 1l\e Wikaxon matched pairs lesl for 
nonparametric data was used \0 compare ratios of UFA 10 SFA in Ihe small nwober of 
samples analysed by GC. St.:ll iSlical significance was accepted a1 P <0.05. 
J,J. Resul lJ 
J,J. I. Lipid anllly~" 
I'er g of raw me3l. the mass of 10lal PL was 2.6 ± 1.2mg lmd TG 1.1 i 0.5m8. Aller 
cool.ing, the l;OIlI;e~rations il'lCreased significantly 10 4.2 '" 1.5 and 1.4::'- O.6mg/g (I' < 
0.000 1 and P - 0.0005 re~livdy). 
J,J.Z. Llpitlilero:lid:uion IInMly,C'S 
1l\e lipid peNxidation pal1Ullders displayed latge variation. All the measurements wen: 
retained for anaIysi5. 
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Although IlOI liIe primary intertSI or tile imt~tigation, the rn'" unmannatW rne:u. "as 
compare\l "uh the rnw marinated ~at for hPld perolidauon products. The results gi\tll 
in Tablt 3.1 indlcatt 11 sigl1ific:mt d«~a)ot 10 CD afttr mannaling flIW ~al. ~r mg of 
hpid. r~w IOtal COIll.Jined lhe f01l0"1I1g: CD 113,2 :!: 56.7. LOOH 51.0:!: 68.3 and 
TBARS 23.2 :: 21.1nnW)1 fo,lwinallng lo"trtJ the CD to 69,9 :!: 33,9 nmol/mg lipid I-
383% change). LOOII 43.2:1: 55.2 nmol/mg lipid (-15.3% cllanyl and TBARS n I :!: 
17,9 nmol/mg hp,d (-.1,7'l, cll,mgt ) (P '" 0.009, 0.868 and 0.918 re,pecti-'tly). Cooking 
~htred the pc:roxldatton Sla lUS of unmanll:t.te\l ~.at In nmoVrng lipid: CD 124.3 : 111.2. 
I.Oem 5".5:!: 95.7 and TBARS 39.2 : 4 7,3 (P '" 0 . .\.11. 0.716 and 0.031 rtsptCth'tly) 
"hertas cooked. marinatcd mtal d,splaye\llhc following rtSUlu;; CD !!6.8 : 46. 1. l.00.1 
40,0 : 55.8 und TBARS 31.8 :I: 32.6 nmol/mg lipid. ~ seen in Table 3.2. The trend to 
10" er CD by marinating ... :t.. nol signi fic~nt (P '" 0.057). Thert were 110 difference, in tile 
LOOI I alld TBARS IP = 0, 172 and P = O.2()1) re'pc:clj\ely). 
T",ltlt .\ .1. Lipid p!;'ro~ id"'li" n pr'Mlnell; ""Id thd r chang~ In nI " IlWlIt. wUh w nd 
"',,houl m~rin~ l ing. 
rwroL'!T1J iptd Raw ImlB(tnalOO Raw fmIlf111100 P~" 
".~ n. 17 
CO 113.2t567 59.9J339 0009 
(0:)8 :r!Ol 
Lex>< 51.0! 58.3 43.21552 0868 
'.15..)'1,j 
IllWIS 23.21214 22 1 t 17,9 0,918 
I" "" 
II. 
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J.~ . l>iscussion and conclusions 
An incr"a.<e in PL and TG COOC1:nlration. in the meac aner micro"' ... '!," coo~ing w .. , 
fOtlnd in this study. as in dIe sC udy de!.Cribcd b} Bad ian i i"I ul (3.\5). a!>CTibcd to tilt-
moislure toss caused by cookJng. ThiS is in concrast lO Igene & Pearsall (338) ..... ho found 
IIiat cooking produced a signifieanc decrease in cOlal PL, and lillie diffeR'nee in TG. Upid 
extr-tClion may be made mor~ difficult by challge.1 in com;;stcncy or by JXltymerisalion. 
The melhod describcd in Ihis chapter i ~ abte to homogenise wry coarse !>llmptes 50 !l!. 10 
male for che besc efficiency of eXlr:lCIion 
Thcre wen: 2 main findings from Ih i~ scudy. Firstly. lhere was .... ide ,·an acion m Ih!.· 
mhe rem lipid pero~idalion studies in the meal far all che products. Gas chromaco8f3phy 
FAME anal}sis was not clone s}~tcrna l iea!ly in the meat ~amplc~ to ret~lc the changes to 
fally acid composlllon. SL"CQndty. winc ~hawcd ~ In:nd lo"ards towering the CD in the 
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m(':lt ~ftcr it had beCII cook~-d. This appeared to be evident even aftL'T the marinating but 
before cooking. 
As cxpcct~-d. cooking increased the conccntration of 311 3 Jlt'roxidation prod lICIS. but 
only the TSARS \WI'l' iocreas"d signiliea lltly (P - 0.031). A harsher form of cooking. for 
cMmple oven roasting. mighl increase Ihe prodoclion of lipid pcTOxidalion prodocts and 
make it easier 10 assess Ih .. impact oflh .. anlioxidant effects of the "i.,.,. The dl'l.""reaS<.' in 
l'OOkcd meat ofLOOH arK! TSARS. compal'l'd I'oilh those in nurinsled cooked meat, was 
nol significant. aJthouglllhcre was II treoo to decrease the CD by marirnlting the meat in 
wine (P - 0.057). This seems to suggest a pmteelive effect from the wine. 
Red meat is commonly-eonswned aoo was therefore the meat of choice for Ihis siudy. 
Poultl)' mighl resisl lipid pero.~idation dll<' to ha ... illg nluin!y MUF A, bUI fish is of intere51 
due 10 luving highly PUFA. I-IOWCVCT. il is not traditional to marinale chicken and fish. 
aithoogilthe former may be cook~-d ill wir>e. Meats are susceptib le to fally acid o.~ idalion. 
due to relatively Iligh concentrations of unsaturated fauy acids in membrane 
phospholipids 35 w~1I as exposuTt' to hllC.'m- and non--hal'm iron. Although the 
concentrations of oxidised lipids in foods are usually lower thnn that required 10 generatc 
acutc IOxicity responses. the cumulative long--Ienn effects of ingcst ion of small quantilies 
oflhese compounds are not kno"Tl (357). Lipid JX"ro.~idalion is associated with navour 
di:teriorat ion (358) and discolouTation (334) in uneooked meal. The t01al lipids in beef 
conslilute on average 10%. In this lipid fraelion an ~\'erage of 5"-. are I'UFA (ahhough in 
Italy this ligure can be as much as 20% (359): 54% are monounsalllflltcd and 41% nrc 
satunned (360). I'hospholipids playa major role in lipid pcroxidalion of becf. compared 
with triacyJgl}\'erol5 which play II millOr role (344). 
Lellll beef 'aries between 6-10"/0 fat. Th.".' ponions of beef selected Ibr tho.. study were 
lea[l lillet. Bnd wh<:n Ig portions oflhc 1I1I'3t WC"I'C subjected to the Folch method of lipid 
extraction. the mean ± SD of the extracted lipid mass was 0.015 ± 0.005S (n=H). or 15· 
25%ofthe anticipated fat mass. The 3.7mg TG + I'L ma5S extracted from t~ meat was 
250/. of thi . extracled lipid. Thi. )0 .. w .... unexpe<..1cd but w .... not >pCcifically 
invcstigated. and cannot be explained. 11 is consistent throughout the extraclions for all 
Ihe mcat samples and. therefore. does nol innucnce the comparisons of lipid JX"roxidation 
products for raw. cooked and cooked marinated mcal. Although the Folch extraction 
122 
procedure in our hands is quantitative, losses may have occurred. It is also possible that 
re-dissolution of fat was incomplete for an aqueous assay, despite this previously having 
being optimised. The PL assay is for phosphatidylcholine and may also therefore 
underestimate. 
Other studies have found major differences in the quality attributes of beef 
(345,346,361). The different beef muscles vary considerably in their cooking properties, 
such as their cooking times. Also, controlling factors as the chill temperature and the time 
of ageing may reduce variation (362). The contact with oxygen, pre- and post--cooking, 
may also be responsible for the oxidative instability of cooked meat (348,363,364) and 
even when meat is cooked in an oxygen-free atmosphere, lipid peroxidation products can 
still be detected (348). Vacuum-packing is the most favourable method for packaging 
meat in order to reduce lipid peroxidation (364). The high variability in lipid peroxidation 
recorded in this study might warrant a study design including the tracking of the meat 
from the abattoir to the shop or the butchery. 
True marinade recipes contain spices, oils and vinegar that can influence lipid content, 
change reactions with different pH and provide additional antioxidants. The effect of 
wine was specifically evaluated in this study. Its ability to penetrate the meat was not 
studied, but while it is possible that small molecules may diffuse in, it is unlikely that 
penetration of cell membranes may occur. Perforating the meat might have enhanced 
penetration, but it was not done because it is not traditional. The volume of marinade 
covered the meat, excluding oxygen owing to its poor solubility in water. No analysis 
was undertaken to assess the penetration of alcohol. 
Oxidation of lipids in the meat may produce lipid hydroperoxides and aldehydes that 
may react with the meat protein. The aldehydes in particular are a group of very active 
products and they easily react with the amine groups of lysine, cysteine and glutathione, 
particularly in the presence of water, causing the formation of insoluble macromolecules 
such as 2,4,6-trimethyl-l,3,5-dithiazine and 2-pentyl-pyridine (326). The amounts of 
peroxidation intermediates measured in these studies may thus under-represent the 
peroxidation in that measurements apply only to these products in the lipid extract. No 
methods were set up to determine reacted peroxidation products with protein or nucleic 
acids. 
123 
The ORAC values of the wines used in this study were very similar to those used in the 
oil-boil study (29.2 ± 7.7 and 24.2 ± 5.1 mmollL TE respectively). 
The choice of microwave as a cooking method established reproducibility and a gentle 
and diffuse means of cooking the meat. Grilling is difficult to reproduce and results in 
layering of temperatures which are often extreme. The choice of cooking container is 
important, with copper and iron containers possibly providing pro-oxidative stress. In 
this setting, wine may chelate the pro-oxidant ions, as for example with the 1OJ.IM copper 
used in Chapter 2. 
Variability is largely dependent on the meat and the storage conditions, and is possibly 
modified by wine during the marinating process but not much during cooking. 
Conjugated dienes, being the most stable, seem to be the most reliable product for 
studying the change in lipid peroxidation. The variability shown in Figure 3.4 indicates in 
general very little difference in the change from raw to cooked meat, with and without 
marinating. However, a few samples behaved very differently. For CD, the 2 highest raw 
sample displayed very different behaviour. These highly variable samples did not behave 
similarly with respect to other parameters. In 2 of the top 3 LOOH values, the marinade 
seemed to make a difference. The apparent impact on TBARS by marinade is less. Taken 
together, the trend that emerges is that CD and LOOH, being specific intermediates in the 
chain of events, may reflect actual peroxidation better than TBARS, which appear to 
reflect a reserve of oxidative PDF A yielding reactive scission products. This is in keeping 
with the lack of change in GC found. 
Future studies in this field might include better compositional analysis of the meat, the 
use of post-abattoir samples and more intense cooking conditions. 
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CHAPTER 4. THE EFFECT OF THE CONCOMITANT CONSUMPTION OF 
RED WINE AND POLYUNSATURATED FATTY ACIDS IN EDIBLE OIL ON 
THE PEROXIDATION STATUS OF CHYLOMICRON LIPIDS AND THE 
PLASMA CATECHIN AND ORAC CONCENTRATIONS 
4.1. Background 
Atherosclerosis is a leading cause of mortality in the western world. and lipid 
peroxidation is an important factor in its pathogenesis (365). Red wine contains phenolic 
compounds that have antioxidant properties (264) that can inhibit in vitro oxidation of 
human low density lipoproteins (LDL) (187,366) and human high density lipoproteins 
(HDL) (367). Despite pro-oxidant effects ascribed to ethanol. van Golde et al (189) 
found that the polyphenols in red wine more than compensated. leading to a prolonged 
lag-time of copper-induced LDL oxidation. Ex vivo inhibition of LDL oxidation by red 
wine consumption with meals has also been demonstrated (190.368). Red wine 
polyphenols were reported to decrease lipid peroxidation in LDL isolated from subjects 3 
hours after ingestion of a meal enriched with the antioxidant phenols (369). Hydrophilic 
antioxidants may spare lipophilic antioxidants. Reduced ex vivo LDL oxidation after 
consumption of red wine taken without meals was found by Covas et al(370). In contrast 
to these results. Sharpe et al (209) and de Rijke et al (371) found that LDL isolated from 
subjects after daily consumption of red wine for 10 days and 4 weeks respectively. 
showed no change in susceptibility to copper-induced oxidation. 
The decrease in susceptibility of LDL to lipid peroxidation has been proposed as a 
reason for a lower incidence of atherosclerosis amongst red wine drinkers. Catechins are 
water-soluble flavonoids and include monomeric catechins such as (+ )-catechin, the 
predominant flavanol in red wine. Catechins possess antioxidant properties (78.372) and 
exert a more potent antioxidant effect than flavonols and polymeric anthocyanidins as 
measured by prolongation of lag time in in vitro copper-induced peroxidation studies of 
LDL (373). 
Chylomicrons (CM) are short-lived, large lipoproteins that contain products of fat 
digestion, which they transport in blood. Approximately 88% of their mass is TG. 8% is 
PL and 3% is cholesterol ester (374). Despite their high content of (dietary) TG that is 
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susceptible to lipid peroxidation, there have been few studies on the lipid peroxidation 
products in CM. 
Postprandial impainnent of endothelial function has been found to occur after 
consumption of meals rich in fat (237,375-377). Endothelial dysfunction is regarded as an 
important early event in, or marker of, atherosclerosis (378,379). A study by Williams et 
al (325) highlights the deleterious influence of lipid peroxidation products on endothelial 
function postprandially. This chapter describes the antioxidant effects of red wine on CM 
derived by a standardised protocol. 
The objectives were: 
i) to compare the lipid peroxidation status of a PDF A--containing oil that was ingested by 
volunteers in the fonn ofa milkshake with that of the lipids in the CM; 
ii) to compare the lipid peroxidation status and susceptibility of these CM to copper-
induced peroxidation, with and without concomitant consumption of red wine. A range of 
spectrophotometric assays was used to describe early and later products of lipid 
peroxidation, as a single assay is not considered sufficient to act as marker for the process 
(285,380); 
iii) plasma ORAC and catechin concentrations were detennined to establish whether 
antioxidant capacity or content was influenced by wine consumption in the postprandial 
phase. 
This appears to be the first investigation of the effects of red wine on the lipid 
peroxidation status of CM as no such studies have been found in the scientific literature. 
4.2. Methods 
4.2.1. Study design 
Fifteen healthy non-smoking volunteers who had no significant dyslipidaemia 
(confinned by lipid biochemistry: Results) and who were not taking any medication or 
vitamin supplements, were recruited. There were 11 males and 4 females, with a mean 
age of35 ± 8 years and a BMI of25.5 ± 4.4 kglm2• They refrained from consuming any 
alcoholic beverage and from taking strenuous exercise for 24 hours before the start of the 
study and they fasted for 12 hours. Subjects ingested a fat-containing meal over 10 
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minutes randomly on days 1 and 3, with or without wine. The fat bolus was in the fonn of 
a milkshake according to the oral fat tolerance test (OFIT), with an equivalent lipid mass 
of PUFA (sunflower) oil in the place of cream (381,382). They ingested 70mL (64g) 
oi1Jm2 body surface area (382,383), which contained 43g PUF A, 13g MUF A and 8g 
saturated fats: tota12380kJ. A time point of3 hours was selected for studying CM as this 
is generally accepted as a reliable time for isolating CM and reflecting plasma catechins 
(384,385,63). The concentrations of CD, LOOH and TBARS in 6 samples of the PUF A 
oil were detennined by the methods described below. The study used a commercially 
available blended red wine for which, owing to availability, 3 vintages were used. The 
alcohol by volume varied from 12-14%. The ORAC values were 24.8 ± 10.1 mmol 
trolox equivalents (TE)/L. The volume of wine consumed was calculated to deliver 0.35g 
alcohol/kg body mass. The study was approved by the University of Cape Town 
Research and Ethics Committee and written consent was given by the participants. 
4.2.2. Blood samples 
Blood samples were taken before and 3 hours after consumption of the meal with and 
without wine. Blood was taken by venepuncture into EDT A-containing (l gIL) vacutainer 
tubes and placed immediately on ice. Plasma was separated by centrifuging at 2000 x g 
for 15min at 4°C in a Beckman G8--6R centrifuge. Baseline and 3 hour plasma aliquots 
were stored under nitrogen at -20°C for future catechin and ORAC testing. 
4.2.3. Lipid and lipoprotein studies 
CM were separated from 3 hour plasma samples by density-graciient ultracentrifugation 
as described by Redgrave et ol (386). Briefly, the density of the plasma was adjusted to 
1.063g1mL by the addition ofNaBr (BDH Laboratory Supplies), with gentle mixing for 
30 minutes at 4°C. A density gradient of NaBr-NaCI was prepared by layering in an 
ultracentrifuge tube (Ultra--clear centrifuge tube, 14 x95 mm: Beckman Instruments, Palo 
Alto, CA) in the following order from the bottom of the tube: density-adjusted plasma 
4.0mL, NaBr-NaCI 3.0mL d=1.040glmL, NaBr-NaCI 3.0mL d=1.020glmL and NaCI 
3.0mL d=1.006g1mL. Ultracentrifugation was perfonned at 100000 x g for 42 minutes at 
10°C. The chylous supernatant was then quantitatively aspirated to l.5mL. 
127 
Plasma total cholesterol and PL concentrations were detennined using enzymatic 
colorimetric kits purchased from Boehringer Mannheim (Germany) (total cholesterol: 
CHOD-PAP method) and TG from Roche Diagnostics (Germany) (GPO-PAP method) 
on a Labsystems multiskan MS analyser. CM TG and PL concentrations were determined 
by the same methods, as described in the Appendix, for standardisation as reference mass 
for lipid peroxidation. 
4.2.4. In vitro oxidation 
CM isolated from subjects after they had consumed the meal, without and with wine, 
were tested for their susceptibility to copper-induced oxidative stress by the method of 
Esterbauer et al (387). Briefly, the CM samples were first diluted to the same lipid 
concentration to control the impact of the intervention, then diluted 5-fold with 9gIL 
NaCI, and CUS04 was added (final concentration 10",molJL). This suspension was 
incubated at 37°C and studied over 27 hours. Beginning at time 0, 200",L was removed, 
placed on ice and EDTA (final concentration 5mmolJL) terminated the oxidation 
reaction. There was an excellent correlation between CD and LOOH in this study (Figure 
4.1: ~ = 0.96, P <0.0001», confirming what had been previously published (387). 
Consequently only CD were assayed for evaluation of the oxidative susceptibility of CM. 
4.2.5. Lipid peroxidation analyses 
Concentrations of CD, LOOH and TBARS were measured in oil and CM by the 
spectrophotometric methods described in detail in the Appendix. 
Briefly, CD were measured at 234nm after appropriate dilution in cyclohexane 
(387,388). After mixing the CM suspension with cyclohexane, separation was enhanced 
by centrifugation (14 000 x g for 10 minutes at 4°), and the supernatant was assayed for 
CD. The inter-assay CV was < 2%. 
To determine LOOH, oil and the CM suspension were assayed in the presence of 
xylenol orange and Fe2+ in the ferrous oxidation/xylenol orange (FOX) assay that was 
adapted to enhance the solubility of non-polar compounds by including chloroform. 
Absorbance of the resulting Fe3+ -xylenol orange complex was measured at 560nm 
(389,390). The inter-assay CV was < 5%. 
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TBARS were measured according to the method of Asakawa et al (391). The samples 
were reacted with ferric chloride in a glycine buffer at pH =3.6 and thiobarbituric acid 
(TBA) reagent with sodium dodecyl sulphate. Absorbance was read at 532nm and the 
inter-assay CV was < 12%. 
4.2.6. Plasma catechin analysis 
A spectrophotometric method (392) was used to determine the plasma catechin 
concentrations after ingestion of the meal, with and without wine. Purchased (+)-catechin 
was used as a standard. The method is detailed in the Appendix. The intra- and inter-
assay CVs were < 2% and < 5% respectively. 
4.2.7. Plasma ORAC analysis 
The total antioxidant capacity of plasma against oxidative stress was assessed by the 
ORAC method as described by Cao et al (298,393) , and modified by Ou et al (299), 
detailed in the Appendix. Briefly, the loss of fluorescence of fluorescein in the presence 
of the peroxyl radical generator AAPH reflects the antioxidant activity and can be 
compared with a standard (Trolox). The reaction was followed from the addition of 
AAPH until completion. The intra-assay CV was 4.5% and the inter-assay CV was 
7.9010. 
4.2.8. Statistical analyses 
Data are expressed as mean ± SO. All statistical analyses were performed with the use 
of Graph pad PRISM software (version 3, San Diego, USA). The Student's t test was used 
to analyse the data, with the exception of the comparison of the oil and CM lipid 
peroxidation data, where the Mann-Whitney test was used. Statistical significance was 
accepted at P < 0.05. PRISM software was also used to determine the AUC values for 
ORAC analysis. 
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4.3. Results 
4.3.1. Lipid biochemistry 
The volunteers were nonnolipidaemic. The fasting plasma total cholesterol was 4.45 ± 
0.85 mmollL, plasma TO was 1.27 ± 0.65 mmollL and plasma PL 1.63 ± 0.41 mmollL. 
Plasma TO increased significantly after consumption of the meal without and with wine 
to 2.46 ± 1.55 mmollL (P = 0.0005) and 2.72 ± 1.83 mmollL (P = 0.0010) respectively, as 
well as PL to 1.99 ± 0.62 mmollL (P = 0.0031) without wine and 1.98 ± 0.57 mmollL (P 
= 0.0003) with wine. The changes in plasma TO and PL concentrations after consumption 
of the wine with the meal compared with the meal alone were not significant (P = 0.22 
and P = 0.91 respectively). 
Neither the TO nor the PL in the CM fraction changed significantly on consumption of 
wine. The TO concentration was 3.47 ± 3.53 mmollL without wine, and 3.62 ± 4.47 
mmollL with wine, P = 0.85 and the PL concentration was 0.46 ± 0.42 and 0.42 ± 0.48 
mmollL without and with wine respectively, P = 0.60. 
4.3.2. Lipid peroxidation status 
A comparison of the peroxidation status of the oil and the CM from the volunteers 
without the influence of red wine showed a significant decrease in the concentration of 
CD and TBARS in the CM. The CD concentrations were 16.5 ± 2.3 in the oil and 1.5 ± 
1.0 IlmoVg lipid in the CM, P = 0.0005, and the TBARS concentrations were 16.6 ± 4.4 
and 3.4 ± 4.2 IlmoVg, P = 0.0005 in the oil and CM respectively. The LOOH 
concentrations were very varied in the CM but not significantly different from the oil: 2.2 
± 0.2 and 29.4 ± 42.7 IlmoVg, P = 0.199 in the oil and CM respectively. There was no 
change in concentration of CD from the original oil and equivalent amount in the fatty 
meal after its preparation, P = 0.25. The peroxidation status of the CM after ingestion of 
the meal, with and without concomitant wine consumption, is shown in Table 4.1. There 
is no significant change after including wine in the meal. 
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Table 4.1. Peroxidation status of lipid in eM from OFTT without (-) and with 
(+) wine at 3 hours. 
-winel + winel Pvalue 
1.46 ± 1.01 1.75 ± 1.70 0.52 
CD 
29.43 ± 42.74 14.75 ± 15.34 0.15 
LOOD 
3.40 ±4.23 2.79±3.06 0.52 
TBARS 
I 
-~moVg TG + PL, mean ± SD, (n= 15) 
4.3.3. In vitro oxidation 
Figure 4.1 shows the kinetics of the oxidation ofCM as measured by CD and LOOH in 
the sample, which indicated close correlation between CD and LOOH. Each time point 
reflects a single value for each assay. The CD analysis extended over 26 hours, and the 
LOOH were analysed to 12 hours, to allow a comparison of CD and LOOH for their 
ability to reflect oxidative change in CM. As expected, the CD changes occurred ahead of 
LOOH changes. 
Figure 4.2 shows the summarised responses from 15 subjects ofCM to copper-induced 
lipid peroxidation over 27 hours as measured by CD. Table 4.2 shows the lag times and 
the calculated AVC from these experiments. Neither the lag times nor the AVC from the 
CM with and without wine consumption showed a significant difference: P = 0.54 and P 
= 0.49 respectively). 
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Figure 4.1. A comparison of the kinetics of the copper-dependent oxidation of 
CM as measured by CD and LOOH. 
132 
300 
0 no wine 
• plus wine 250 
..J 
a. 
+ 200 ~ 
~ Q 150 
0 
15 
E 100 
:::L 
50 
04-----~----~----~----~----~----~----~ 
o 240 480 720 960 1200 1440 1680 
Time (min) 
Figure 4.2. Comparison of the kinetics of copper-dependent oxidation of CM 
from 15 subjects as determined by CD, mean and SEM. 
Table 4.2. Lag times and AVC of copper-dependent oxidation of CM from 
OFTT without (-) and with (+) wine at 3 hours. 
-wine 
Lag times! 60±26.6 
AVCl by 27 hours 1.91 ±0.37 
Values are expressed as mean ± SD (n=15) 
I min, 2 JA.mol.minlg TG +PL x 104 
+ wine 
60±23.4 
2.00 ± 0.53 
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P value 
0.54 
0.49 
4.3.4. Plasma catechin and ORAC analyses 
Three hours after consumption of the OFfT meal alone, the plasma catechin 
concentration increased from the baseline of 0.20 ± 0.24 to 0.27 ± 0.22 IJmollL, and to 
0.41 ± 0.23 IJmollL after consumption of wine with the meal. After controlling for the 
baseline values, the consumption of red wine significantly increased the catechin 
concentration: P = 0.001. After controlling for the plasma ORAC values at baseline (9.59 
± 2.94 mmollL TE), the values after the meal alone (11.76 ± 2.99) were compared with 
those after the meal with wine (11.48 ± 3.21 mmollL TE). The difference was not 
statistically significant: P = 0.53. 
4.4. Discussion and conclusions 
Given the paucity of published information about lipid peroxidation products in CM, 
this study took a novel approach by comparing the lipid peroxidation products in a 
PUF A-rich edible oil with the CM produced after its consumption without and with red 
wine as an antioxidant. There are 3 chief findings from the study. Firstly, there is an 
altered profile of lipid peroxidation products between the oil and CM: CD decreased, 
LOOH were very variable, but not statistically significantly increased, and less TBARS 
were generated in CM. Secondly, the consumption of red wine increases plasma catechin 
concentration at the time of chylomicronaemia but the total antioxidant capacity of 
plasma appears not to be altered. Thirdly, the consumption of red wine together with 
PUF A-rich edible oils does not influence the lipid peroxidation status and susceptibility 
ofCM. 
In this study, a small number of subjects acted as their own controls to explore whether 
the concomitant consumption of wine and PUF A affected the lipid peroxidation state of 
CM Although only a single postprandial time-point was used to evaluate changes from 
the baseline state, the timing was appropriate for adequate CM collection for studies and 
for increasing plasma catechins that might be expected to influence oxidation status and 
susceptibility. A popular commercially available blended red wine with known 
antioxidant capacity was used in a dose that effected a significant increase in 
concentration in plasma catechins. Although a limited effect may be overlooked by this 
study, a dramatic effect of wine on postprandial (CM) lipid peroxidation was not found. 
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The PUF A-containing oil and the CM in this study contained low concentrations of 
peroxidation products that pertain to normal human nutrition. Additional complexity 
might be introduced by antioxidant additives to the oil but such additives are often not 
declared in South Africa. It was noted that the sunflower oil used in this study had a 
higher inherent concentration of total TBARS compared with the sunflower oils 
described in chapter 2 (16.6 ± 4.4 J.lffiollg lipid from the oil used in this study and 0.2 ± 
0.03 J.lffiollg oil described in chapter 2), although there was not much variation in the CD 
and LOOH concentrations. As discussed in Chapter 2, the inherent oxidation status 
depends on factors including fatty acid composition of the oil, which was not declared on 
the bottles of oil under study. Different storage conditions, as well as antioxidant 
additives could also result in different ratios of the peroxidation products in the different 
oils. 
The majority of studies have concentrated on the effects of wine on LDL to investigate 
protection against atherosclerosis by an antioxidant action. Oxidation of LDL is thought 
to play an important causative role in atherosclerosis (394,395). Frankel et al (187) were 
the first to show that red wine protected LDL from oxidation in vitro. The results of 
many subsequent studies have been inconsistent. A number of studies have shown that 
wine and its phenols have significant antioxidant activity as measured by increase in 
resistance of LDL to lipid peroxidation (375,396-399) whereas other studies found no 
change (400,401). 
Although PUF A are protected against peroxidation in their natural state, processing 
and storage may permit lipid peroxidation. The products of lipid. peroxidation are reactive 
and potentially harmful. After ingestion, PUF A are absorbed and incorporated into CM, 
which have a short half-life of approximately 35 minutes compared with that of LDL 
(approximately 2.5 days). That postprandial metabolic phenomena are associated with 
atherogenesis was first proposed by Zilversmit (402). Subsequently there has been 
confirmation of penetration and retention of CM remnants in carotid arteries of animals 
(403). CM remnants produced in response to a meal rich in PUFA have been found to be 
more injurious to fimctional responses by arteries when compared with a meal rich in 
saturated fatty acids (404). Further associations between CM and atherosclerosis have 
been made by Stender et al (405) whose in vivo study showed that CM remnants deposit 
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in arterial walls. Van Lenten et al (406) showed that CM remnants are able to promote 
cholesterol esterification and cholesterol ester accumulation in monocyte-macrophages. 
Ventura et al (407) reported increases of reactive oxygen species and plasma 
malondialdehyde concentration after a high fat meal. Consumption of red wine during the 
meal reduced this oxidative stress. Staprans et al (408) showed that the CD and TBARS 
in the diet were reflected in the CM but they were unable to detect LOOH. An increase in 
plasma TBARS was found after consumption of thermallY-Qxidised oil compared with a 
minimal increase after consumption of fresh oil (307). Furthermore, CM isolated after 
ingestion of oil containing high levels of oxidised fatty acids, were more susceptible to 
copper-induced lipid peroxidation. 
The different distribution of the lipid peroxidation products in the fat meal and the CM 
in the present study is interesting. The lower concentrations of CD and TBARS could be 
explained by a dilution with endogenously synthesised or exchanged saturated or neutral 
lipids. A change in lipid peroxidation status during the preparation of the meal was 
excluded as a contributing factor to the difference in peroxidation status. Further studies 
will be required to evaluate whether there is on-going peroxidation in the alimentary 
tract, or differential absorption of peroxidised fatty acids into the enterocyte, or 
differential utilisation of fatty acids for re-esterification into glycerolipids. It is possible 
that LOOH may be produced during oxidative stress in the enterocyte or lipoprotein. The 
short residence time of CM probably will not permit significant compositional changes 
attributable to lipid exchange between lipoproteins or modification due to enzymes. 
There was no significant difference in the peroxidation status, as measured by 
concentrations of CD, TBARS and LOOH, in the CM collected 3 hours after the fatty 
meal without and with red wine consumption (Table 4.1). There was also no difference in 
the susceptibility of these CM to copper-induced peroxidation. Interestingly, 1 individual 
displayed much greater susceptibility. This was not investigated further but may be 
speculated to be due to a difference in absorption of intrinsic antioxidants to CM 
(tocopherol). 
De Beer et al (409) found that the flavanol concentration of red wines is a good 
predictor of antioxidant capacity. The antioxidant activities of the major South African 
red wines were evaluated for their ability to inhibit in vitro microsomal lipid 
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peroxidation (410) and also demonstrated a wide variation in antioxidant capacity. The 
median ORAC value of the red wines in this study compared favourably with that of 
Maxwell et al (411) and Davalos et al (412). Although the mean plasma ORAC values in 
this study increased after consumption of the meal, with and without wine, the individual 
changes were not significant. A study by Alberti-Fidanza et al (413) showed similar 
plasma values, with the ORAC reaching a maximum at 90 minutes and sustaining it up to 
360 minutes after ingestion of the wine. The results described in the present study reflect 
an appropriate time point for the plasma ORAC determinations as catechin concentrations 
increase. Although there is clearly an increase of plasma catechins with wine ingestion, 
these do not appear to provide significant additional antioxidant activity at this point in 
time. The similarity of lipid peroxidation products in CM derived from the meals with 
and without wine is likely due to the fact that the water-soluble antioxidants in wine will 
not protect lipids against peroxidation. These antioxidants may penetrate tissues where 
lipoprotein oxidation or cellular responses may be favourably affected. Even if the 
antioxidant molecules are water-soluble, they could prevent oxidation of lipoproteins by 
providing better buffering of reactive oxygen species in this milieu and spare lipid-
soluble antioxidants and thus extend protection to lipoproteins indirectly. It could be 
speculated that antioxidant activity in tissue fluids may rely more on small molecules 
than large proteins that are not expected to enter tissue fluids. Plasma antioxidant activity 
may reside in phenols of amino acids in proteins as suggested by Ninfali and Aluigi 
(414). 
Although each of the 15 subjects displayed the same trend in their results, a larger 
cohort might identify individuals whose CM are more susceptible to oxidative stress. An 
optimal time for the study of CM was selected. Additional time points may provide better 
information about antioxidant activity of plasma and the consistency of the lipid 
peroxidation status of CM. Although wine in general has good antioxidant activity and 
the same cultivar was selected, there was a variation in ORAC values in the bottles of 
wine used in this study. Testing subjects with wines that have identical and higher ORAC 
values might be preferable. Since bioavailability of the antioxidants may also be affected 
by nutrient interactions (for example insoluble complex formation of tannins and proteins 
(398)), findings such as these may not apply to the free-living state. 
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The studies in this chapter indicated little direct benefit on the peroxidation status of 
lipids in eM with the consumption of wine. despite increasing catechins and possibly 
other antioxidant compounds. The findings are however limited to a small number of 
subjects. and a single blended red wine and edible oil. Although no significant 
peroxidation is found between ingestion of fat and secretion of chylomicrons, this 
investigation can compare chylomicrons and ingested oil for changes. Should such 
changes occur. they are likely to be detected as the circulating time of chylomicrons is 
short, preventing significant oxidation or exchange during residence time in plasma. 
Since there is no a priori expectation of discriminant uptake of oxidised or normal fatty 
acids for chylomicron assembly, any sample would be appropriate. but systematic 
examination of such phenomenon could be done on future studies. 
The absence of an effect in the plasma does not exclude a beneficial effect in tissues. 
Final proof of antioxidant benefits would require an outcome study rather than a 
mechanistic study. Nevertheless. the findings in this study suggest that there is a need to 
further explore the path that PUF A follow in digestion, absorption and lipoprotein 
metabolism, and possible differences amongst individuals in susceptibility. When such 
information is available, better directed studies can be undertaken, including studies with 
edible oils that have undergone more peroxidation. 
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CHAPTER 5. THE EFFECTS OF ACUTE WINE CONSUMPTION ON 
FLOW-MEDIATED DILATATION OF THE BRACHIAL ARTERY 
5.1. Background 
The vascular endotheliwn is a cell layer that lines all blood vessels. It occurs between 
the lwnen and the vascular smooth muscle and secretes potent vasorelaxing substances 
such as nitric oxide (NO) and vasoconstricting substances such as endothelin-l. 
Prior to the 1970s, it was thought to be relatively inert. Since then, however, research 
has shown that it is capable of a nwnber of important functions including control over 
vascular growth and arterial tone (415). In 1986, Ludmer et al reported that endothelial 
dysfunction was associated with atherosclerosis (416), and this has subsequently been 
confIrmed (417,418). Endothelial dysfunction has been demonstrated in asymptomatic 
children and young adults with risk factors for atherosclerosis, such as familial 
hypercholesterolaemia, lipoprotein(a) and smoking (419,420). An association between 
coronary risk factors (hyperlipidaemia, diabetes mellitus, hypertension and smoking) and 
endothelial dysfunction was described by Hashimoto et al (421). Endothelial dysfunction 
has also been shown to be reversible under certain conditions: Clarkson et al found oral 
treatment of young hypercholesteraemic adults with L-arginine, a precursor of NO, 
improved endotheliwn-dependent dilatation signifIcantly (422). It has been reported that 
oxidative stress has a role to play in impaired endothelial function, from the action of 
some reactive oxygen species (ROS) that have not been efficiently removed by 
endogenous antioxidant systems. These ROS might decrease the local production of NO 
by reacting with scavenging NO itself, thereby producing peroxynitrite. Alternatively, 
ROS might affect the expression levels of eNOS (423). 
Research has shown that flow-mediated dilatation (FMD) is endotheliwn-dependent 
(424): in arteries with healthy endothelium, increased blood flow causes dilatation of the 
artery (425) via release of NO (426,427). This does not occur during endothelial 
dysfunction where there is an impaired vasodilatation response (428). Determination of 
FMD of the brachial artery is a non-invasive, ultrasonographio-imaging method for 
detecting endothelial dysfunction. The technique was fIrst described by Celermajer et al 
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in 1992 (419). Arterial diameter is measured in response to an increase in shear stress 
caused by increased blood flow after occlusion of the artery, causing endothelium-
dependent dilatation, and to sublingual trinitroglycerine (TNG), an endothelium-
independent donor of NO. FMD has been shown to be stable and reproducible and to 
correlate well with invasive intra-arterial testing of coronary endothelial function (429). 
Changes in arterial diameter of 0.1 to 0.2 mm can be detected accurately (420,430). 
Guidelines for the technique have been published (426). The objectives of this study 
were: 
i) To determine the brachial artery diameter, blood flow and FMD after acute 
consumption of red wine 
ii) To determine the effect ofice and TNG on the brachial artery diameter. 
5.1. Methods 
5.1.1. Study design 
Sixteen healthy, norr-smoking volunteers, who were not taking any medication, were 
recruited into the study. There were 11 males (aged 23-48) years and 5 females (aged 
19-43) years. Informed consent for the study was obtained from the subjects after the 
procedure had been explained to them. They refrained from exercise within 4-6 hours 
before the study. Testing was performed in the morning, after a 12-hour fast, in a quiet 
room. An Acuson 128 ultrasound machine equipped with a 7.5 MHz Acuson 7 transducer 
was used to generate images of the artery, which were recorded on a Sony VHS video 
recorder. The blood pressure and pulse rates were recorded at baseline, 30, 60 and 120 
minutes by means of an Accutorr Plus Datascope electronic blood pressure recorder. 
Each subject consumed the same cultivar and vintage of red wine as 0.35 g ethanollkg 
body mass over 5 minutes. This was considered a moderate volume of wine, and was the 
same mass of ethanol used in the chylomicron study (Chapter 4). 
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5.3.1. Blood pressure and pulse rate determination 
Neither the systolic blood pressures nor the pulse rates varied significantly from 
baseline to 2 hours after wine consumption, (p =: 0.397 and P =: 0.338 respectively). The 
trend for the diastolic blood pressures to decrease was not significant (P = 0.054), (Table 
5.1). 
5.3.2. Brachial artery diameter, calculated blood flow and FMD assessment 
6.0 
5.5 
*** *** *** 
E 5.0 E 
-I 4.5 4.0 
" Q 3.5 
3.0 
2.5 
baseline +30 min +60 min +120 min 
Figure 5.4. The resting brachial artery diameter at baseline and over 2 
hours after wine consumption. *** denotes a significance olP < 0.0001, relative 
to the baseline. 
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Figure 5.5. The FMD percent change at baseline and over 2 hours after wine 
consumption. *** denotes a significance or P < 0.0001, and * denotes a 
significance or P < 0.05, relative to the baseline. 
The diameter of the artery increased significantly from baseline to 120 minutes after 
consumption of wine (P < 0.0001). The mean baseline diameter of 3.8 increased to 4.4, 
4.4 and 4.5 mm respectively at 30, 60 and 120 minutes. At the same time, the FMD 
decreased significantly: 10.8% at baseline, 6.1% at 30 minutes, 5.6% at 60 minutes and 
7.5% at 120 minutes after wine consumption (P < 0.0001). The blood flow in mL/min 
was calculated from the measured diameter of the artery and the measured blood velocity 
(Figure 5.2), and did not change significantly from baseline (P = 0.6). 
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Figure 5.6. The effects of ice and TNG on the brachial artery diameter at 
baseline and 60 minutes. *** denotes a significance of P < 0.0001. 
There was a statistically significant difference between the ice response before and after 
wine consumption, but no significant difference between the TNG responses 
(P < 0.000 I and P = 0.07 respectively). 
The physiological range of brachial artery diameter was taken as that between the 
diameter on ice immersion (vasoconstriction) and that after TNG absorbance 
(vasodilatation). Out of interest, the baseline diameter was compared with this excursion. 
which was expressed as a percentage calculation as: 
(baseline diamete .... minimum diameter (ice»! (maximum diameter (TNG)-minimum diameter (ice» 
expressed as a percent 
The mean brachial artery diameter for the group was 3.8 ± 0.6mm. The mean baseline 
excursion for the group was 91.3 ± 25.3%. Investigating whether males and females 
differed in their percent excursion showed there was no gender effect (84.6 ± 27.3 and 
106.0 ± 11.4% respectively, P = 0.12). Similar analyses revealed no difference in the 
percent excursion between the younger and older halves of the subjects studied (87.5 ± 
29.6 and 95.0 ± 21.4% respectively, P = 0.57). The baseline upper and lower half of the 
excursion percent was not associated with different FMD responses (9.9 ± 3.2 and 11.8 ± 
5.8% FMD change respectively, P = 0.43). 
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5.3.3. ORAC analysis 
The red wines that were analysed for their total antioxidant potential showed a range 
of results with a mean of 10.25 ± 9.33 mmollL TE. 
5.4. Discussion and conclusions 
Brachial artery FMD is a non-invasive technique for assessing endothelial (vascular) 
function and dysfunction. Research studies have shown that abnormal endothelial 
function may be associated with atherosclerosis. This study found that a representative 
sample of red wine mediated vascular dilatation but did not improve FMD. The diameter 
of the brachial artery increased significantly within 30 minutes and lasted at least 2 hours 
after consumption of red wine. The systolic and diastolic blood pressure, heart rate and 
blood flow did not change significantly. FMD decreased significantly over 2 hours. 
The subjects investigated in this small study were all healthy. It is possible that a larger 
number of subjects might have experienced an increase in FMD response. It is also 
possible that if subjects with CHD were studied or if the effects of chronic consumption 
of wine were studied, they might have revealed an increase in FMD status. 
Previous studies have found that a number of factors may interfere with FMD, for 
example some studies found that FMD is inversely related to baseline arterial diameter 
(431,432), as did the present study. Ageing is associated with decreased FMD (433), as is 
sleep apnea (434), hypertension (435), circadian variations (436) and mental stress (437). 
In the present study, FMD was not affected by age. Other factors that may impede FMD 
are hypercholesteraemia, diabetes mellitus, smoking (active and passive) and obesity 
(428), as well as high-fat meals (194,438), although some have found that the latter did 
not influence endothelial function (193). Meals rich in thermally-stressed fats have also 
been shown to reduce FMD (325). Levenson et al found significant gender differences in 
shear-mediated vasoconstriction and vasodilatation, with women constricting more than 
men during arterial occlusion, and also undergoing greater changes in FMD than men 
(439). FMD was also found to be significantly different between men and women after a 
high-fat meal, with men showing a greater reduction in FMD than women (440). This 
study did not show significant gender differences. 
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Burns et al found that the capacity of different red wines to act as vasodilators varied 
widely, and this capacity was associated with concentrations of specific phenolic 
compounds in the wine, in particular resveratrol and catechins (441). Red wine has been 
found to inhibit endothelin-l synthesis, possibly by modifying tyrosine kinase signalling 
in the endothelial cells (442). The antioxidant activity of the same cultivar and vintage of 
red wine in this study showed wide variation by ORAC, as did the South African red 
wines described by de Beer et ai, by inhibition of microsomal lipid peroxidation (410). 
The activity of the red wines in this study was also lower than that described in the 
chylomicron study (chapter 4): 10.3 ± 9.3 compared with 24.8 ± 10.1 mmollL TE. It is 
possible that wine with higher ORAC values might have resulted in an improved FMD 
response in this study. A study described by Hashimoto et al found no significant change 
in systolic blood pressure, a significant increase in heart rate and resting brachial artery 
diameter and, contrary to this study, a significant improvement in FMD by 120 minutes 
after red wine consumption (192). They, however, employed more than double the 
amount of wine compared with this study: 0.8g1kg body mass compared with 0.35g1kg 
body mass, for alcohol, in this study. 
It is possible that a dose-related response would reveal a volume of ethanol that would 
result in improved FMD. It is also possible that beneficial effects on FMD relate only to 
specific time points beyond those studied in the volunteers. As shown in Chapter 4, the 
catechin concentration is increased at 3 hours postprandially. It is, however, likely that 
the catechins being water-soluble compounds like alcohol, could achieve increased 
concentration within the time course of the present FMD studies. 
As the arterial diameter approaches its physiological limit upon dilating in response to 
the wine, its capacity to dilate becomes impaired. The baseline diameter relative to the 
physiological excursion did not seem to influence the response in FMD. There was a 
trend for the brachial artery to increase in diameter upon nitrite absorbance from baseline 
compared with 60 minutes after wine consumption. The decrease in response to ice 
immersion was significant. The duration of this effect is not known, but is likely to be the 
same as the vasodilatory effect. 
This study did not attempt to separate the different effects of the antioxidant phenols 
and the ethanol on vascular function. Wine is a complex beverage made up of a large 
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number of different polyphenols as well as ethanol. Some studies have found that 
phenols, particularly the flavonoids in wine, improve endothelial function (195) and that 
the ethanol in the wine is not implicated (69,192). Red grape juice has been found to 
improve FMD (443), suggesting that ethanol is not essential. However, it may still 
provide additional improvement in endothelial function. Future studies will include 
assessment of the effects of water and ethanol consumption on endothelial function 
parameters. 
In conclusion, this study found that arterial diameter increased after acute consumption 
of red wine, although FMD did not. Although this may appear to be a negative finding for 
health benefits of wine, this study considered only a small number of healthy rather than 
diseased subjects and only viewed the impact over 2 hours. Extending the duration of 
study and including larger numbers of subjects may result in an increase in FMD status. 
150 
CHAPTER 6. FINAL DISCUSSION AND CONCLUSIONS 
Atherosclerosis is a major cause of morbidity and mortality in developed cOWltries, and 
is rising rapidly in developing coWltries (263). In the Western Cape region of South 
Africa, despite it being predominantly a population regarded as similar to a developing 
COWltry, CVD is the leading cause of mortality. The significantly lower rate of CVD in 
France compared with other developed cOWltries, in spite of their similar dietary intake, 
prompted the French Paradox hypothesis, in which it was claimed that the increased 
consumption of red wine was responsible for the decreased CHD. 
The social and economic implications of diseases such as CHD and cancer are huge. 
These common disorders have prompted extensive research into risk factors associated 
with influencing their prevalence and outcome. Amongst these factors is the detrimental 
effect of free radicals, and more specifically the free radicals associated with lipid 
peroxidation. Lipid peroxidation is a biochemical process that involves the potentially 
harmful constellation of products such as CD, LOOH and TBARS. These products have 
been implicated in deleterious health effects. Alcoholic beverages, in particular red wine, 
contain antioxidant phenolic compoWlds that may reduce lipid peroxidation. Many 
studies have been Wldertaken over the last several decades to prove this, and there is 
much support for the hypothesis that the moderate consumption of red wine is 
antithrombotic, antimicrobial and anticarcinogenic. Alcohol abuse, however, is a very 
real problem worldwide, and is responsible for many murders and road accidents. The 
incidence of fetal alcohol syndrome in South Africa is the highest in the world (33,35). In 
order that even moderate use can be advised, it is important to establish conclusively 
from epidemiological and experimental studies, as well as outcome studies, whether or 
not real benefits can be attained. 
In this thesis, novel approaches were set up to determine the antioxidant effects of wine 
and some potentially beneficial effects on health, namely: 
• A study to determine the protective effect of wine in an emulsion with PUF A-
containing oil Wldergoing heating; 
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• A study involving volunteers who consmned a PUF A milkshake with and without 
wine, to determine the effects of the wine on the postprandial TG-containing 
lipoproteins; 
• A study in which marinating red meat in red wine prior to cooking, was used to 
determine whether the wine could alter the progression of lipid peroxidation and 
prevent heat-induced production of lipid peroxidation products and 
• A study which detennined the effect of moderate consmnption of wine on 
vascular function. 
The studies described in this thesis present some interesting findings. There is a large 
variation in the inherent lipid peroxidation in MUF A and PUF A oils, as well as in red 
meat, both freshly-bought and after cooking. Wines have antioxidant potential 
demonstrable by the oil-boil assays as well as ORAC. 
Research into lipid peroxidation is relatively new. A broad range of products needs to 
be examined and simpler, more affordable techniques for research into CHD in the 
developing world is desirable. In the studies described in this thesis, the methods used are 
applicable to most general laboratories. Recourse to more sophisticated analytical 
techniques were limited. Refined investigations to identify reactive intermediates and 
their products as well as to determine detailed compositional analysis of the substrates, 
could promote better targeted analyses. 
Foodstuffs need care for their production and storage. Preparation techniques need 
consideration for avoidance of oxidative stress. The lipid peroxide contents in foodstuffs 
need systematic description and if confirmed to be noxious, may need to be declared with 
other nutrients on the label, along with fatty acid composition. Meats other than red meat 
may be more susceptible to lipid peroxidation although their PUF A reserves may be 
larger, but only future systematic studies can elucidate this. 
While meat may be regarded simply as a protein source by the public, pHs have already 
assmned importance in health-conscious members of the public. The wide variation in 
lipid peroxidation products even within the same class of oils, indicates the need for 
studies to improve the qualities of oil. This may need legislation and deliberate quality 
control should further studies prove these lipid peroxidation products to be important. 
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The impact of food preparation (temperature and cooking environment for example) 
needs to be investigated in detail for its influence on lipid peroxidation and health as 
heated edible oils are forming a large part ofthe diet of convenience foods. 
Wme appears to be a good generic antioxidant which may not be amenable to much 
improvement, except that white wines have the potential to approach red wines in their 
antioxidant capabilities. Although it is not the objective of this thesis to compare the 
antioxidant effects of vitamins with the antioxidant effects of phenolic compounds in 
wine, it must be noted that the results of2 large meta-analyses published in 2003 (444) 
and 2004 (445), showed that supplementation with various doses of antioxidant vitamins 
(A, C, E and ~arotene) had no beneficial effect on the risk of CVD or gastrointestinal 
cancers. Individual compounds such as resveratrol may provide future avenues of 
beneficial products with scope to be pharmaceutical agents. Application of wine as a 
marinade may preserve meat, but appears to confer little benefit in moderate cooking. 
More intense cooking may perhaps show benefit, especially in a baste to protect the 
exterior during grilling. Experiments from this thesis indicate scope for wine as an 
antioxidant in preparation of food where water and oil are heated in a mixture. This, as 
well as using wine in copper or iron pots, needs to be explored. 
Studies on vascular function need to be interpreted with caution. The variability of 
brachial artery diameter along with its excursion from minimum to maximum is an 
interesting observation that may be useful to explore in understanding vascular behavior, 
and may provide insight into disease. The impact on FMD was apparently not positive, 
but has to be extended to chronic exposure or longer follow-up and contrasted with FMD 
on similar diameters achieved with other conditions. 
Ultimately, beneficial effects of alcoholic beverages are best evaluated with an outcome 
study on healthy individuals with a healthy lifestyle but at moderate to high risk for CHD, 
by conducting a controlled, randomised, long-term, single-blind study. The studies in 
this thesis, where healthy chiefly Caucasian individuals were used, did not show any 
obviously different results for the different ethnic griups, but detailed studies of large 
numbers may reveal differences. In the meantime, epidemiological studies as well as 
experimental studies are suggestive of health benefits from moderate consumption. In this 
thesis, additional experimental evidence has been found for use of wine in food 
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preparation after demonstrating susceptibility and variability in foods, with prevention of 
oxidation under conditions simulating cooking. These findings contribute to the body of 
knowledge and clearly indicate no deleterious effects; they may even be interpreted as 
supportive of a beneficial effect 
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APPENDIX 
GENERAL MEmODS 
1.1 PREPARATION OF PLASMA AND SERUM FROM BWOD SAMPLES 
Blood samples were taken by venepuncture into either EDTA-containing (lgIL) 
vacutainer tubes (for plasma) or SST vacutainer tubes (for serum) and placed on ice. 
Plasma and serum were separated by centrifuging at 2000 x g for 15 minutes at 4°C in a 
Beckman GS-6R centrifuge. If storage was necessary, samples were stored under 
nitrogen gas at -20°C in the dark. 
1.2 LIPID EXTRACTION 
The Bligh and Dyer method (353), a modification ofthe Folch method (354) was used. 
1.2.1 Lipid extraction of meat samplesi 
To 3.2mL homogenised meat was added 4mL chloroform and 8mL methanol. The 
mixture was vortexed for 30 seconds and then centrifuged at 2000 x g for 15min at 4°C in 
a Beckman Gs-6R centrifuge. The monophasic supernatant was transferred to a separate 
tube on ice. Lipid extraction was performed twice more on the meat pellet, adding 2.4mL 
phosphate buffer, 3mL chloroform and 6mL methanol and again transferring the 
supernatant to the same separate tube. After this, 10mL chloroform and 10mL phosphate 
buffer were added to the monophasic supernatant, effectively separating the phases into 
an upper aqueous phase containing the non-lipid compounds and an organic phase 
containing the purified lipids. After centrifugation at 2000 x g for 15min at 4°C to ensure 
complete phase separation, the top phase was removed by aspiration and the bottom 
phase was dried in a Pierce Reacti-therm 1Il (Reacti-Vap Ill) module (Rockford, IL) 
under nitrogen gas. The dried lipid extract was then re-suspended in 200",L chloroform 
and aliquoted into 10 x 20llL tubes. The extracts were again dried under nitrogen as 
above. Samples were stored under nitrogen gas at -20°C in the dark. 
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1.3 LIPID ANALYSES 
1.3.1 TG and PL assays on lipid extracts: 
The GPO-PAP kit was used for the TG assay and the MPR2 kit was used for PL assay. 
The inter-assay CV for TG and PL was <3%. 
Standard curves using the supplied calibrators were prepared, from O-IOOllg in a total 
volume of 500llL with physiological saline for TG and 0-151lg choline in a total volume 
of 30llL for PL. To each standard was added 50llL ethanol and 151lL 1 % v/v Triton X-
100, and the mixtures were vortexed for 20 seconds. Likewise, to each dried lipid extract 
sample was added 50 ilL ethanol and 15 ilL Triton, followed by vortexing, and the 
addition of 500 ilL physiological saline. The samples were vortexed again. Precinorm® 
U was used as a commercial quality control calibrator, at a volume of IOIlL, and assayed 
in a similar manner to the standards and samples. Into transparent Greiner microtitre plate 
wells were added 1251lL of each of the standards and samples and 1251lL assay reagent, 
followed by mixing. The TG and PL reactions were complete after 30 minutes at room 
temperature, after which the absorbance was read in a Labsystems spectrophotometer at 
50Onm. The mass ofTG and PL in each sample was derived from linear regression of the 
set of standards. Since the standard was a choline solution, a conversion from choline to 
PL was made. The conversion factor was supplied in the kit insert. 
1.3.2 Plasma and chylomicron TG assay: 
The GPO-PAP kit was used for the TG assay. The inter-assay CV was 2.4%. 
The standard curve was prepared as above but to a total volume of 50llL with 9g/L saline 
in the microtitre well. Plasma samples and chylomicron samples were likewise prepared 
by the addition of IOIlL plasma/chylomicron sample to a final volume of 50llL with 
saline. After mixing, 250llL of the reagent was added and after a final shaking to mix, the 
reaction was complete after 20 minutes at room temperature. The absorbance was read in 
a Labsystems spectrophotometer at 500nm.The mass of TG in each sample was derived 
from linear regression of the set of standards as in 1.3.1. Precinorm U was used as a 
calibrator. 
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1.3.3 Serum and ehylomieron PL assay: 
The MPR2 kit was used for the PL assay. The inter-assay CV was 2.1%. 
The standard curve was prepared as in 1.3.1, but to a total volume of 30j.lL with saline. 
Serum samples were prepared by the addition of 1 OJ.lL to a total volume of 30j.lL, while 
chylomicron samples were prepared by adding 15 j.lL sample to 15 j.lL saline. After 
mixing, 220j.lL of the reagent was added. The reaction was complete after 20 minutes at 
room temperature, the absorbance was read at 500nm and the mass ofPL in each sample 
was derived as in 1.3.1. 
1.3.4 Plasma T.Chol assay: 
The MPR 1 kit was used for the assay. The inter-assay CV was 2.0%. 
The standard curve was prepared with the use of a known human cholesterol plasma 
sample, in 9w'f., saline, to a total volume of 50j.lL, at 0-5 0 j.lg. Plasma samples were 
prepared by adding 10j.lL of the sample to a total volume of 50j.lL in saline. To each of 
the standards and the samples was added 250j.lL of kit reagent in a microtitre plate well. 
These were mixed by shaking and allowed to react for 10 minutes at room temperature, 
after which the absorbance was read at 500nm. Precinorm U was used as the calibrator. 
1.4 LIPID PEROXIDATION ANALYSES 
1.4.1 CD measurement: 
The method as described by Esterbauer et al and Pryor et al was used (387,388). 
Dried extracted lipid samples, chylomicron samples and oil samples were dissolved in 
cyclohexane at appropriate dilutions, vortexed for 30 seeonds and the absorbance of each 
sample was read at 234nm using the GBC spectrophotometer. To each lipid extract was 
added 2mL cyclohexane, to 100j.lL of each chylomicron sample was added ImL 
cyclohexane and the dilution for oil to be in the range for the assay was 0.5-2mglmL 
cyclohexane. The concentration of the CD in the samples was calculated by molar 
extinction. The extinction coefficient is 2.95 x 104M1cm-l. The inter-assay CV was < 
2%. 
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1.4.2 LOOD measurement: 
The method as described by Jiang et al was used (389,390). 
Dried extracted lipid samples were dissolved in 100llL chlorofonn. 100llL chylomicron 
samples and oil samples at 0.5-2mglmL chlorofonn were mixed with 350llL methanol 
and then vortexed for 30 seconds to generate a monophase. To each tube was added 50llL 
deionised water and 600llL FOX 2 Mix (l part FOX 2A (2.5mM ferrous ammoniwn 
sulphate, 2mM Xylenol Orange (3, 3'-bis[N, N-di (Carboxymethyl}-aminomethyl]-o-
cresolsulfonephthalein) (sodiwn salt) (Sigma Chemical Co, St Louis, USA) in 0.25M 
H2S04) to 4.5 parts FOX 2B (0.88mM BHT in methanol», prepared fresh for each assay. 
FeCh and BHP standard curves were prepared as below in tables 1 and 2. Standard 
reactions were prepared by adding 50llL of each standard solution to lOOIlL chlorofonn 
and 350llL methanol, and then vortexing. FOX 2 Mix was added as above. Reactions 
were complete after 20 minutes at room temperature, after which the absorbance was read 
spectrophotometrica11y at 56Onm. The consistency of each assay was assessed by 
calculating the ratio of BHP to FeCI3 when absorbance was 1. The ratio was 5-6. The 
concentration of LOOH in each sample was detennined by interpolation of non-linear 
regression ofthe t-BHP standards. The inter-assay CV was < 5%. 
Table 1. FeCb standard curve for the LOOH assay (stock FeCb solution is4mM). 
Volume FeCI) Concentration 
stock solution 
VolumeHzO 
of working 
Mass of FeCI) 
(JlL) 
(JLL) 
solution (mM) in assay (nmol) 
100 900 0.4 20 
200 800 0.8 40 
400 600 1.6 80 
500 500 2.0 100 
800 200 3.2 160 
158 
Table 2. I- SliP "l aooard cun~ for the LOOIl IbS;IY l~lock UIII' solution is 
6.%n..\llloo "orkIng solulion is 0.6% m:'ll : Iml. siock solulhm + 11011. delonist>d 
" ·wln). 
Volume Concenlralion 
Volume 11:0 Mass or IlHP 
working or \\ork inA 
in assay (nll1Ol ) htL) 
solution (1111\1) solution (~L) 
40 96. 0,03 1.5 
200 800 0.14 7 
400 600 0. 28 14 
800 200 O.Sfi 28 
120~L stork 880 0 .... 42 
Figure I . The LOOH reaction. 
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IA3 TUAKS nwa<Un'fl1ol'n i i 
TSARS ... ·ere meas.ured aemnl,ng .o.1Ie melhod or Asa~aw;l rllli (J91). "i,1l minor 
modifications. 
Dm:d utracted lipId \ampIC~ ... -ere d,»Qh'ed m 5O!-IL chloroform Fif,y ilL ch~lomicmn 
\ampl"" and 5OJoL oil ~mples III 1_IOmglmL chloroform were mi\w wllh 50!.L 0.27g<;< 
FL<:k Fifty I.L ethanol ... -ere IlIldI:d '0 lhe: .u~ measunng lot31 TBARS (,TSARS) (or 
those jlI',,~nl at ,1Jc, tmle uf t"Slm, a~ 1'..:11115 I~ gcnet:lIC'd dUling le5,"II) and SO!,L 
0.22g% BIIT hill anHO~ldall\) (UI nh;u1<)l) "'Cff :sdtkd 10 the: IUbc~ mcll5uring free 
TBARS IITO,\RS) lor lh()\C jlI'hen! as the lime orl~ung) Water and chloroform blllnl.~ 
"ue prepared b) adding 5OJ,L dcionl.s.cd water and SOt,L chloroform 10 the :.,1m"" 
reagcm~ a' abo\'c. All i'/Implc .. were lonued for 10 second-.. mu.eel ... ,th 75OJ,1L gl)cine 
buffer i bufrers helo"), and 7$OtJL TOA reagen. (0.5g~ I -T BA. O.Jg~ SDS) and 
lonc\l'(/ again Sumplc~ ... ere healed ;II 100 C for 20 mlnllles. File hundrc-d ilL glao:ial 
ace llc acid and ImL chloroform ... ere added 10 each sampk. AII .... mpk~ ... ere I'onc~cd 
JrKl then ccmrifugcd at 2000 ~ g for 15 mInutes. Tho: ab.'oOfb.lna o f lhe aqueou~ 
,upcmalant "II. determined ~pcClropholOmetricall) 31 5-lOnm. The ma~lmum :m..orptlon 
I~ nonnan)' at 5.1211111. but only a 5-lOnm filter .. -as al-ailable The '"ter~) cv "'1J;!. < 
12% 
( .".. 
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1.5 CAnCHI N ASSAY 
The method of Ki" its t l uJ (392) was used. 
One mL sampln of EDTA plasma. ~pa:ro ali dI:scribed in 1.1 llbove. v.'CII: mixed wilh 
3mL 1&fL BHT in melllJllloi to precipitate IOC proteins. The mixture was centrifuged at 
2000 x i for IS minutes at4·C and the 5UpcmatWlI was reoct.,.'<1 l'Iilh 0.15g alLlll1inium 
oxide (wlid-phase alumina) for 4-6 hours in lhe dark at 4°C under nitrogen gas for 
ooSOfJltion onlo the solid- phase. provCIlting the inK'l'fcrcrw.:e of turbidity in the assay, 
After ccntrifugalion al 2000 x II for IS minules al 4"C. the alwnina was washed l'Iim 3m!. 
ether, dried under nitrogen and then 1I:!lCied by \·ortexing for I minute with ImL p-
diml!1hyl amino cinlUlmaldehydc (DMACA) reagenl (6mmollL in methanol:perohluric 
lICid:wllter 8: 1.1 "Iv). The alumina 1'I'll$ centrifuged al 2000 x g al 4°C for 2 minutes and 
lhe absorbance oflhe supcmaWllI was measu!'Cd al 637nm al 7 minutes in a Labs)'Slcms 
SpttlrophOlomcler. A slMdard curve of (+)<alcehin (0 - ~) dissolved in 
BIITfmcilwnol lind dilulCd in de-catcehini5ed plasma lhal had been pre-rcacled with 
alumina 10 remove any calCChins. was similarly Ircalcd to delermine lbe unImov.TI 
catechin cOIlCenlJ'8lions. The inl~f'-il$/ily CV was <$%. 
J,6 ORAC ASSAY 
The method as dCSl:ribed by ClIO rl oJ (298,393) .nd modified by 011 rl uI (2991 "as 
""". 
All ORAC analyses on wine and plasma were pcrfonncd on a nuorescenc:~ 
5p;Xuuphotoml!1er in whi le flal-bottomed 96-wcl1 microtilre pJaIcS. Red " inc was diluted 
10 I: 1600 in 7SI1U'IIOl!l.. phospbale buffer. pll -7.4. One hundred " L plasma was mixed 
"im 200pL clharollO pra:ipilate proleins and after t'Ctllri fuplion al 2000 x g ror ISm;n 
at 4"C. the 6cproteinised plasma sample ",as d ilulCd 400-fokl in 7Smmol/l. phosplllie 
buffer. pH - 7.4. Fifty "L samples of ..... inc and plasng "-ere added to SO "L buffer. 100 
"L Iloon:scein (3',6'-4ih)'droxyspiro[isobcruo(un.n-1 P IIj.9'[9hl- xanlhenl-J-
OOI!'}(disodium) (96nmo1/l.) and I()() "I. M PH (2,2'-azo-bi!, (2- amidinopropanc 
dihydrochloridc) (101mmolll). The tuCtion "'lIS follo"\-d from the mldilion of AAPH 
unli l completion. "ith nuores<:cnce readings being taken al time 0, 2min. Smin and ~v~ry 
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2.3 PHYSIOLOGICAL SALINE 
NaCI 
Distilled H20 
9g 
to lL 
3. MATERIALS AND INSTRUMENTS 
Chemicals and instruments were obtained from the following suppliers: 
AEC Amersham Company, South Africa Labsystems Multiskan MS analyzer 
spectrophotometer, polysorp Nunc 
microtitre plates, 96-well, flat-bottomed, 
white 
BDH Chemicals 
Boehringer Mannheim, Germany 
Fluka Chemie, Switzerland 
Fried Electric, Haifa, Israel 
G. Pohl-Boskamp GmbH and Co, 
Germany 
Kardia, Netherlands 
Laboratory and Scientific Equipment 
Company (Pty) Ltd, South Africa 
Merck Laboratory Supplies (Pty) Ltd, 
South Africa 
Pierce, Rockford, IL 
Roche Diagnostics, Germany 
Scientific Associates cc, T okai, South 
Africa 
Methanol, chloroform, cyclohexane 
MPRI T.Chol kit 
MPR2PLkit 
Ferric chloride 
FREED Electric magnetic stirrer 
Nitrolingual Spray (TNG) 
Acuson 128 ultrasound machine 
Acuson 7.5 MHz transducer 
Greiner microtitre plates, 96-well, flat-
bottomed, transparent; Kimble 
borosilicate 13 x 100 mm tubes 
Glacial acetic acid, perchloric acid 
Reacti-therm 111 (Reacti-Vap 111) 
heating/stirring module 
GPO-PAP TG kit, Precinorm U 
commercial calibrator 
Digitron 2006T Thermocouple 
thermometer; Physitemp NJ07013 probe 
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Sigma Chemical Company, St Louis, 
USA/Sigma-Aldrich Chemie, Gennany 
AAPH, aluminium oxide, t-BHP, BHT, 
(+)-catechin, DMACA, fluorescein, 
perchloric acid, TBA. Trolox 
SMM Instruments, Set Point Technology, Varian Cary Eclipse fluorescence 
South Africa spectrophotometer 
Sony Corporation, South Africa. VHS Videorecorder SVO 9500 MDP 
South African Scientific Products, South Jouan MR 1812 microcentrifuge 
Africa. 
The VirTis Company, Gardiner, NY 
Varian Analytical Instruments, Walton-
on-Thames, UK 
Vitalcare Technologies, South Africa 
WliSam Scientific and Precision 
Equipment, South Africa 
VirTis handishear 
Gas Chromatograph Varian CP - 3800 
Electronic BP apparatus Acutorr Plus 
(Datascope ) 
GBC UV NIS spectrophotometer 
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